id	sid	tid	token	lemma	pos
aji-28	1	1	_	_	PUNCT
aji-28	2	1	_	_	PUNCT
aji-28	3	1	_	_	PUNCT
aji-28	4	1	_	_	PUNCT
aji-28	5	1	_	_	PUNCT
aji-28	6	1	_	_	PUNCT
aji-28	7	1	_	_	PUNCT
aji-28	8	1	_	_	PUNCT
aji-28	9	1	_	_	PUNCT
aji-28	10	1	_	_	PUNCT
aji-28	11	1	_	_	PUNCT
aji-28	12	1	_	_	PUNCT
aji-28	13	1	_	_	PUNCT
aji-28	14	1	_	_	PUNCT
aji-28	15	1	_	_	PUNCT
aji-28	16	1	_	_	PUNCT
aji-28	17	1	_	_	PUNCT
aji-28	18	1	_	_	PUNCT
aji-28	19	1	_	_	PUNCT
aji-28	20	1	_	_	PUNCT
aji-28	21	1	_	_	PUNCT
aji-28	22	1	_	_	PUNCT
aji-28	23	1	_	_	PUNCT
aji-28	24	1	_	_	PUNCT
aji-28	25	1	_	_	PUNCT
aji-28	26	1	_	_	PUNCT
aji-28	27	1	_	_	PUNCT
aji-28	28	1	_	_	PUNCT
aji-28	29	1	_	_	PUNCT
aji-28	30	1	_	_	PUNCT
aji-28	31	1	_	_	PUNCT
aji-28	32	1	_	_	PUNCT
aji-28	33	1	_	_	PUNCT
aji-28	34	1	_	_	PUNCT
aji-28	35	1	_	_	PUNCT
aji-28	36	1	_	_	PUNCT
aji-28	37	1	_	_	PUNCT
aji-28	38	1	_	_	PUNCT
aji-28	39	1	_	_	PUNCT
aji-28	40	1	_	_	PUNCT
aji-28	41	1	_	_	PUNCT
aji-28	42	1	_	_	PUNCT
aji-28	43	1	_	_	PUNCT
aji-28	44	1	_	_	PUNCT
aji-28	45	1	_	_	PUNCT
aji-28	46	1	_	_	PUNCT
aji-28	47	1	_	_	PUNCT
aji-28	48	1	_	_	PUNCT
aji-28	49	1	_	_	PUNCT
aji-28	50	1	_	_	PUNCT
aji-28	51	1	_	_	PUNCT
aji-28	52	1	_	_	PUNCT
aji-28	53	1	_	_	PUNCT
aji-28	54	1	_	_	PUNCT
aji-28	55	1	_	_	PUNCT
aji-28	56	1	_	_	PUNCT
aji-28	57	1	_	_	PUNCT
aji-28	58	1	_	_	PUNCT
aji-28	59	1	_	_	PUNCT
aji-28	60	1	_	_	PUNCT
aji-28	61	1	_	_	PUNCT
aji-28	62	1	_	_	PUNCT
aji-28	63	1	_	_	PUNCT
aji-28	64	1	_	_	PUNCT
aji-28	65	1	_	_	PUNCT
aji-28	66	1	_	_	PUNCT
aji-28	67	1	_	_	PUNCT
aji-28	68	1	_	_	PUNCT
aji-28	69	1	_	_	PUNCT
aji-28	70	1	_	_	PUNCT
aji-28	71	1	_	_	PUNCT
aji-28	72	1	_	_	PUNCT
aji-28	73	1	_	_	PUNCT
aji-28	74	1	_	_	PUNCT
aji-28	75	1	_	_	PUNCT
aji-28	76	1	_	_	PUNCT
aji-28	77	1	_	_	PUNCT
aji-28	78	1	_	_	PUNCT
aji-28	79	1	_	_	PUNCT
aji-28	80	1	_	_	PUNCT
aji-28	81	1	_	_	PUNCT
aji-28	82	1	_	_	PUNCT
aji-28	83	1	_	_	PUNCT
aji-28	84	1	_	_	PUNCT
aji-28	85	1	_	_	PUNCT
aji-28	86	1	_	_	PUNCT
aji-28	87	1	_	_	PUNCT
aji-28	88	1	_	_	PUNCT
aji-28	89	1	_	_	PUNCT
aji-28	90	1	_	_	PUNCT
aji-28	91	1	_	_	PUNCT
aji-28	92	1	_	_	PUNCT
aji-28	93	1	_	_	PUNCT
aji-28	94	1	_	_	PUNCT
aji-28	95	1	_	_	PUNCT
aji-28	96	1	_	_	PUNCT
aji-28	97	1	_	_	PUNCT
aji-28	98	1	_	_	PUNCT
aji-28	99	1	_	_	PUNCT
aji-28	100	1	_	_	PUNCT
aji-28	101	1	_	_	PUNCT
aji-28	102	1	*	*	PUNCT
aji-28	102	2	corresponding	correspond	VERB
aji-28	102	3	author	author	NOUN
aji-28	102	4	:	:	PUNCT
aji-28	102	5	e	e	NOUN
aji-28	102	6	-	-	NOUN
aji-28	102	7	mail	mail	NOUN
aji-28	102	8	:	:	PUNCT
aji-28	102	9	salamakasang2@gmail.com	salamakasang2@gmail.com	PROPN
aji-28	102	10	;	;	PUNCT
aji-28	102	11	asian	asian	ADJ
aji-28	102	12	journal	journal	NOUN
aji-28	102	13	of	of	ADP
aji-28	102	14	immunology	immunology	NOUN
aji-28	102	15	3(1	3(1	NUM
aji-28	102	16	):	):	PUNCT
aji-28	102	17	291	291	NUM
aji-28	102	18	-	-	SYM
aji-28	102	19	297	297	NUM
aji-28	102	20	,	,	PUNCT
aji-28	102	21	2020	2020	NUM
aji-28	102	22	;	;	PUNCT
aji-28	102	23	article	article	NOUN
aji-28	102	24	no.aji.60171	no.aji.60171	VERB
aji-28	102	25	immunological	immunological	ADJ
aji-28	102	26	response	response	NOUN
aji-28	102	27	to	to	ADP
aji-28	102	28	recombinant	recombinant	ADJ
aji-28	102	29	hepatitis	hepatitis	PROPN
aji-28	102	30	b	b	PROPN
aji-28	102	31	virus	virus	NOUN
aji-28	102	32	(	(	PUNCT
aji-28	102	33	hbv	hbv	NOUN
aji-28	102	34	)	)	PUNCT
aji-28	102	35	vaccine	vaccine	NOUN
aji-28	102	36	among	among	ADP
aji-28	102	37	vaccinated	vaccinated	ADJ
aji-28	102	38	adults	adult	NOUN
aji-28	102	39	in	in	ADP
aji-28	102	40	kaduna	kaduna	PROPN
aji-28	102	41	south	south	PROPN
aji-28	102	42	,	,	PUNCT
aji-28	102	43	nigeria	nigeria	PROPN
aji-28	102	44	salama	salama	PROPN
aji-28	102	45	k.	k.	PROPN
aji-28	102	46	ibrahim1	ibrahim1	PROPN
aji-28	102	47	*	*	PROPN
aji-28	102	48	,	,	PUNCT
aji-28	102	49	yetunde	yetunde	PROPN
aji-28	102	50	faidero	faidero	PROPN
aji-28	102	51	isa2	isa2	PROPN
aji-28	102	52	,	,	PUNCT
aji-28	102	53	hosea	hosea	PROPN
aji-28	102	54	s.	s.	PROPN
aji-28	102	55	hamafyelto3	hamafyelto3	PROPN
aji-28	102	56	,	,	PUNCT
aji-28	102	57	lohya	lohya	PROPN
aji-28	102	58	nimzing4	nimzing4	NOUN
aji-28	103	1	and	and	CCONJ
aji-28	103	2	zakka	zakka	PROPN
aji-28	103	3	sheyin5	sheyin5	PROPN
aji-28	103	4	1	1	NUM
aji-28	103	5	hope	hope	NOUN
aji-28	103	6	for	for	ADP
aji-28	103	7	the	the	DET
aji-28	103	8	village	village	NOUN
aji-28	103	9	child	child	NOUN
aji-28	103	10	foundation	foundation	PROPN
aji-28	103	11	,	,	PUNCT
aji-28	103	12	km	km	PROPN
aji-28	103	13	2	2	NUM
aji-28	103	14	along	along	ADP
aji-28	103	15	kachia	kachia	PROPN
aji-28	103	16	road	road	PROPN
aji-28	103	17	,	,	PUNCT
aji-28	103	18	p.m.b	p.m.b	NOUN
aji-28	103	19	.	.	PROPN
aji-28	103	20	500	500	NUM
aji-28	103	21	,	,	PUNCT
aji-28	103	22	kaduna	kaduna	PROPN
aji-28	103	23	state	state	PROPN
aji-28	103	24	,	,	PUNCT
aji-28	103	25	nigeria	nigeria	PROPN
aji-28	103	26	.	.	PUNCT
aji-28	104	1	2	2	NUM
aji-28	104	2	apin	apin	NOUN
aji-28	104	3	/	/	SYM
aji-28	104	4	pepfar	pepfar	ADJ
aji-28	104	5	laboratory	laboratory	NOUN
aji-28	104	6	,	,	PUNCT
aji-28	104	7	juth	juth	ADV
aji-28	104	8	,	,	PUNCT
aji-28	104	9	p.m.b	p.m.b	ADJ
aji-28	104	10	.	.	PROPN
aji-28	104	11	2076	2076	NUM
aji-28	104	12	,	,	PUNCT
aji-28	104	13	jos	jos	PROPN
aji-28	104	14	plateau	plateau	PROPN
aji-28	104	15	state	state	PROPN
aji-28	104	16	,	,	PUNCT
aji-28	104	17	jos	jos	PROPN
aji-28	104	18	,	,	PUNCT
aji-28	104	19	nigeria	nigeria	PROPN
aji-28	104	20	.	.	PUNCT
aji-28	105	1	3	3	NUM
aji-28	105	2	department	department	NOUN
aji-28	105	3	of	of	ADP
aji-28	105	4	medical	medical	ADJ
aji-28	105	5	microbiology	microbiology	NOUN
aji-28	105	6	,	,	PUNCT
aji-28	105	7	university	university	NOUN
aji-28	105	8	of	of	ADP
aji-28	105	9	jos	jos	PROPN
aji-28	105	10	,	,	PUNCT
aji-28	105	11	plateau	plateau	NOUN
aji-28	105	12	state	state	PROPN
aji-28	105	13	,	,	PUNCT
aji-28	105	14	nigeria	nigeria	PROPN
aji-28	105	15	.	.	PUNCT
aji-28	106	1	4	4	NUM
aji-28	106	2	department	department	NOUN
aji-28	106	3	of	of	ADP
aji-28	106	4	microbiology	microbiology	NOUN
aji-28	106	5	,	,	PUNCT
aji-28	106	6	university	university	NOUN
aji-28	106	7	of	of	ADP
aji-28	106	8	maiduguri	maiduguri	PROPN
aji-28	106	9	,	,	PUNCT
aji-28	106	10	p.m.b	p.m.b	ADJ
aji-28	106	11	.	.	PROPN
aji-28	106	12	1069	1069	NUM
aji-28	106	13	,	,	PUNCT
aji-28	106	14	maiduguri	maiduguri	PROPN
aji-28	106	15	,	,	PUNCT
aji-28	106	16	borno	borno	PROPN
aji-28	106	17	state	state	PROPN
aji-28	106	18	,	,	PUNCT
aji-28	106	19	nigeria	nigeria	PROPN
aji-28	106	20	.	.	PUNCT
aji-28	107	1	5	5	NUM
aji-28	107	2	department	department	NOUN
aji-28	107	3	of	of	ADP
aji-28	107	4	medical	medical	ADJ
aji-28	107	5	laboratory	laboratory	NOUN
aji-28	107	6	science	science	NOUN
aji-28	107	7	,	,	PUNCT
aji-28	107	8	university	university	PROPN
aji-28	107	9	of	of	ADP
aji-28	107	10	jos	jos	PROPN
aji-28	107	11	,	,	PUNCT
aji-28	107	12	plateau	plateau	NOUN
aji-28	107	13	state	state	PROPN
aji-28	107	14	,	,	PUNCT
aji-28	107	15	jos	jos	PROPN
aji-28	107	16	,	,	PUNCT
aji-28	107	17	nigeria	nigeria	PROPN
aji-28	107	18	.	.	PUNCT
aji-28	108	1	authors	author	NOUN
aji-28	108	2	’	'	PUNCT
aji-28	108	3	contributions	contribution	NOUN
aji-28	108	4	this	this	DET
aji-28	108	5	work	work	NOUN
aji-28	108	6	was	be	AUX
aji-28	108	7	carried	carry	VERB
aji-28	108	8	out	out	ADP
aji-28	108	9	in	in	ADP
aji-28	108	10	collaboration	collaboration	NOUN
aji-28	108	11	among	among	ADP
aji-28	108	12	all	all	DET
aji-28	108	13	authors	author	NOUN
aji-28	108	14	.	.	PUNCT
aji-28	109	1	author	author	NOUN
aji-28	109	2	ski	ski	PROPN
aji-28	109	3	designed	design	VERB
aji-28	109	4	the	the	DET
aji-28	109	5	study	study	NOUN
aji-28	109	6	,	,	PUNCT
aji-28	109	7	wrote	write	VERB
aji-28	109	8	the	the	DET
aji-28	109	9	protocol	protocol	NOUN
aji-28	109	10	and	and	CCONJ
aji-28	109	11	the	the	DET
aji-28	109	12	first	first	ADJ
aji-28	109	13	draft	draft	NOUN
aji-28	109	14	of	of	ADP
aji-28	109	15	the	the	DET
aji-28	109	16	manuscript	manuscript	NOUN
aji-28	109	17	.	.	PUNCT
aji-28	110	1	author	author	PROPN
aji-28	110	2	hsh	hsh	PROPN
aji-28	110	3	performed	perform	VERB
aji-28	110	4	the	the	DET
aji-28	110	5	statistical	statistical	ADJ
aji-28	110	6	analysis	analysis	NOUN
aji-28	110	7	.	.	PUNCT
aji-28	111	1	author	author	NOUN
aji-28	111	2	yfi	yfi	PROPN
aji-28	111	3	managed	manage	VERB
aji-28	111	4	the	the	DET
aji-28	111	5	laboratory	laboratory	NOUN
aji-28	111	6	analyses	analysis	NOUN
aji-28	111	7	of	of	ADP
aji-28	111	8	the	the	DET
aji-28	111	9	study	study	NOUN
aji-28	111	10	.	.	PUNCT
aji-28	112	1	authors	author	NOUN
aji-28	112	2	ln	ln	ADJ
aji-28	112	3	and	and	CCONJ
aji-28	112	4	zs	zs	PROPN
aji-28	112	5	supervised	supervise	VERB
aji-28	112	6	and	and	CCONJ
aji-28	112	7	monitored	monitor	VERB
aji-28	112	8	the	the	DET
aji-28	112	9	entire	entire	ADJ
aji-28	112	10	work	work	NOUN
aji-28	112	11	.	.	PUNCT
aji-28	113	1	all	all	DET
aji-28	113	2	authors	author	NOUN
aji-28	113	3	read	read	VERB
aji-28	113	4	and	and	CCONJ
aji-28	113	5	approved	approve	VERB
aji-28	113	6	the	the	DET
aji-28	113	7	final	final	ADJ
aji-28	113	8	manuscript	manuscript	NOUN
aji-28	113	9	.	.	PUNCT
aji-28	114	1	article	article	NOUN
aji-28	114	2	information	information	PROPN
aji-28	114	3	editor(s	editor(s	PROPN
aji-28	114	4	):	):	PUNCT
aji-28	114	5	(	(	PUNCT
aji-28	114	6	1	1	X
aji-28	114	7	)	)	PUNCT
aji-28	114	8	dr	dr	PROPN
aji-28	114	9	.	.	PROPN
aji-28	114	10	darko	darko	PROPN
aji-28	114	11	nozic	nozic	PROPN
aji-28	114	12	,	,	PUNCT
aji-28	114	13	university	university	PROPN
aji-28	114	14	of	of	ADP
aji-28	114	15	belgrade	belgrade	PROPN
aji-28	114	16	,	,	PUNCT
aji-28	114	17	serbia	serbia	PROPN
aji-28	114	18	.	.	PUNCT
aji-28	115	1	reviewers	reviewer	NOUN
aji-28	115	2	:	:	PUNCT
aji-28	115	3	(	(	PUNCT
aji-28	115	4	1	1	X
aji-28	115	5	)	)	PUNCT
aji-28	115	6	manoj	manoj	PROPN
aji-28	115	7	sharma	sharma	PROPN
aji-28	115	8	,	,	PUNCT
aji-28	115	9	csk	csk	PROPN
aji-28	115	10	himachal	himachal	PROPN
aji-28	115	11	pradesh	pradesh	PROPN
aji-28	115	12	agriculture	agriculture	PROPN
aji-28	115	13	university	university	PROPN
aji-28	115	14	palampur	palampur	PROPN
aji-28	115	15	,	,	PUNCT
aji-28	115	16	india	india	PROPN
aji-28	115	17	.	.	PUNCT
aji-28	116	1	(	(	PUNCT
aji-28	116	2	2	2	X
aji-28	116	3	)	)	PUNCT
aji-28	116	4	ibrahim	ibrahim	PROPN
aji-28	116	5	m.	m.	PROPN
aji-28	116	6	s.	s.	PROPN
aji-28	116	7	shnawa	shnawa	PROPN
aji-28	116	8	,	,	PUNCT
aji-28	116	9	qassim	qassim	PROPN
aji-28	116	10	university	university	PROPN
aji-28	116	11	,	,	PUNCT
aji-28	116	12	iraq	iraq	PROPN
aji-28	116	13	.	.	PUNCT
aji-28	117	1	complete	complete	ADJ
aji-28	117	2	peer	peer	NOUN
aji-28	117	3	review	review	NOUN
aji-28	117	4	history	history	NOUN
aji-28	117	5	:	:	PUNCT
aji-28	117	6	http://www.sdiarticle4.com/review-history/60171	http://www.sdiarticle4.com/review-history/60171	PROPN
aji-28	117	7	received	receive	VERB
aji-28	117	8	10	10	NUM
aji-28	117	9	june	june	PROPN
aji-28	117	10	2020	2020	NUM
aji-28	117	11	accepted	accept	VERB
aji-28	117	12	17	17	NUM
aji-28	117	13	august	august	PROPN
aji-28	117	14	2020	2020	NUM
aji-28	117	15	published	publish	VERB
aji-28	117	16	27	27	NUM
aji-28	117	17	august	august	PROPN
aji-28	117	18	2020	2020	NUM
aji-28	117	19	abstract	abstract	ADJ
aji-28	117	20	aim	aim	NOUN
aji-28	117	21	:	:	PUNCT
aji-28	117	22	the	the	DET
aji-28	117	23	aim	aim	NOUN
aji-28	117	24	of	of	ADP
aji-28	117	25	this	this	DET
aji-28	117	26	study	study	NOUN
aji-28	117	27	was	be	AUX
aji-28	117	28	to	to	PART
aji-28	117	29	determine	determine	VERB
aji-28	117	30	the	the	DET
aji-28	117	31	rate	rate	NOUN
aji-28	117	32	of	of	ADP
aji-28	117	33	immunological	immunological	ADJ
aji-28	117	34	response	response	NOUN
aji-28	117	35	to	to	ADP
aji-28	117	36	recombinant	recombinant	ADJ
aji-28	117	37	hepatitis	hepatitis	PROPN
aji-28	117	38	b	b	PROPN
aji-28	117	39	virus	virus	NOUN
aji-28	117	40	(	(	PUNCT
aji-28	117	41	hbv	hbv	NOUN
aji-28	117	42	)	)	PUNCT
aji-28	117	43	vaccine	vaccine	NOUN
aji-28	117	44	among	among	ADP
aji-28	117	45	vaccinated	vaccinated	ADJ
aji-28	117	46	residents	resident	NOUN
aji-28	117	47	of	of	ADP
aji-28	117	48	kaduna	kaduna	PROPN
aji-28	117	49	south	south	PROPN
aji-28	117	50	senatorial	senatorial	PROPN
aji-28	117	51	district	district	NOUN
aji-28	117	52	.	.	PUNCT
aji-28	118	1	materials	material	NOUN
aji-28	118	2	and	and	CCONJ
aji-28	118	3	methods	method	NOUN
aji-28	118	4	:	:	PUNCT
aji-28	118	5	this	this	PRON
aji-28	118	6	was	be	AUX
aji-28	118	7	a	a	DET
aji-28	118	8	cross	cross	ADJ
aji-28	118	9	-	-	ADJ
aji-28	118	10	sectional	sectional	ADJ
aji-28	118	11	study	study	NOUN
aji-28	118	12	of	of	ADP
aji-28	118	13	180	180	NUM
aji-28	118	14	consented	consented	ADJ
aji-28	118	15	residents	resident	NOUN
aji-28	118	16	of	of	ADP
aji-28	118	17	kaduna	kaduna	PROPN
aji-28	118	18	south	south	PROPN
aji-28	118	19	senatorial	senatorial	PROPN
aji-28	118	20	district	district	NOUN
aji-28	118	21	,	,	PUNCT
aji-28	118	22	kaduna	kaduna	PROPN
aji-28	118	23	state	state	PROPN
aji-28	118	24	who	who	PRON
aji-28	118	25	have	have	AUX
aji-28	118	26	been	be	AUX
aji-28	118	27	vaccinated	vaccinate	VERB
aji-28	118	28	with	with	ADP
aji-28	118	29	hbv	hbv	NOUN
aji-28	118	30	vaccines	vaccine	NOUN
aji-28	118	31	.	.	PUNCT
aji-28	119	1	systematic	systematic	ADJ
aji-28	119	2	sampling	sampling	NOUN
aji-28	119	3	technique	technique	NOUN
aji-28	119	4	and	and	CCONJ
aji-28	119	5	written	write	VERB
aji-28	119	6	informed	informed	ADJ
aji-28	119	7	consent	consent	NOUN
aji-28	119	8	were	be	AUX
aji-28	119	9	used	use	VERB
aji-28	119	10	in	in	ADP
aji-28	119	11	recruiting	recruit	VERB
aji-28	119	12	subjects	subject	NOUN
aji-28	119	13	for	for	ADP
aji-28	119	14	this	this	DET
aji-28	119	15	study	study	NOUN
aji-28	119	16	.	.	PUNCT
aji-28	120	1	five	five	NUM
aji-28	120	2	(	(	PUNCT
aji-28	120	3	5mls	5mls	NOUN
aji-28	120	4	)	)	PUNCT
aji-28	120	5	of	of	ADP
aji-28	120	6	venous	venous	ADJ
aji-28	120	7	blood	blood	NOUN
aji-28	120	8	was	be	AUX
aji-28	120	9	collected	collect	VERB
aji-28	120	10	from	from	ADP
aji-28	120	11	each	each	DET
aji-28	120	12	subject	subject	NOUN
aji-28	120	13	after	after	ADP
aji-28	120	14	filling	fill	VERB
aji-28	120	15	a	a	DET
aji-28	120	16	structured	structured	ADJ
aji-28	120	17	questionnaire	questionnaire	NOUN
aji-28	120	18	.	.	PUNCT
aji-28	121	1	sera	sera	NOUN
aji-28	121	2	obtained	obtain	VERB
aji-28	121	3	from	from	ADP
aji-28	121	4	180	180	NUM
aji-28	121	5	subject	subject	NOUN
aji-28	121	6	were	be	AUX
aji-28	121	7	qualitatively	qualitatively	ADV
aji-28	121	8	assayed	assayed	ADJ
aji-28	121	9	for	for	ADP
aji-28	121	10	hbv	hbv	NOUN
aji-28	121	11	markers	marker	NOUN
aji-28	121	12	using	use	VERB
aji-28	121	13	skytech	skytech	NOUN
aji-28	121	14	profile	profile	NOUN
aji-28	121	15	and	and	CCONJ
aji-28	121	16	quantitatively	quantitatively	ADV
aji-28	121	17	tested	test	VERB
aji-28	121	18	for	for	ADP
aji-28	121	19	anti	anti	ADJ
aji-28	121	20	-	-	ADJ
aji-28	121	21	hbs	hbs	ADJ
aji-28	121	22	using	use	VERB
aji-28	121	23	elisa	elisa	NOUN
aji-28	121	24	kit	kit	NOUN
aji-28	121	25	(	(	PUNCT
aji-28	121	26	enzyme	enzyme	NOUN
aji-28	121	27	linked	link	VERB
aji-28	121	28	immunoassay	immunoassay	NOUN
aji-28	121	29	for	for	ADP
aji-28	121	30	qualitative	qualitative	ADJ
aji-28	121	31	and	and	CCONJ
aji-28	121	32	quantitative	quantitative	ADJ
aji-28	121	33	determination	determination	NOUN
aji-28	121	34	of	of	ADP
aji-28	121	35	antibodies	antibody	NOUN
aji-28	121	36	to	to	ADP
aji-28	121	37	hepatitis	hepatitis	PROPN
aji-28	121	38	b	b	PROPN
aji-28	121	39	surface	surface	NOUN
aji-28	121	40	antigen	antigen	ADV
aji-28	121	41	by	by	ADP
aji-28	121	42	dia.pro	dia.pro	ADJ
aji-28	121	43	original	original	ADJ
aji-28	121	44	research	research	NOUN
aji-28	121	45	article	article	NOUN
aji-28	121	46	ibrahim	ibrahim	PROPN
aji-28	121	47	et	et	PROPN
aji-28	121	48	al	al	PROPN
aji-28	121	49	.	.	PROPN
aji-28	121	50	;	;	PUNCT
aji-28	122	1	aji	aji	PROPN
aji-28	122	2	,	,	PUNCT
aji-28	122	3	3(1	3(1	NUM
aji-28	122	4	):	):	PUNCT
aji-28	122	5	291	291	NUM
aji-28	122	6	-	-	SYM
aji-28	122	7	297	297	NUM
aji-28	122	8	,	,	PUNCT
aji-28	122	9	2020	2020	NUM
aji-28	122	10	;	;	PUNCT
aji-28	122	11	article	article	NOUN
aji-28	122	12	no.aji.60171	no.aji.60171	VERB
aji-28	122	13	292	292	NUM
aji-28	122	14	in	in	ADP
aji-28	122	15	italy	italy	PROPN
aji-28	122	16	)	)	PUNCT
aji-28	122	17	.	.	PUNCT
aji-28	123	1	the	the	DET
aji-28	123	2	results	result	NOUN
aji-28	123	3	from	from	ADP
aji-28	123	4	the	the	DET
aji-28	123	5	laboratory	laboratory	NOUN
aji-28	123	6	analysis	analysis	NOUN
aji-28	123	7	of	of	ADP
aji-28	123	8	the	the	DET
aji-28	123	9	specimens	specimen	NOUN
aji-28	123	10	were	be	AUX
aji-28	123	11	computed	compute	VERB
aji-28	123	12	using	use	VERB
aji-28	123	13	spss	spss	PROPN
aji-28	123	14	version	version	NOUN
aji-28	123	15	21	21	NUM
aji-28	123	16	.	.	PUNCT
aji-28	124	1	results	result	NOUN
aji-28	124	2	:	:	PUNCT
aji-28	124	3	the	the	DET
aji-28	124	4	results	result	NOUN
aji-28	124	5	represent	represent	VERB
aji-28	124	6	51.7	51.7	NUM
aji-28	124	7	%	%	NOUN
aji-28	124	8	seropositive	seropositive	ADJ
aji-28	124	9	of	of	ADP
aji-28	124	10	hbsab	hbsab	NOUN
aji-28	124	11	among	among	ADP
aji-28	124	12	subjects	subject	NOUN
aji-28	124	13	with	with	ADP
aji-28	124	14	male	male	NOUN
aji-28	124	15	having	have	VERB
aji-28	124	16	18.9	18.9	NUM
aji-28	124	17	%	%	NOUN
aji-28	124	18	and	and	CCONJ
aji-28	124	19	female	female	NOUN
aji-28	124	20	had	have	VERB
aji-28	124	21	32.8	32.8	NUM
aji-28	124	22	%	%	NOUN
aji-28	124	23	which	which	PRON
aji-28	124	24	statistically	statistically	ADV
aji-28	124	25	showed	show	VERB
aji-28	124	26	no	no	DET
aji-28	124	27	significant	significant	ADJ
aji-28	124	28	difference	difference	NOUN
aji-28	124	29	between	between	ADP
aji-28	124	30	the	the	DET
aji-28	124	31	groups	group	NOUN
aji-28	124	32	(	(	PUNCT
aji-28	124	33	χ	χ	NOUN
aji-28	124	34	2	2	NUM
aji-28	124	35	=	=	SYM
aji-28	124	36	3.612,p	3.612,p	NUM
aji-28	124	37	=	=	SYM
aji-28	124	38	.43	.43	NUM
aji-28	124	39	)	)	PUNCT
aji-28	124	40	see	see	VERB
aji-28	124	41	table	table	NOUN
aji-28	124	42	1	1	NUM
aji-28	124	43	.in	.in	PUNCT
aji-28	124	44	respect	respect	NOUN
aji-28	124	45	to	to	ADP
aji-28	124	46	age	age	NOUN
aji-28	124	47	,	,	PUNCT
aji-28	124	48	26	26	NUM
aji-28	124	49	–	–	PUNCT
aji-28	124	50	30years	30years	NUM
aji-28	124	51	age	age	NOUN
aji-28	124	52	grouped	group	VERB
aji-28	124	53	had	have	VERB
aji-28	124	54	the	the	DET
aji-28	124	55	highest	high	ADJ
aji-28	124	56	sero	sero	ADJ
aji-28	124	57	-	-	PUNCT
aji-28	124	58	conversion	conversion	NOUN
aji-28	124	59	rate	rate	NOUN
aji-28	124	60	of	of	ADP
aji-28	124	61	10.0	10.0	NUM
aji-28	124	62	%	%	NOUN
aji-28	124	63	.	.	PUNCT
aji-28	125	1	this	this	PRON
aji-28	125	2	however	however	ADV
aji-28	125	3	,	,	PUNCT
aji-28	125	4	was	be	AUX
aji-28	125	5	not	not	PART
aji-28	125	6	statistically	statistically	ADV
aji-28	125	7	significant	significant	ADJ
aji-28	125	8	(	(	PUNCT
aji-28	125	9	table	table	NOUN
aji-28	125	10	2	2	NUM
aji-28	125	11	)	)	PUNCT
aji-28	125	12	(	(	PUNCT
aji-28	125	13	χ	χ	X
aji-28	125	14	2	2	NUM
aji-28	125	15	=	=	SYM
aji-28	125	16	5.604	5.604	NUM
aji-28	125	17	,	,	PUNCT
aji-28	125	18	p	p	X
aji-28	125	19	=	=	NOUN
aji-28	125	20	.70	.70	NUM
aji-28	125	21	)	)	PUNCT
aji-28	125	22	.	.	PUNCT
aji-28	126	1	for	for	ADP
aji-28	126	2	the	the	DET
aji-28	126	3	number	number	NOUN
aji-28	126	4	of	of	ADP
aji-28	126	5	vaccine	vaccine	NOUN
aji-28	126	6	shots	shot	VERB
aji-28	126	7	(	(	PUNCT
aji-28	126	8	table	table	NOUN
aji-28	126	9	3	3	NUM
aji-28	126	10	)	)	PUNCT
aji-28	126	11	taken	take	VERB
aji-28	126	12	,	,	PUNCT
aji-28	126	13	40.6	40.6	NUM
aji-28	126	14	%	%	NOUN
aji-28	126	15	of	of	ADP
aji-28	126	16	those	those	PRON
aji-28	126	17	who	who	PRON
aji-28	126	18	completed	complete	VERB
aji-28	126	19	their	their	PRON
aji-28	126	20	vaccination	vaccination	NOUN
aji-28	126	21	were	be	AUX
aji-28	126	22	sero	sero	NOUN
aji-28	126	23	-	-	PUNCT
aji-28	126	24	converted	convert	VERB
aji-28	126	25	followed	follow	VERB
aji-28	126	26	by	by	ADP
aji-28	126	27	those	those	PRON
aji-28	126	28	who	who	PRON
aji-28	126	29	took	take	VERB
aji-28	126	30	two	two	NUM
aji-28	126	31	shots	shot	NOUN
aji-28	126	32	with	with	ADP
aji-28	126	33	4.4	4.4	NUM
aji-28	126	34	%	%	NOUN
aji-28	126	35	while	while	SCONJ
aji-28	126	36	those	those	PRON
aji-28	126	37	who	who	PRON
aji-28	126	38	had	have	VERB
aji-28	126	39	one	one	NUM
aji-28	126	40	shot	shot	NOUN
aji-28	126	41	had	have	VERB
aji-28	126	42	6.7	6.7	NUM
aji-28	126	43	%	%	NOUN
aji-28	126	44	hbsab	hbsab	NOUN
aji-28	126	45	(	(	PUNCT
aji-28	126	46	χ	χ	NOUN
aji-28	126	47	2	2	NUM
aji-28	126	48	=	=	SYM
aji-28	126	49	30.665	30.665	NUM
aji-28	126	50	,	,	PUNCT
aji-28	126	51	p	p	X
aji-28	126	52	<	<	X
aji-28	126	53	.001	.001	NUM
aji-28	126	54	)	)	PUNCT
aji-28	126	55	.	.	PUNCT
aji-28	127	1	sero	sero	NOUN
aji-28	127	2	-	-	PUNCT
aji-28	127	3	conversion	conversion	NOUN
aji-28	127	4	in	in	ADP
aji-28	127	5	relation	relation	NOUN
aji-28	127	6	to	to	ADP
aji-28	127	7	the	the	DET
aji-28	127	8	quantity	quantity	NOUN
aji-28	127	9	of	of	ADP
aji-28	127	10	hbv	hbv	NOUN
aji-28	127	11	vaccine	vaccine	NOUN
aji-28	127	12	with	with	ADP
aji-28	127	13	titre	titre	NOUN
aji-28	127	14	values	value	NOUN
aji-28	127	15	of	of	ADP
aji-28	127	16	≥100iu	≥100iu	NOUN
aji-28	127	17	/	/	SYM
aji-28	127	18	ml	ml	VERB
aji-28	127	19	had	have	VERB
aji-28	127	20	34.6%while	34.6%while	NUM
aji-28	127	21	≤	≤	NUM
aji-28	127	22	100iu	100iu	NOUN
aji-28	127	23	/	/	SYM
aji-28	127	24	ml	ml	NOUN
aji-28	127	25	had	have	VERB
aji-28	127	26	16.1	16.1	NUM
aji-28	127	27	%	%	NOUN
aji-28	127	28	respectively	respectively	ADV
aji-28	127	29	.	.	PUNCT
aji-28	128	1	the	the	DET
aji-28	128	2	result	result	NOUN
aji-28	128	3	therefore	therefore	ADV
aji-28	128	4	showed	show	VERB
aji-28	128	5	statistically	statistically	ADV
aji-28	128	6	significant	significant	ADJ
aji-28	128	7	difference	difference	NOUN
aji-28	128	8	to	to	ADP
aji-28	128	9	the	the	DET
aji-28	128	10	quantity	quantity	NOUN
aji-28	128	11	of	of	ADP
aji-28	128	12	the	the	DET
aji-28	128	13	vaccine	vaccine	NOUN
aji-28	128	14	administered	administer	VERB
aji-28	128	15	at	at	ADP
aji-28	128	16	χ2	χ2	PROPN
aji-28	128	17	=	=	PUNCT
aji-28	128	18	6.98	6.98	NUM
aji-28	128	19	,	,	PUNCT
aji-28	128	20	p	p	X
aji-28	128	21	=	=	NOUN
aji-28	128	22	.08	.08	NUM
aji-28	128	23	.	.	PUNCT
aji-28	129	1	in	in	ADP
aji-28	129	2	table	table	NOUN
aji-28	129	3	4	4	NUM
aji-28	129	4	.	.	PUNCT
aji-28	130	1	conclusion	conclusion	NOUN
aji-28	130	2	:	:	PUNCT
aji-28	130	3	the	the	DET
aji-28	130	4	findings	finding	NOUN
aji-28	130	5	in	in	ADP
aji-28	130	6	the	the	DET
aji-28	130	7	research	research	NOUN
aji-28	130	8	show	show	VERB
aji-28	130	9	that	that	SCONJ
aji-28	130	10	none	none	NOUN
aji-28	130	11	of	of	ADP
aji-28	130	12	the	the	DET
aji-28	130	13	subjects	subject	NOUN
aji-28	130	14	tested	test	VERB
aji-28	130	15	positive	positive	ADJ
aji-28	130	16	for	for	ADP
aji-28	130	17	hepatitis	hepatitis	PROPN
aji-28	130	18	b	b	PROPN
aji-28	130	19	envelope	envelope	NOUN
aji-28	130	20	antigen	antigen	NOUN
aji-28	130	21	or	or	CCONJ
aji-28	130	22	hepatitis	hepatitis	PROPN
aji-28	130	23	b	b	AUX
aji-28	130	24	envelop	envelop	VERB
aji-28	130	25	antibody	antibody	NOUN
aji-28	130	26	.	.	PUNCT
aji-28	131	1	this	this	PRON
aji-28	131	2	could	could	AUX
aji-28	131	3	due	due	ADP
aji-28	131	4	to	to	ADP
aji-28	131	5	prior	prior	ADJ
aji-28	131	6	resolved	resolve	VERB
aji-28	131	7	hbv	hbv	NOUN
aji-28	131	8	infection	infection	NOUN
aji-28	131	9	before	before	ADP
aji-28	131	10	the	the	DET
aji-28	131	11	onset	onset	NOUN
aji-28	131	12	of	of	ADP
aji-28	131	13	vaccination	vaccination	NOUN
aji-28	131	14	or	or	CCONJ
aji-28	131	15	a	a	DET
aji-28	131	16	resolved	resolve	VERB
aji-28	131	17	hbv	hbv	NOUN
aji-28	131	18	infection	infection	NOUN
aji-28	131	19	mid	mid	NOUN
aji-28	131	20	-	-	NOUN
aji-28	131	21	way	way	NOUN
aji-28	131	22	into	into	ADP
aji-28	131	23	the	the	DET
aji-28	131	24	vaccination	vaccination	NOUN
aji-28	131	25	process	process	NOUN
aji-28	131	26	.	.	PUNCT
aji-28	132	1	low	low	ADJ
aji-28	132	2	sero	sero	NOUN
aji-28	132	3	-	-	PUNCT
aji-28	132	4	conversion	conversion	NOUN
aji-28	132	5	rate	rate	NOUN
aji-28	132	6	was	be	AUX
aji-28	132	7	observed	observe	VERB
aji-28	132	8	which	which	PRON
aji-28	132	9	could	could	AUX
aji-28	132	10	be	be	AUX
aji-28	132	11	due	due	ADJ
aji-28	132	12	to	to	ADP
aji-28	132	13	the	the	DET
aji-28	132	14	inclusion	inclusion	NOUN
aji-28	132	15	of	of	ADP
aji-28	132	16	subjects	subject	NOUN
aji-28	132	17	who	who	PRON
aji-28	132	18	failed	fail	VERB
aji-28	132	19	to	to	PART
aji-28	132	20	complete	complete	VERB
aji-28	132	21	their	their	PRON
aji-28	132	22	vaccination	vaccination	NOUN
aji-28	132	23	.	.	PUNCT
aji-28	133	1	keywords	keyword	NOUN
aji-28	133	2	:	:	PUNCT
aji-28	133	3	hepatitis	hepatitis	PROPN
aji-28	133	4	b	b	PROPN
aji-28	133	5	virus	virus	NOUN
aji-28	133	6	;	;	PUNCT
aji-28	133	7	sero	sero	NOUN
aji-28	133	8	-	-	PUNCT
aji-28	133	9	conversion	conversion	NOUN
aji-28	133	10	;	;	PUNCT
aji-28	133	11	sero	sero	NOUN
aji-28	133	12	-	-	PUNCT
aji-28	133	13	protection	protection	NOUN
aji-28	133	14	;	;	PUNCT
aji-28	133	15	vaccination	vaccination	NOUN
aji-28	133	16	;	;	PUNCT
aji-28	133	17	adults	adult	NOUN
aji-28	133	18	.	.	PUNCT
aji-28	134	1	1	1	X
aji-28	134	2	.	.	X
aji-28	134	3	introduction	introduction	NOUN
aji-28	134	4	hepatitis	hepatitis	NOUN
aji-28	134	5	is	be	AUX
aji-28	134	6	a	a	DET
aji-28	134	7	general	general	ADJ
aji-28	134	8	term	term	NOUN
aji-28	134	9	meaning	mean	VERB
aji-28	134	10	inflammation	inflammation	NOUN
aji-28	134	11	of	of	ADP
aji-28	134	12	the	the	DET
aji-28	134	13	liver	liver	NOUN
aji-28	134	14	.	.	PUNCT
aji-28	135	1	this	this	PRON
aji-28	135	2	can	can	AUX
aji-28	135	3	be	be	AUX
aji-28	135	4	caused	cause	VERB
aji-28	135	5	by	by	ADP
aji-28	135	6	viruses	virus	NOUN
aji-28	135	7	,	,	PUNCT
aji-28	135	8	drugs	drug	NOUN
aji-28	135	9	,	,	PUNCT
aji-28	135	10	and	and	CCONJ
aji-28	135	11	poisons	poison	NOUN
aji-28	135	12	e.tc	e.tc	PROPN
aji-28	135	13	.	.	PUNCT
aji-28	136	1	among	among	ADP
aji-28	136	2	the	the	DET
aji-28	136	3	many	many	ADJ
aji-28	136	4	known	know	VERB
aji-28	136	5	causes	cause	NOUN
aji-28	136	6	of	of	ADP
aji-28	136	7	hepatitis	hepatitis	NOUN
aji-28	136	8	,	,	PUNCT
aji-28	136	9	viruses	virus	NOUN
aji-28	136	10	are	be	AUX
aji-28	136	11	the	the	DET
aji-28	136	12	most	most	ADV
aji-28	136	13	important	important	ADJ
aji-28	136	14	,	,	PUNCT
aji-28	136	15	with	with	ADP
aji-28	136	16	hepatitis	hepatitis	PROPN
aji-28	136	17	b	b	PROPN
aji-28	136	18	virus	virus	NOUN
aji-28	136	19	being	be	AUX
aji-28	136	20	the	the	DET
aji-28	136	21	most	most	ADV
aji-28	136	22	critical	critical	ADJ
aji-28	136	23	in	in	ADP
aji-28	136	24	terms	term	NOUN
aji-28	136	25	of	of	ADP
aji-28	136	26	complications	complication	NOUN
aji-28	136	27	,	,	PUNCT
aji-28	136	28	morbidity	morbidity	NOUN
aji-28	136	29	and	and	CCONJ
aji-28	136	30	mortality	mortality	NOUN
aji-28	136	31	.	.	PUNCT
aji-28	137	1	it	it	PRON
aji-28	137	2	is	be	AUX
aji-28	137	3	50	50	NUM
aji-28	137	4	to	to	PART
aji-28	137	5	100	100	NUM
aji-28	137	6	times	time	NOUN
aji-28	137	7	more	more	ADV
aji-28	137	8	infectious	infectious	ADJ
aji-28	137	9	than	than	ADP
aji-28	137	10	hiv	hiv	PROPN
aji-28	137	11	and	and	CCONJ
aji-28	137	12	can	can	AUX
aji-28	137	13	survive	survive	VERB
aji-28	137	14	outside	outside	ADP
aji-28	137	15	the	the	DET
aji-28	137	16	body	body	NOUN
aji-28	137	17	for	for	ADP
aji-28	137	18	at	at	ADV
aji-28	137	19	least	least	ADV
aji-28	137	20	7	7	NUM
aji-28	137	21	days	day	NOUN
aji-28	137	22	[	[	X
aji-28	137	23	1	1	NUM
aji-28	137	24	]	]	PUNCT
aji-28	137	25	.	.	PUNCT
aji-28	138	1	hepatitis	hepatitis	PROPN
aji-28	138	2	b	b	PROPN
aji-28	138	3	virus	virus	NOUN
aji-28	138	4	is	be	AUX
aji-28	138	5	a	a	DET
aji-28	138	6	member	member	NOUN
aji-28	138	7	of	of	ADP
aji-28	138	8	the	the	DET
aji-28	138	9	hepadnavirus	hepadnavirus	PROPN
aji-28	138	10	family	family	NOUN
aji-28	139	1	[	[	X
aji-28	139	2	2	2	NUM
aji-28	139	3	]	]	PUNCT
aji-28	139	4	.	.	PUNCT
aji-28	140	1	the	the	DET
aji-28	140	2	virus	virus	NOUN
aji-28	140	3	particle	particle	NOUN
aji-28	140	4	called	call	VERB
aji-28	140	5	dane	dane	NOUN
aji-28	140	6	particle	particle	NOUN
aji-28	140	7	/	/	SYM
aji-28	140	8	virion	virion	NOUN
aji-28	140	9	[	[	X
aji-28	140	10	3	3	X
aji-28	140	11	]	]	PUNCT
aji-28	140	12	consist	consist	NOUN
aji-28	140	13	of	of	ADP
aji-28	140	14	an	an	DET
aji-28	140	15	outer	outer	ADJ
aji-28	140	16	lipid	lipid	NOUN
aji-28	140	17	envelope	envelope	NOUN
aji-28	140	18	and	and	CCONJ
aji-28	140	19	an	an	DET
aji-28	140	20	icosahedral	icosahedral	ADJ
aji-28	140	21	nucleocapsid	nucleocapsid	ADJ
aji-28	140	22	core	core	NOUN
aji-28	140	23	composed	compose	VERB
aji-28	140	24	of	of	ADP
aji-28	140	25	protein	protein	NOUN
aji-28	140	26	.	.	PUNCT
aji-28	141	1	the	the	DET
aji-28	141	2	nucleocapsid	nucleocapsid	ADJ
aji-28	141	3	encloses	enclose	VERB
aji-28	141	4	the	the	DET
aji-28	141	5	viral	viral	ADJ
aji-28	141	6	dna	dna	NOUN
aji-28	141	7	(	(	PUNCT
aji-28	141	8	a	a	DET
aji-28	141	9	dna	dna	PROPN
aji-28	141	10	polymerase	polymerase	NOUN
aji-28	141	11	that	that	PRON
aji-28	141	12	has	have	AUX
aji-28	141	13	reverse	reverse	VERB
aji-28	141	14	transcriptase	transcriptase	NOUN
aji-28	141	15	activity	activity	NOUN
aji-28	141	16	similar	similar	ADJ
aji-28	141	17	to	to	ADP
aji-28	141	18	retroviruses	retrovirus	NOUN
aji-28	141	19	)	)	PUNCT
aji-28	141	20	.	.	PUNCT
aji-28	142	1	the	the	DET
aji-28	142	2	outer	outer	ADJ
aji-28	142	3	envelope	envelope	NOUN
aji-28	142	4	contains	contain	VERB
aji-28	142	5	embedded	embed	VERB
aji-28	142	6	proteins	protein	NOUN
aji-28	142	7	which	which	PRON
aji-28	142	8	are	be	AUX
aji-28	142	9	involved	involve	VERB
aji-28	142	10	in	in	ADP
aji-28	142	11	viral	viral	ADJ
aji-28	142	12	binding	binding	NOUN
aji-28	142	13	of	of	ADP
aji-28	142	14	,	,	PUNCT
aji-28	142	15	and	and	CCONJ
aji-28	142	16	entry	entry	NOUN
aji-28	142	17	into	into	ADP
aji-28	142	18	susceptible	susceptible	ADJ
aji-28	142	19	cells	cell	NOUN
aji-28	142	20	[	[	X
aji-28	142	21	4	4	NUM
aji-28	142	22	]	]	PUNCT
aji-28	142	23	.	.	PUNCT
aji-28	143	1	the	the	DET
aji-28	143	2	hepatitis	hepatitis	PROPN
aji-28	143	3	b	b	PROPN
aji-28	143	4	virus	virus	NOUN
aji-28	143	5	is	be	AUX
aji-28	143	6	known	know	VERB
aji-28	143	7	as	as	ADP
aji-28	143	8	a	a	DET
aji-28	143	9	blood	blood	NOUN
aji-28	143	10	-	-	PUNCT
aji-28	143	11	borne	bear	VERB
aji-28	143	12	virus	virus	NOUN
aji-28	143	13	because	because	SCONJ
aji-28	143	14	it	it	PRON
aji-28	143	15	is	be	AUX
aji-28	143	16	transmitted	transmit	VERB
aji-28	143	17	from	from	ADP
aji-28	143	18	one	one	NUM
aji-28	143	19	person	person	NOUN
aji-28	143	20	to	to	ADP
aji-28	143	21	another	another	PRON
aji-28	143	22	via	via	ADP
aji-28	143	23	blood	blood	NOUN
aji-28	143	24	or	or	CCONJ
aji-28	143	25	fluids	fluid	NOUN
aji-28	143	26	contaminated	contaminate	VERB
aji-28	143	27	with	with	ADP
aji-28	143	28	blood	blood	NOUN
aji-28	143	29	.	.	PUNCT
aji-28	144	1	another	another	DET
aji-28	144	2	important	important	ADJ
aji-28	144	3	route	route	NOUN
aji-28	144	4	of	of	ADP
aji-28	144	5	transmission	transmission	NOUN
aji-28	144	6	is	be	AUX
aji-28	144	7	from	from	ADP
aji-28	144	8	an	an	DET
aji-28	144	9	infected	infected	ADJ
aji-28	144	10	mother	mother	NOUN
aji-28	144	11	to	to	ADP
aji-28	144	12	a	a	DET
aji-28	144	13	newborn	newborn	ADJ
aji-28	144	14	child	child	NOUN
aji-28	144	15	,	,	PUNCT
aji-28	144	16	which	which	PRON
aji-28	144	17	occurs	occur	VERB
aji-28	144	18	during	during	ADP
aji-28	144	19	or	or	CCONJ
aji-28	144	20	shortly	shortly	ADV
aji-28	144	21	after	after	ADP
aji-28	144	22	birth	birth	NOUN
aji-28	144	23	[	[	X
aji-28	144	24	5	5	NUM
aji-28	144	25	]	]	PUNCT
aji-28	144	26	.	.	PUNCT
aji-28	145	1	currently	currently	ADV
aji-28	145	2	,	,	PUNCT
aji-28	145	3	an	an	DET
aji-28	145	4	estimated	estimate	VERB
aji-28	145	5	2	2	NUM
aji-28	145	6	billion	billion	NUM
aji-28	145	7	people	people	NOUN
aji-28	145	8	worldwide	worldwide	ADV
aji-28	145	9	have	have	AUX
aji-28	145	10	had	have	VERB
aji-28	145	11	contact	contact	NOUN
aji-28	145	12	with	with	ADP
aji-28	145	13	the	the	DET
aji-28	145	14	virus	virus	NOUN
aji-28	145	15	.	.	PUNCT
aji-28	146	1	360	360	NUM
aji-28	146	2	million	million	NUM
aji-28	146	3	of	of	ADP
aji-28	146	4	such	such	ADJ
aji-28	146	5	infected	infected	ADJ
aji-28	146	6	persons	person	NOUN
aji-28	146	7	progress	progress	VERB
aji-28	146	8	to	to	ADP
aji-28	146	9	chronicity	chronicity	NOUN
aji-28	146	10	with	with	ADP
aji-28	146	11	about25	about25	NOUN
aji-28	146	12	%	%	NOUN
aji-28	146	13	of	of	ADP
aji-28	146	14	chronic	chronic	ADJ
aji-28	146	15	cases	case	NOUN
aji-28	146	16	developing	develop	VERB
aji-28	146	17	cirrhosis	cirrhosis	NOUN
aji-28	146	18	and	and	CCONJ
aji-28	146	19	hepatocellular	hepatocellular	ADJ
aji-28	146	20	carcinoma	carcinoma	NOUN
aji-28	146	21	[	[	X
aji-28	146	22	6	6	NUM
aji-28	146	23	]	]	PUNCT
aji-28	146	24	.	.	PUNCT
aji-28	147	1	hbv	hbv	NOUN
aji-28	147	2	infection	infection	NOUN
aji-28	147	3	is	be	AUX
aji-28	147	4	of	of	ADP
aji-28	147	5	great	great	ADJ
aji-28	147	6	concern	concern	NOUN
aji-28	147	7	in	in	ADP
aji-28	147	8	most	most	ADJ
aji-28	147	9	developing	develop	VERB
aji-28	147	10	countries	country	NOUN
aji-28	147	11	.	.	PUNCT
aji-28	148	1	sub	sub	ADJ
aji-28	148	2	-	-	ADJ
aji-28	148	3	saharan	saharan	ADJ
aji-28	148	4	countries	country	NOUN
aji-28	148	5	are	be	AUX
aji-28	148	6	reported	report	VERB
aji-28	148	7	to	to	PART
aji-28	148	8	be	be	AUX
aji-28	148	9	hyper	hyper	ADJ
aji-28	148	10	endemic	endemic	ADJ
aji-28	148	11	(	(	PUNCT
aji-28	148	12	i.e.>8	i.e.>8	PROPN
aji-28	148	13	%	%	NOUN
aji-28	148	14	of	of	ADP
aji-28	148	15	the	the	DET
aji-28	148	16	population	population	NOUN
aji-28	148	17	are	be	AUX
aji-28	148	18	infected	infect	VERB
aji-28	148	19	)	)	PUNCT
aji-28	149	1	[	[	X
aji-28	149	2	7	7	NUM
aji-28	149	3	]	]	PUNCT
aji-28	149	4	.	.	PUNCT
aji-28	150	1	among	among	ADP
aji-28	150	2	these	these	DET
aji-28	150	3	sub	sub	ADJ
aji-28	150	4	-	-	ADJ
aji-28	150	5	saharan	saharan	ADJ
aji-28	150	6	countries	country	NOUN
aji-28	150	7	,	,	PUNCT
aji-28	150	8	nigeria	nigeria	PROPN
aji-28	150	9	has	have	VERB
aji-28	150	10	a	a	DET
aji-28	150	11	pooled	pooled	ADJ
aji-28	150	12	prevalence	prevalence	NOUN
aji-28	150	13	rate	rate	NOUN
aji-28	150	14	of	of	ADP
aji-28	150	15	13.6	13.6	NUM
aji-28	150	16	%	%	NOUN
aji-28	150	17	[	[	X
aji-28	150	18	8	8	NUM
aji-28	150	19	]	]	PUNCT
aji-28	150	20	.	.	PUNCT
aji-28	151	1	though	though	SCONJ
aji-28	151	2	drugs	drug	NOUN
aji-28	151	3	are	be	AUX
aji-28	151	4	now	now	ADV
aji-28	151	5	available	available	ADJ
aji-28	151	6	for	for	ADP
aji-28	151	7	treatment	treatment	NOUN
aji-28	151	8	of	of	ADP
aji-28	151	9	hbv	hbv	NOUN
aji-28	151	10	infection	infection	NOUN
aji-28	151	11	,	,	PUNCT
aji-28	151	12	present	present	ADJ
aji-28	151	13	treatments	treatment	NOUN
aji-28	151	14	are	be	AUX
aji-28	151	15	very	very	ADV
aji-28	151	16	costly	costly	ADJ
aji-28	151	17	and	and	CCONJ
aji-28	151	18	not	not	PART
aji-28	151	19	readily	readily	ADV
aji-28	151	20	available	available	ADJ
aji-28	151	21	.	.	PUNCT
aji-28	152	1	however	however	ADV
aji-28	152	2	,	,	PUNCT
aji-28	152	3	vaccination	vaccination	NOUN
aji-28	152	4	is	be	AUX
aji-28	152	5	now	now	ADV
aji-28	152	6	the	the	DET
aji-28	152	7	most	most	ADV
aji-28	152	8	effective	effective	ADJ
aji-28	152	9	and	and	CCONJ
aji-28	152	10	economical	economical	ADJ
aji-28	152	11	means	mean	NOUN
aji-28	152	12	for	for	ADP
aji-28	152	13	the	the	DET
aji-28	152	14	prevention	prevention	NOUN
aji-28	152	15	of	of	ADP
aji-28	152	16	this	this	DET
aji-28	152	17	disease	disease	NOUN
aji-28	152	18	[	[	X
aji-28	152	19	9	9	NUM
aji-28	152	20	]	]	PUNCT
aji-28	152	21	.	.	PUNCT
aji-28	153	1	who	who	PRON
aji-28	153	2	in	in	ADP
aji-28	153	3	1991	1991	NUM
aji-28	153	4	recommended	recommend	VERB
aji-28	153	5	the	the	DET
aji-28	153	6	inclusion	inclusion	NOUN
aji-28	153	7	of	of	ADP
aji-28	153	8	hepatitis	hepatitis	PROPN
aji-28	153	9	b	b	PROPN
aji-28	153	10	vaccines	vaccine	NOUN
aji-28	153	11	in	in	ADP
aji-28	153	12	the	the	DET
aji-28	153	13	national	national	ADJ
aji-28	153	14	vaccination	vaccination	NOUN
aji-28	153	15	program	program	NOUN
aji-28	153	16	in	in	ADP
aji-28	153	17	all	all	DET
aji-28	153	18	countries	country	NOUN
aji-28	153	19	with	with	ADP
aji-28	153	20	the	the	DET
aji-28	153	21	aim	aim	NOUN
aji-28	153	22	of	of	ADP
aji-28	153	23	reducing	reduce	VERB
aji-28	153	24	the	the	DET
aji-28	153	25	global	global	ADJ
aji-28	153	26	impact	impact	NOUN
aji-28	153	27	of	of	ADP
aji-28	153	28	hbv	hbv	NOUN
aji-28	153	29	infections	infection	NOUN
aji-28	153	30	.	.	PUNCT
aji-28	154	1	hepatitis	hepatitis	PROPN
aji-28	154	2	b	b	PROPN
aji-28	154	3	vaccine	vaccine	NOUN
aji-28	154	4	is	be	AUX
aji-28	154	5	a	a	DET
aji-28	154	6	genetically	genetically	ADV
aji-28	154	7	engineered	engineer	VERB
aji-28	154	8	(	(	PUNCT
aji-28	154	9	man	man	NOUN
aji-28	154	10	-	-	PUNCT
aji-28	154	11	made	make	VERB
aji-28	154	12	in	in	ADP
aji-28	154	13	the	the	DET
aji-28	154	14	laboratory	laboratory	NOUN
aji-28	154	15	)	)	PUNCT
aji-28	154	16	piece	piece	NOUN
aji-28	154	17	of	of	ADP
aji-28	154	18	the	the	DET
aji-28	154	19	virus	virus	NOUN
aji-28	154	20	.	.	PUNCT
aji-28	155	1	it	it	PRON
aji-28	155	2	does	do	AUX
aji-28	155	3	not	not	PART
aji-28	155	4	contain	contain	VERB
aji-28	155	5	live	live	ADJ
aji-28	155	6	virus	virus	NOUN
aji-28	155	7	,	,	PUNCT
aji-28	155	8	thus	thus	ADV
aji-28	155	9	can	can	AUX
aji-28	155	10	not	not	PART
aji-28	155	11	cause	cause	VERB
aji-28	155	12	hepatitis	hepatitis	NOUN
aji-28	155	13	due	due	ADP
aji-28	155	14	to	to	ADP
aji-28	155	15	reversion	reversion	NOUN
aji-28	155	16	as	as	ADP
aji-28	155	17	in	in	ADP
aji-28	155	18	some	some	DET
aji-28	155	19	live	live	ADJ
aji-28	155	20	attenuated	attenuated	ADJ
aji-28	155	21	vaccines	vaccine	NOUN
aji-28	155	22	.	.	PUNCT
aji-28	156	1	this	this	DET
aji-28	156	2	vaccine	vaccine	NOUN
aji-28	156	3	works	work	VERB
aji-28	156	4	by	by	ADP
aji-28	156	5	helping	help	VERB
aji-28	156	6	the	the	DET
aji-28	156	7	body	body	NOUN
aji-28	156	8	produce	produce	VERB
aji-28	156	9	immunity	immunity	NOUN
aji-28	156	10	(	(	PUNCT
aji-28	156	11	through	through	ADP
aji-28	156	12	antibody	antibody	NOUN
aji-28	156	13	production	production	NOUN
aji-28	156	14	)	)	PUNCT
aji-28	156	15	that	that	PRON
aji-28	156	16	prevents	prevent	VERB
aji-28	156	17	infection	infection	NOUN
aji-28	156	18	from	from	ADP
aji-28	156	19	hepatitis	hepatitis	PROPN
aji-28	156	20	b	b	PROPN
aji-28	156	21	virus	virus	NOUN
aji-28	156	22	.	.	PUNCT
aji-28	157	1	it	it	PRON
aji-28	157	2	is	be	AUX
aji-28	157	3	pertinent	pertinent	ADJ
aji-28	157	4	to	to	PART
aji-28	157	5	note	note	VERB
aji-28	157	6	hepatitis	hepatitis	PROPN
aji-28	157	7	b	b	PROPN
aji-28	157	8	vaccine	vaccine	NOUN
aji-28	157	9	does	do	AUX
aji-28	157	10	not	not	PART
aji-28	157	11	protect	protect	VERB
aji-28	157	12	from	from	ADP
aji-28	157	13	other	other	ADJ
aji-28	157	14	viral	viral	ADJ
aji-28	157	15	infections	infection	NOUN
aji-28	157	16	1	1	NUM
aji-28	157	17	.	.	PUNCT
aji-28	158	1	there	there	PRON
aji-28	158	2	are	be	VERB
aji-28	158	3	two	two	NUM
aji-28	158	4	types	type	NOUN
aji-28	158	5	of	of	ADP
aji-28	158	6	products	product	NOUN
aji-28	158	7	available	available	ADJ
aji-28	158	8	for	for	ADP
aji-28	158	9	immunization	immunization	NOUN
aji-28	158	10	against	against	ADP
aji-28	158	11	hepatitis	hepatitis	PROPN
aji-28	158	12	b	b	PROPN
aji-28	158	13	:	:	PUNCT
aji-28	158	14	a	a	DET
aji-28	158	15	vaccine	vaccine	NOUN
aji-28	158	16	that	that	PRON
aji-28	158	17	confers	confer	VERB
aji-28	158	18	active	active	ADJ
aji-28	158	19	immunity	immunity	NOUN
aji-28	158	20	and	and	CCONJ
aji-28	158	21	a	a	DET
aji-28	158	22	specific	specific	ADJ
aji-28	158	23	immunoglobulin	immunoglobulin	NOUN
aji-28	158	24	that	that	PRON
aji-28	158	25	provides	provide	VERB
aji-28	158	26	passive	passive	ADJ
aji-28	158	27	and	and	CCONJ
aji-28	158	28	temporary	temporary	ADJ
aji-28	158	29	immunity	immunity	NOUN
aji-28	158	30	while	while	SCONJ
aji-28	158	31	awaiting	await	VERB
aji-28	158	32	response	response	NOUN
aji-28	158	33	to	to	ADP
aji-28	158	34	vaccine	vaccine	NOUN
aji-28	158	35	.	.	PUNCT
aji-28	159	1	hepatitis	hepatitis	PROPN
aji-28	159	2	b	b	PROPN
aji-28	159	3	vaccines	vaccine	NOUN
aji-28	159	4	are	be	AUX
aji-28	159	5	routinely	routinely	ADV
aji-28	159	6	given	give	VERB
aji-28	159	7	intramuscularly	intramuscularly	ADV
aji-28	159	8	in	in	ADP
aji-28	159	9	the	the	DET
aji-28	159	10	upper	upper	ADJ
aji-28	159	11	arm	arm	NOUN
aji-28	159	12	or	or	CCONJ
aji-28	159	13	anterolateral	anterolateral	ADJ
aji-28	159	14	thigh	thigh	NOUN
aji-28	159	15	.	.	PUNCT
aji-28	160	1	the	the	DET
aji-28	160	2	buttock	buttock	NOUN
aji-28	160	3	must	must	AUX
aji-28	160	4	not	not	PART
aji-28	160	5	be	be	AUX
aji-28	160	6	used	use	VERB
aji-28	160	7	because	because	SCONJ
aji-28	160	8	vaccine	vaccine	NOUN
aji-28	160	9	efficacy	efficacy	NOUN
aji-28	160	10	may	may	AUX
aji-28	160	11	be	be	AUX
aji-28	160	12	reduced	reduce	VERB
aji-28	160	13	[	[	PUNCT
aji-28	160	14	10	10	NUM
aji-28	160	15	]	]	PUNCT
aji-28	160	16	.	.	PUNCT
aji-28	161	1	protection	protection	NOUN
aji-28	161	2	by	by	ADP
aji-28	161	3	hbv	hbv	NOUN
aji-28	161	4	vaccine	vaccine	NOUN
aji-28	161	5	is	be	AUX
aji-28	161	6	based	base	VERB
aji-28	161	7	on	on	ADP
aji-28	161	8	the	the	DET
aji-28	161	9	production	production	NOUN
aji-28	161	10	of	of	ADP
aji-28	161	11	immunity	immunity	NOUN
aji-28	161	12	or	or	CCONJ
aji-28	161	13	antibodies	antibody	NOUN
aji-28	161	14	to	to	ADP
aji-28	161	15	the	the	DET
aji-28	161	16	ibrahim	ibrahim	PROPN
aji-28	161	17	et	et	PROPN
aji-28	161	18	al	al	PROPN
aji-28	161	19	.	.	PROPN
aji-28	161	20	;	;	PUNCT
aji-28	162	1	aji	aji	PROPN
aji-28	162	2	,	,	PUNCT
aji-28	162	3	3(1	3(1	NUM
aji-28	162	4	):	):	PUNCT
aji-28	162	5	291	291	NUM
aji-28	162	6	-	-	SYM
aji-28	162	7	297	297	NUM
aji-28	162	8	,	,	PUNCT
aji-28	162	9	2020	2020	NUM
aji-28	162	10	;	;	PUNCT
aji-28	162	11	article	article	NOUN
aji-28	162	12	no.aji.60171	no.aji.60171	VERB
aji-28	162	13	293	293	NUM
aji-28	162	14	surface	surface	NOUN
aji-28	162	15	protein	protein	NOUN
aji-28	162	16	or	or	CCONJ
aji-28	162	17	outer	outer	ADJ
aji-28	162	18	coat	coat	NOUN
aji-28	162	19	of	of	ADP
aji-28	162	20	the	the	DET
aji-28	162	21	virus	virus	NOUN
aji-28	162	22	.	.	PUNCT
aji-28	163	1	this	this	DET
aji-28	163	2	outer	outer	ADJ
aji-28	163	3	coat	coat	NOUN
aji-28	163	4	is	be	AUX
aji-28	163	5	called	call	VERB
aji-28	163	6	hepatitis	hepatitis	PROPN
aji-28	163	7	b	b	PROPN
aji-28	163	8	surface	surface	NOUN
aji-28	163	9	antigen	antigen	NOUN
aji-28	163	10	or	or	CCONJ
aji-28	163	11	hbsag	hbsag	ADJ
aji-28	163	12	[	[	X
aji-28	163	13	11	11	NUM
aji-28	163	14	]	]	PUNCT
aji-28	163	15	.	.	PUNCT
aji-28	164	1	successfully	successfully	ADV
aji-28	164	2	vaccinated	vaccinate	VERB
aji-28	164	3	individuals	individual	NOUN
aji-28	164	4	will	will	AUX
aji-28	164	5	be	be	AUX
aji-28	164	6	positive	positive	ADJ
aji-28	164	7	for	for	ADP
aji-28	164	8	only	only	ADV
aji-28	164	9	antihbs	antihbs	ADJ
aji-28	164	10	while	while	SCONJ
aji-28	164	11	persons	person	NOUN
aji-28	164	12	who	who	PRON
aji-28	164	13	got	get	VERB
aji-28	164	14	immunity	immunity	NOUN
aji-28	164	15	as	as	ADP
aji-28	164	16	a	a	DET
aji-28	164	17	result	result	NOUN
aji-28	164	18	of	of	ADP
aji-28	164	19	hbv	hbv	NOUN
aji-28	164	20	infection	infection	NOUN
aji-28	164	21	will	will	AUX
aji-28	164	22	be	be	AUX
aji-28	164	23	positive	positive	ADJ
aji-28	164	24	for	for	ADP
aji-28	164	25	both	both	CCONJ
aji-28	164	26	antihbc	antihbc	PROPN
aji-28	164	27	and	and	CCONJ
aji-28	164	28	antihbs	antihbs	ADJ
aji-28	165	1	[	[	X
aji-28	165	2	12	12	NUM
aji-28	165	3	]	]	PUNCT
aji-28	165	4	.	.	PUNCT
aji-28	166	1	however	however	ADV
aji-28	166	2	,	,	PUNCT
aji-28	166	3	around	around	ADP
aji-28	166	4	10	10	NUM
aji-28	166	5	%	%	NOUN
aji-28	166	6	to	to	PART
aji-28	166	7	15	15	NUM
aji-28	166	8	%	%	NOUN
aji-28	166	9	of	of	ADP
aji-28	166	10	adults	adult	NOUN
aji-28	166	11	fail	fail	VERB
aji-28	166	12	to	to	PART
aji-28	166	13	respond	respond	VERB
aji-28	166	14	to	to	ADP
aji-28	166	15	three	three	NUM
aji-28	166	16	shots	shot	NOUN
aji-28	166	17	of	of	ADP
aji-28	166	18	vaccine	vaccine	NOUN
aji-28	166	19	or	or	CCONJ
aji-28	166	20	respond	respond	VERB
aji-28	166	21	poorly	poorly	ADV
aji-28	166	22	.	.	PUNCT
aji-28	167	1	poor	poor	ADJ
aji-28	167	2	responses	response	NOUN
aji-28	167	3	are	be	AUX
aji-28	167	4	mostly	mostly	ADV
aji-28	167	5	associated	associate	VERB
aji-28	167	6	with	with	ADP
aji-28	167	7	age	age	NOUN
aji-28	167	8	(	(	PUNCT
aji-28	167	9	over	over	ADP
aji-28	167	10	40	40	NUM
aji-28	167	11	years	year	NOUN
aji-28	167	12	)	)	PUNCT
aji-28	167	13	,	,	PUNCT
aji-28	167	14	obesity	obesity	NOUN
aji-28	167	15	and	and	CCONJ
aji-28	167	16	smoking	smoking	NOUN
aji-28	167	17	[	[	X
aji-28	167	18	13	13	NUM
aji-28	167	19	]	]	PUNCT
aji-28	167	20	.	.	PUNCT
aji-28	168	1	lower	low	ADJ
aji-28	168	2	sero	sero	NOUN
aji-28	168	3	-	-	PUNCT
aji-28	168	4	conversion	conversion	NOUN
aji-28	168	5	rates	rate	NOUN
aji-28	168	6	have	have	AUX
aji-28	168	7	also	also	ADV
aji-28	168	8	been	be	AUX
aji-28	168	9	reported	report	VERB
aji-28	168	10	in	in	ADP
aji-28	168	11	alcoholics	alcoholic	NOUN
aji-28	168	12	,	,	PUNCT
aji-28	168	13	particularly	particularly	ADV
aji-28	168	14	those	those	PRON
aji-28	168	15	with	with	ADP
aji-28	168	16	advanced	advanced	ADJ
aji-28	168	17	liver	liver	NOUN
aji-28	168	18	disease	disease	NOUN
aji-28	168	19	[	[	X
aji-28	168	20	14	14	NUM
aji-28	168	21	]	]	PUNCT
aji-28	168	22	.	.	PUNCT
aji-28	169	1	thus	thus	ADV
aji-28	169	2	the	the	DET
aji-28	169	3	need	need	NOUN
aji-28	169	4	for	for	ADP
aji-28	169	5	post	post	NOUN
aji-28	169	6	vaccination	vaccination	NOUN
aji-28	169	7	testing	testing	NOUN
aji-28	169	8	for	for	ADP
aji-28	169	9	hbsag	hbsag	NOUN
aji-28	169	10	and	and	CCONJ
aji-28	169	11	antihbs	antihbs	ADJ
aji-28	169	12	following	follow	VERB
aji-28	169	13	hbv	hbv	NOUN
aji-28	169	14	vaccination	vaccination	NOUN
aji-28	169	15	.	.	PUNCT
aji-28	170	1	though	though	SCONJ
aji-28	170	2	this	this	DET
aji-28	170	3	vaccine	vaccine	NOUN
aji-28	170	4	is	be	AUX
aji-28	170	5	commonly	commonly	ADV
aji-28	170	6	used	use	VERB
aji-28	170	7	in	in	ADP
aji-28	170	8	nigeria	nigeria	PROPN
aji-28	170	9	,	,	PUNCT
aji-28	170	10	there	there	PRON
aji-28	170	11	is	be	VERB
aji-28	170	12	no	no	DET
aji-28	170	13	sufficient	sufficient	ADJ
aji-28	170	14	data	datum	NOUN
aji-28	170	15	on	on	ADP
aji-28	170	16	nigerian	nigerian	ADJ
aji-28	170	17	subjects	subject	NOUN
aji-28	170	18	regarding	regard	VERB
aji-28	170	19	immunologic	immunologic	ADJ
aji-28	170	20	response	response	NOUN
aji-28	170	21	or	or	CCONJ
aji-28	170	22	lack	lack	NOUN
aji-28	170	23	thereof	thereof	ADV
aji-28	170	24	in	in	ADP
aji-28	170	25	terms	term	NOUN
aji-28	170	26	of	of	ADP
aji-28	170	27	its	its	PRON
aji-28	170	28	immunogenicity	immunogenicity	NOUN
aji-28	170	29	[	[	X
aji-28	170	30	15	15	NUM
aji-28	170	31	]	]	PUNCT
aji-28	170	32	.	.	PUNCT
aji-28	171	1	and	and	CCONJ
aji-28	171	2	many	many	ADJ
aji-28	171	3	among	among	ADP
aji-28	171	4	those	those	PRON
aji-28	171	5	who	who	PRON
aji-28	171	6	start	start	VERB
aji-28	171	7	to	to	PART
aji-28	171	8	receive	receive	VERB
aji-28	171	9	the	the	DET
aji-28	171	10	vaccine	vaccine	NOUN
aji-28	171	11	fail	fail	VERB
aji-28	171	12	to	to	PART
aji-28	171	13	complete	complete	VERB
aji-28	171	14	the	the	DET
aji-28	171	15	3	3	NUM
aji-28	171	16	recommended	recommend	VERB
aji-28	171	17	doses	dose	NOUN
aji-28	171	18	of	of	ADP
aji-28	171	19	the	the	DET
aji-28	171	20	vaccine.thus	vaccine.thus	NOUN
aji-28	171	21	the	the	DET
aji-28	171	22	need	need	NOUN
aji-28	171	23	to	to	PART
aji-28	171	24	study	study	VERB
aji-28	171	25	the	the	DET
aji-28	171	26	immunological	immunological	ADJ
aji-28	171	27	response	response	NOUN
aji-28	171	28	to	to	ADP
aji-28	171	29	hbv	hbv	NOUN
aji-28	171	30	vaccine	vaccine	NOUN
aji-28	171	31	,	,	PUNCT
aji-28	171	32	among	among	ADP
aji-28	171	33	vaccinated	vaccinated	ADJ
aji-28	171	34	persons	person	NOUN
aji-28	171	35	,	,	PUNCT
aji-28	171	36	in	in	ADP
aji-28	171	37	kaduna	kaduna	PROPN
aji-28	171	38	south	south	PROPN
aji-28	171	39	senatorial	senatorial	PROPN
aji-28	171	40	district	district	NOUN
aji-28	171	41	.	.	PUNCT
aji-28	172	1	2	2	X
aji-28	172	2	.	.	X
aji-28	172	3	materials	material	NOUN
aji-28	172	4	and	and	CCONJ
aji-28	172	5	methods	method	NOUN
aji-28	172	6	2.1	2.1	NUM
aji-28	172	7	study	study	NOUN
aji-28	172	8	area	area	NOUN
aji-28	172	9	blood	blood	NOUN
aji-28	172	10	random	random	ADJ
aji-28	172	11	samples	sample	NOUN
aji-28	172	12	were	be	AUX
aji-28	172	13	collected	collect	VERB
aji-28	172	14	from	from	ADP
aji-28	172	15	residents	resident	NOUN
aji-28	172	16	of	of	ADP
aji-28	172	17	kaduna	kaduna	PROPN
aji-28	172	18	south	south	PROPN
aji-28	172	19	senatorial	senatorial	ADJ
aji-28	172	20	district	district	NOUN
aji-28	172	21	in	in	ADP
aji-28	172	22	kaduna	kaduna	PROPN
aji-28	172	23	state	state	PROPN
aji-28	172	24	.	.	PUNCT
aji-28	173	1	kaduna	kaduna	PROPN
aji-28	173	2	state	state	PROPN
aji-28	173	3	is	be	AUX
aji-28	173	4	located	locate	VERB
aji-28	173	5	at	at	ADP
aji-28	173	6	10	10	NUM
aji-28	173	7	°	°	NUM
aji-28	173	8	31”n7	31”n7	NUM
aji-28	173	9	°	°	NOUN
aji-28	173	10	26’25”e	26’25”e	NUM
aji-28	173	11	in	in	ADP
aji-28	173	12	north	north	NOUN
aji-28	173	13	-	-	PUNCT
aji-28	173	14	western	western	NOUN
aji-28	173	15	nigeria	nigeria	PROPN
aji-28	173	16	.	.	PUNCT
aji-28	174	1	the	the	DET
aji-28	174	2	population	population	NOUN
aji-28	174	3	of	of	ADP
aji-28	174	4	kaduna	kaduna	PROPN
aji-28	174	5	as	as	ADP
aji-28	174	6	at	at	ADP
aji-28	174	7	the	the	DET
aji-28	174	8	2006	2006	NUM
aji-28	174	9	nigerian	nigerian	ADJ
aji-28	174	10	census	census	NOUN
aji-28	174	11	was	be	AUX
aji-28	174	12	760,084	760,084	NUM
aji-28	174	13	but	but	CCONJ
aji-28	174	14	this	this	PRON
aji-28	174	15	is	be	AUX
aji-28	174	16	believed	believe	VERB
aji-28	174	17	to	to	PART
aji-28	174	18	have	have	AUX
aji-28	174	19	grown	grow	VERB
aji-28	174	20	to	to	ADP
aji-28	174	21	over	over	ADP
aji-28	174	22	1.8	1.8	NUM
aji-28	174	23	million	million	NUM
aji-28	174	24	as	as	ADP
aji-28	174	25	of	of	ADP
aji-28	174	26	2013	2013	NUM
aji-28	174	27	.	.	PUNCT
aji-28	175	1	collected	collect	VERB
aji-28	175	2	samples	sample	NOUN
aji-28	175	3	will	will	AUX
aji-28	175	4	be	be	AUX
aji-28	175	5	appropriately	appropriately	ADV
aji-28	175	6	.	.	PUNCT
aji-28	176	1	2.1.1	2.1.1	NUM
aji-28	176	2	study	study	NOUN
aji-28	176	3	population	population	NOUN
aji-28	176	4	persons	person	NOUN
aji-28	176	5	with	with	ADP
aji-28	176	6	any	any	DET
aji-28	176	7	history	history	NOUN
aji-28	176	8	of	of	ADP
aji-28	176	9	hepatitis	hepatitis	PROPN
aji-28	176	10	b	b	PROPN
aji-28	176	11	vaccination	vaccination	NOUN
aji-28	176	12	who	who	PRON
aji-28	176	13	had	have	VERB
aji-28	176	14	no	no	DET
aji-28	176	15	knowledge	knowledge	NOUN
aji-28	176	16	of	of	ADP
aji-28	176	17	being	be	AUX
aji-28	176	18	hbsag	hbsag	ADJ
aji-28	176	19	positive	positive	ADJ
aji-28	176	20	and	and	CCONJ
aji-28	176	21	consented	consent	VERB
aji-28	176	22	to	to	PART
aji-28	176	23	be	be	AUX
aji-28	176	24	part	part	NOUN
aji-28	176	25	of	of	ADP
aji-28	176	26	the	the	DET
aji-28	176	27	study	study	NOUN
aji-28	176	28	were	be	AUX
aji-28	176	29	included	include	VERB
aji-28	176	30	and	and	CCONJ
aji-28	176	31	also	also	ADV
aji-28	176	32	excluded	exclude	VERB
aji-28	176	33	subjects	subject	NOUN
aji-28	176	34	who	who	PRON
aji-28	176	35	had	have	VERB
aji-28	176	36	knowledge	knowledge	NOUN
aji-28	176	37	of	of	ADP
aji-28	176	38	being	be	AUX
aji-28	176	39	hbsag	hbsag	ADJ
aji-28	176	40	-	-	PUNCT
aji-28	176	41	positive	positive	ADJ
aji-28	176	42	,	,	PUNCT
aji-28	176	43	above	above	ADP
aji-28	176	44	the	the	DET
aji-28	176	45	age	age	NOUN
aji-28	176	46	of	of	ADP
aji-28	176	47	60	60	NUM
aji-28	176	48	,	,	PUNCT
aji-28	176	49	non	non	ADJ
aji-28	176	50	hbv	hbv	NOUN
aji-28	176	51	vaccinated	vaccinate	VERB
aji-28	176	52	,	,	PUNCT
aji-28	176	53	between	between	ADP
aji-28	176	54	july	july	PROPN
aji-28	176	55	and	and	CCONJ
aji-28	176	56	november	november	PROPN
aji-28	176	57	20	20	NUM
aji-28	177	1	[	[	SYM
aji-28	177	2	16	16	NUM
aji-28	177	3	]	]	PUNCT
aji-28	177	4	from	from	ADP
aji-28	177	5	kaduna	kaduna	PROPN
aji-28	177	6	south	south	PROPN
aji-28	177	7	senatorial	senatorial	PROPN
aji-28	177	8	district	district	NOUN
aji-28	177	9	.	.	PUNCT
aji-28	178	1	2.1.2	2.1.2	NUM
aji-28	178	2	study	study	NOUN
aji-28	178	3	design	design	NOUN
aji-28	178	4	the	the	DET
aji-28	178	5	study	study	NOUN
aji-28	178	6	was	be	AUX
aji-28	178	7	a	a	DET
aji-28	178	8	hospital	hospital	NOUN
aji-28	178	9	based	base	VERB
aji-28	178	10	descriptive	descriptive	ADJ
aji-28	178	11	,	,	PUNCT
aji-28	178	12	cross	cross	ADJ
aji-28	178	13	-	-	ADJ
aji-28	178	14	sectional	sectional	ADJ
aji-28	178	15	study	study	NOUN
aji-28	178	16	that	that	PRON
aji-28	178	17	recruited	recruit	VERB
aji-28	178	18	180	180	NUM
aji-28	178	19	consenting	consenting	ADJ
aji-28	178	20	adults	adult	NOUN
aji-28	178	21	in	in	ADP
aji-28	178	22	kaduna	kaduna	PROPN
aji-28	178	23	south	south	PROPN
aji-28	178	24	senatorial	senatorial	PROPN
aji-28	178	25	district	district	NOUN
aji-28	178	26	,	,	PUNCT
aji-28	178	27	kaduna	kaduna	PROPN
aji-28	178	28	state	state	PROPN
aji-28	178	29	.	.	PUNCT
aji-28	179	1	2.2	2.2	NUM
aji-28	179	2	sample	sample	NOUN
aji-28	179	3	collection	collection	NOUN
aji-28	179	4	five	five	NUM
aji-28	179	5	(	(	PUNCT
aji-28	179	6	5	5	NUM
aji-28	179	7	)	)	PUNCT
aji-28	179	8	ml	ml	NOUN
aji-28	179	9	of	of	ADP
aji-28	179	10	venous	venous	ADJ
aji-28	179	11	blood	blood	NOUN
aji-28	179	12	was	be	AUX
aji-28	179	13	collected	collect	VERB
aji-28	179	14	from	from	ADP
aji-28	179	15	the	the	DET
aji-28	179	16	forearm	forearm	NOUN
aji-28	179	17	of	of	ADP
aji-28	179	18	one	one	NUM
aji-28	179	19	hundred	hundred	NUM
aji-28	179	20	and	and	CCONJ
aji-28	179	21	eighty	eighty	NUM
aji-28	179	22	residents	resident	NOUN
aji-28	179	23	of	of	ADP
aji-28	179	24	kaduna	kaduna	PROPN
aji-28	179	25	south	south	PROPN
aji-28	179	26	senatorial	senatorial	PROPN
aji-28	179	27	district	district	NOUN
aji-28	179	28	,	,	PUNCT
aji-28	179	29	kaduna	kaduna	PROPN
aji-28	179	30	state	state	PROPN
aji-28	179	31	after	after	ADP
aji-28	179	32	the	the	DET
aji-28	179	33	signing	signing	NOUN
aji-28	179	34	of	of	ADP
aji-28	179	35	a	a	DET
aji-28	179	36	consent	consent	NOUN
aji-28	179	37	form	form	NOUN
aji-28	179	38	and	and	CCONJ
aji-28	179	39	the	the	DET
aji-28	179	40	administration	administration	NOUN
aji-28	179	41	of	of	ADP
aji-28	179	42	questionnaire	questionnaire	NOUN
aji-28	179	43	.	.	PUNCT
aji-28	180	1	collected	collect	VERB
aji-28	180	2	samples	sample	NOUN
aji-28	180	3	were	be	AUX
aji-28	180	4	placed	place	VERB
aji-28	180	5	in	in	ADP
aji-28	180	6	sterile	sterile	ADJ
aji-28	180	7	plain	plain	ADJ
aji-28	180	8	tubes	tube	NOUN
aji-28	180	9	and	and	CCONJ
aji-28	180	10	labeled	label	VERB
aji-28	180	11	appropriately	appropriately	ADV
aji-28	180	12	.	.	PUNCT
aji-28	181	1	the	the	DET
aji-28	181	2	blood	blood	NOUN
aji-28	181	3	samples	sample	NOUN
aji-28	181	4	were	be	AUX
aji-28	181	5	centrifuged	centrifuge	VERB
aji-28	181	6	at	at	ADP
aji-28	181	7	2000	2000	NUM
aji-28	181	8	rpm	rpm	NOUN
aji-28	181	9	for	for	ADP
aji-28	181	10	five	five	NUM
aji-28	181	11	minutes	minute	NOUN
aji-28	181	12	.	.	PUNCT
aji-28	182	1	sera	sera	NOUN
aji-28	182	2	were	be	AUX
aji-28	182	3	separated	separate	VERB
aji-28	182	4	using	use	VERB
aji-28	182	5	automated	automate	VERB
aji-28	182	6	pipette	pipette	NOUN
aji-28	182	7	and	and	CCONJ
aji-28	182	8	stored	store	VERB
aji-28	182	9	in	in	ADP
aji-28	182	10	the	the	DET
aji-28	182	11	freezer	freezer	NOUN
aji-28	182	12	at	at	ADP
aji-28	182	13	-20	-20	PROPN
aji-28	182	14	°	°	NOUN
aji-28	182	15	c	c	NOUN
aji-28	182	16	prior	prior	ADV
aji-28	182	17	to	to	ADP
aji-28	182	18	usage	usage	NOUN
aji-28	182	19	.	.	PUNCT
aji-28	183	1	all	all	DET
aji-28	183	2	samples	sample	NOUN
aji-28	183	3	were	be	AUX
aji-28	183	4	qualitatively	qualitatively	ADV
aji-28	183	5	tested	test	VERB
aji-28	183	6	for	for	ADP
aji-28	183	7	five	five	NUM
aji-28	183	8	hepatitis	hepatitis	PROPN
aji-28	183	9	b	b	PROPN
aji-28	183	10	markers	marker	NOUN
aji-28	183	11	hbsag	hbsag	NOUN
aji-28	183	12	,	,	PUNCT
aji-28	183	13	hbsab	hbsab	NOUN
aji-28	183	14	,	,	PUNCT
aji-28	183	15	hbeag	hbeag	ADJ
aji-28	183	16	,	,	PUNCT
aji-28	183	17	hbeab	hbeab	NOUN
aji-28	183	18	and	and	CCONJ
aji-28	183	19	hbcab	hbcab	NOUN
aji-28	183	20	using	use	VERB
aji-28	183	21	hbv	hbv	NOUN
aji-28	183	22	5	5	NUM
aji-28	183	23	-	-	PUNCT
aji-28	183	24	panel	panel	NOUN
aji-28	183	25	test	test	NOUN
aji-28	183	26	kit	kit	NOUN
aji-28	183	27	(	(	PUNCT
aji-28	183	28	skytech	skytech	PROPN
aji-28	183	29	,	,	PUNCT
aji-28	183	30	usa	usa	PROPN
aji-28	183	31	)	)	PUNCT
aji-28	183	32	.	.	PUNCT
aji-28	184	1	quantity	quantity	NOUN
aji-28	184	2	of	of	ADP
aji-28	184	3	hbsab	hbsab	NOUN
aji-28	184	4	was	be	AUX
aji-28	184	5	also	also	ADV
aji-28	184	6	tested	test	VERB
aji-28	184	7	using	use	VERB
aji-28	184	8	elisa	elisa	NOUN
aji-28	184	9	kit	kit	NOUN
aji-28	184	10	(	(	PUNCT
aji-28	184	11	enzyme	enzyme	NOUN
aji-28	184	12	linked	link	VERB
aji-28	184	13	immunoassay	immunoassay	NOUN
aji-28	184	14	for	for	ADP
aji-28	184	15	qualitative	qualitative	ADJ
aji-28	184	16	and	and	CCONJ
aji-28	184	17	quantitative	quantitative	ADJ
aji-28	184	18	determination	determination	NOUN
aji-28	184	19	of	of	ADP
aji-28	184	20	antibodies	antibody	NOUN
aji-28	184	21	to	to	ADP
aji-28	184	22	hepatitis	hepatitis	PROPN
aji-28	184	23	b	b	PROPN
aji-28	184	24	surface	surface	NOUN
aji-28	184	25	antigen	antigen	ADV
aji-28	184	26	in	in	ADP
aji-28	184	27	human	human	ADJ
aji-28	184	28	serum	serum	NOUN
aji-28	184	29	and	and	CCONJ
aji-28	184	30	plasma	plasma	NOUN
aji-28	184	31	by	by	ADP
aji-28	184	32	dia.pro	dia.pro	PROPN
aji-28	184	33	in	in	ADP
aji-28	184	34	italy	italy	PROPN
aji-28	184	35	)	)	PUNCT
aji-28	184	36	.	.	PUNCT
aji-28	185	1	2.3	2.3	NUM
aji-28	185	2	qualitative	qualitative	ADJ
aji-28	185	3	analysis	analysis	NOUN
aji-28	185	4	using	use	VERB
aji-28	185	5	hbv	hbv	NOUN
aji-28	185	6	profile	profile	PROPN
aji-28	185	7	test	test	NOUN
aji-28	185	8	kit	kit	NOUN
aji-28	185	9	2.3.1	2.3.1	NUM
aji-28	185	10	principle	principle	NOUN
aji-28	185	11	of	of	ADP
aji-28	185	12	hbv	hbv	NOUN
aji-28	185	13	detection	detection	NOUN
aji-28	185	14	with	with	ADP
aji-28	185	15	hbv	hbv	NOUN
aji-28	185	16	profile	profile	PROPN
aji-28	185	17	test	test	NOUN
aji-28	185	18	kit	kit	NOUN
aji-28	185	19	the	the	DET
aji-28	185	20	product	product	NOUN
aji-28	185	21	uses	use	VERB
aji-28	185	22	the	the	DET
aji-28	185	23	colloidal	colloidal	NOUN
aji-28	185	24	gold	gold	NOUN
aji-28	185	25	and	and	CCONJ
aji-28	185	26	membrane	membrane	NOUN
aji-28	185	27	chromatography	chromatography	NOUN
aji-28	185	28	technology	technology	NOUN
aji-28	185	29	,	,	PUNCT
aji-28	185	30	measures	measure	VERB
aji-28	185	31	hbsag	hbsag	ADJ
aji-28	185	32	,	,	PUNCT
aji-28	185	33	hbeag	hbeag	ADV
aji-28	185	34	in	in	ADP
aji-28	185	35	whole	whole	ADJ
aji-28	185	36	blood	blood	NOUN
aji-28	185	37	,	,	PUNCT
aji-28	185	38	serum	serum	NOUN
aji-28	185	39	and	and	CCONJ
aji-28	185	40	plasma	plasma	NOUN
aji-28	185	41	with	with	ADP
aji-28	185	42	dual	dual	ADJ
aji-28	185	43	-	-	PUNCT
aji-28	185	44	antibody	antibody	NOUN
aji-28	185	45	sandwich	sandwich	NOUN
aji-28	185	46	method	method	NOUN
aji-28	185	47	,	,	PUNCT
aji-28	185	48	measures	measure	NOUN
aji-28	185	49	hbsab	hbsab	VERB
aji-28	185	50	with	with	ADP
aji-28	185	51	dual	dual	ADJ
aji-28	185	52	–	–	PUNCT
aji-28	185	53	antigen	antigen	ADJ
aji-28	185	54	sandwich	sandwich	NOUN
aji-28	185	55	method	method	NOUN
aji-28	185	56	and	and	CCONJ
aji-28	185	57	measures	measure	VERB
aji-28	185	58	hbeab	hbeab	NOUN
aji-28	185	59	and	and	CCONJ
aji-28	185	60	hbcab	hbcab	NOUN
aji-28	185	61	with	with	ADP
aji-28	185	62	neutralization	neutralization	NOUN
aji-28	185	63	competitive	competitive	ADJ
aji-28	185	64	inhibition	inhibition	NOUN
aji-28	185	65	method	method	NOUN
aji-28	185	66	.	.	PUNCT
aji-28	186	1	2.3.2	2.3.2	NUM
aji-28	186	2	assay	assay	NOUN
aji-28	186	3	procedure	procedure	NOUN
aji-28	186	4	of	of	ADP
aji-28	186	5	hbv	hbv	NOUN
aji-28	186	6	profile	profile	NOUN
aji-28	186	7	test	test	VERB
aji-28	186	8	the	the	DET
aji-28	186	9	right	right	ADJ
aji-28	186	10	side	side	NOUN
aji-28	186	11	of	of	ADP
aji-28	186	12	the	the	DET
aji-28	186	13	hbv	hbv	NOUN
aji-28	186	14	profile	profile	PROPN
aji-28	186	15	test	test	NOUN
aji-28	186	16	card	card	NOUN
aji-28	186	17	were	be	AUX
aji-28	186	18	placed	place	VERB
aji-28	186	19	horizontally	horizontally	ADV
aji-28	186	20	from	from	ADP
aji-28	186	21	the	the	DET
aji-28	186	22	original	original	ADJ
aji-28	186	23	package	package	NOUN
aji-28	186	24	,	,	PUNCT
aji-28	186	25	from	from	ADP
aji-28	186	26	left	leave	VERB
aji-28	186	27	to	to	ADP
aji-28	186	28	right	right	NOUN
aji-28	186	29	,	,	PUNCT
aji-28	186	30	respectively	respectively	ADV
aji-28	186	31	corresponding	correspond	VERB
aji-28	186	32	to	to	ADP
aji-28	186	33	hbsag	hbsag	NOUN
aji-28	186	34	,	,	PUNCT
aji-28	186	35	hbsab	hbsab	NOUN
aji-28	186	36	,	,	PUNCT
aji-28	186	37	hbeag	hbeag	ADV
aji-28	186	38	,	,	PUNCT
aji-28	186	39	hbeab	hbeab	ADV
aji-28	186	40	,	,	PUNCT
aji-28	186	41	hbcab	hbcab	PROPN
aji-28	186	42	.	.	PUNCT
aji-28	187	1	serum	serum	PROPN
aji-28	187	2	was	be	AUX
aji-28	187	3	dropped	drop	VERB
aji-28	187	4	into	into	ADP
aji-28	187	5	each	each	PRON
aji-28	187	6	of	of	ADP
aji-28	187	7	the	the	DET
aji-28	187	8	five	five	NUM
aji-28	187	9	sample	sample	NOUN
aji-28	187	10	wells	well	NOUN
aji-28	187	11	of	of	ADP
aji-28	187	12	the	the	DET
aji-28	187	13	test	test	NOUN
aji-28	187	14	board	board	NOUN
aji-28	187	15	using	use	VERB
aji-28	187	16	micropipettes	micropipette	NOUN
aji-28	187	17	.	.	PUNCT
aji-28	188	1	a	a	DET
aji-28	188	2	drop	drop	NOUN
aji-28	188	3	of	of	ADP
aji-28	188	4	buffer	buffer	NOUN
aji-28	188	5	was	be	AUX
aji-28	188	6	added	add	VERB
aji-28	188	7	to	to	ADP
aji-28	188	8	each	each	PRON
aji-28	188	9	of	of	ADP
aji-28	188	10	the	the	DET
aji-28	188	11	five	five	NUM
aji-28	188	12	wells	well	NOUN
aji-28	188	13	on	on	ADP
aji-28	188	14	the	the	DET
aji-28	188	15	test	test	NOUN
aji-28	188	16	card	card	NOUN
aji-28	188	17	.	.	PUNCT
aji-28	189	1	the	the	DET
aji-28	189	2	results	result	NOUN
aji-28	189	3	were	be	AUX
aji-28	189	4	observed	observe	VERB
aji-28	189	5	and	and	CCONJ
aji-28	189	6	recorded	record	VERB
aji-28	189	7	within	within	ADP
aji-28	189	8	fifteen	fifteen	NUM
aji-28	189	9	minutes	minute	NOUN
aji-28	189	10	.	.	PUNCT
aji-28	190	1	2.3.3	2.3.3	NUM
aji-28	190	2	results	result	VERB
aji-28	190	3	determination	determination	NOUN
aji-28	190	4	negative	negative	ADJ
aji-28	190	5	results	result	NOUN
aji-28	190	6	for	for	ADP
aji-28	190	7	hbsag	hbsag	NOUN
aji-28	190	8	,	,	PUNCT
aji-28	190	9	hbsab	hbsab	NOUN
aji-28	190	10	,	,	PUNCT
aji-28	190	11	hbeag	hbeag	ADV
aji-28	190	12	(	(	PUNCT
aji-28	190	13	sandwich	sandwich	NOUN
aji-28	190	14	method	method	PROPN
aji-28	190	15	)	)	PUNCT
aji-28	190	16	,	,	PUNCT
aji-28	190	17	were	be	AUX
aji-28	190	18	represented	represent	VERB
aji-28	190	19	with	with	ADP
aji-28	190	20	only	only	ADV
aji-28	190	21	one	one	NUM
aji-28	190	22	purple	purple	ADJ
aji-28	190	23	bar	bar	NOUN
aji-28	190	24	at	at	ADP
aji-28	190	25	the	the	DET
aji-28	190	26	control	control	NOUN
aji-28	190	27	line	line	NOUN
aji-28	190	28	in	in	ADP
aji-28	190	29	the	the	DET
aji-28	190	30	control	control	NOUN
aji-28	190	31	(	(	PUNCT
aji-28	190	32	c	c	NOUN
aji-28	190	33	)	)	PUNCT
aji-28	190	34	zone	zone	NOUN
aji-28	190	35	.	.	PUNCT
aji-28	191	1	while	while	SCONJ
aji-28	191	2	positive	positive	ADJ
aji-28	191	3	results	result	NOUN
aji-28	191	4	were	be	AUX
aji-28	191	5	by	by	ADP
aji-28	191	6	detecting	detect	VERB
aji-28	191	7	two	two	NUM
aji-28	191	8	purple	purple	ADJ
aji-28	191	9	bars	bar	NOUN
aji-28	191	10	,	,	PUNCT
aji-28	191	11	one	one	NUM
aji-28	191	12	in	in	ADP
aji-28	191	13	the	the	DET
aji-28	191	14	test	test	NOUN
aji-28	191	15	(	(	PUNCT
aji-28	191	16	t	t	NOUN
aji-28	191	17	)	)	PUNCT
aji-28	191	18	zone	zone	NOUN
aji-28	191	19	and	and	CCONJ
aji-28	191	20	the	the	DET
aji-28	191	21	other	other	ADJ
aji-28	191	22	in	in	ADP
aji-28	191	23	the	the	DET
aji-28	191	24	control	control	NOUN
aji-28	191	25	(	(	PUNCT
aji-28	191	26	c	c	NOUN
aji-28	191	27	)	)	PUNCT
aji-28	191	28	zone	zone	NOUN
aji-28	191	29	.	.	PUNCT
aji-28	192	1	negative	negative	ADJ
aji-28	192	2	results	result	NOUN
aji-28	192	3	for	for	ADP
aji-28	192	4	hbeab	hbeab	NOUN
aji-28	192	5	and	and	CCONJ
aji-28	192	6	hbcab	hbcab	NOUN
aji-28	192	7	(	(	PUNCT
aji-28	192	8	competition	competition	NOUN
aji-28	192	9	method	method	NOUN
aji-28	192	10	)	)	PUNCT
aji-28	192	11	was	be	AUX
aji-28	192	12	done	do	VERB
aji-28	192	13	by	by	ADP
aji-28	192	14	detecting	detect	VERB
aji-28	192	15	two	two	NUM
aji-28	192	16	ibrahim	ibrahim	PROPN
aji-28	192	17	et	et	PROPN
aji-28	192	18	al	al	PROPN
aji-28	192	19	.	.	PROPN
aji-28	192	20	;	;	PUNCT
aji-28	192	21	aji	aji	PROPN
aji-28	192	22	,	,	PUNCT
aji-28	192	23	3(1	3(1	NUM
aji-28	192	24	):	):	PUNCT
aji-28	192	25	291	291	NUM
aji-28	192	26	-	-	SYM
aji-28	192	27	297	297	NUM
aji-28	192	28	,	,	PUNCT
aji-28	192	29	2020	2020	NUM
aji-28	192	30	;	;	PUNCT
aji-28	192	31	article	article	NOUN
aji-28	192	32	no.aji.60171	no.aji.60171	VERB
aji-28	192	33	294	294	NUM
aji-28	192	34	purple	purple	ADJ
aji-28	192	35	bars	bar	NOUN
aji-28	192	36	in	in	ADP
aji-28	192	37	t	t	PROPN
aji-28	192	38	and	and	CCONJ
aji-28	192	39	c	c	PROPN
aji-28	192	40	zone	zone	NOUN
aji-28	192	41	and	and	CCONJ
aji-28	192	42	positive	positive	ADJ
aji-28	192	43	results	result	NOUN
aji-28	192	44	were	be	AUX
aji-28	192	45	by	by	ADP
aji-28	192	46	detecting	detect	VERB
aji-28	192	47	only	only	ADV
aji-28	192	48	one	one	NUM
aji-28	192	49	purple	purple	ADJ
aji-28	192	50	bar	bar	NOUN
aji-28	192	51	(	(	PUNCT
aji-28	192	52	control	control	NOUN
aji-28	192	53	line	line	NOUN
aji-28	192	54	)	)	PUNCT
aji-28	192	55	in	in	ADP
aji-28	192	56	the	the	DET
aji-28	192	57	control	control	NOUN
aji-28	192	58	zone	zone	NOUN
aji-28	192	59	.	.	PUNCT
aji-28	193	1	2.4	2.4	NUM
aji-28	193	2	data	datum	NOUN
aji-28	193	3	analysis	analysis	NOUN
aji-28	193	4	the	the	DET
aji-28	193	5	data	datum	NOUN
aji-28	193	6	obtained	obtain	VERB
aji-28	193	7	from	from	ADP
aji-28	193	8	the	the	DET
aji-28	193	9	study	study	NOUN
aji-28	193	10	were	be	AUX
aji-28	193	11	analysed	analyse	VERB
aji-28	193	12	using	use	VERB
aji-28	193	13	statistical	statistical	ADJ
aji-28	193	14	package	package	NOUN
aji-28	193	15	for	for	ADP
aji-28	193	16	social	social	ADJ
aji-28	193	17	sciences	science	NOUN
aji-28	193	18	(	(	PUNCT
aji-28	193	19	spss	spss	PROPN
aji-28	193	20	)	)	PUNCT
aji-28	193	21	version	version	NOUN
aji-28	193	22	21	21	NUM
aji-28	193	23	(	(	PUNCT
aji-28	193	24	ibm	ibm	PROPN
aji-28	193	25	spss	spss	PROPN
aji-28	193	26	inc	inc	PROPN
aji-28	193	27	,	,	PUNCT
aji-28	193	28	usa).proportions	usa).proportions	PROPN
aji-28	193	29	were	be	AUX
aji-28	193	30	compared	compare	VERB
aji-28	193	31	using	use	VERB
aji-28	193	32	chisquare	chisquare	NOUN
aji-28	193	33	with	with	ADP
aji-28	193	34	confidence	confidence	NOUN
aji-28	193	35	limit	limit	NOUN
aji-28	193	36	(	(	PUNCT
aji-28	193	37	p	p	NOUN
aji-28	193	38	-	-	PUNCT
aji-28	193	39	value	value	NOUN
aji-28	193	40	)	)	PUNCT
aji-28	193	41	of	of	ADP
aji-28	193	42	<	<	X
aji-28	193	43	0.05considered	0.05considere	VERB
aji-28	193	44	significant	significant	ADJ
aji-28	193	45	.	.	PUNCT
aji-28	194	1	3	3	X
aji-28	194	2	.	.	X
aji-28	194	3	results	result	NOUN
aji-28	194	4	of	of	ADP
aji-28	194	5	the	the	DET
aji-28	194	6	180	180	NUM
aji-28	194	7	respondents	respondent	NOUN
aji-28	194	8	,	,	PUNCT
aji-28	194	9	61	61	NUM
aji-28	194	10	were	be	AUX
aji-28	194	11	male	male	ADJ
aji-28	194	12	while	while	SCONJ
aji-28	194	13	119	119	NUM
aji-28	194	14	were	be	AUX
aji-28	194	15	female	female	ADJ
aji-28	194	16	.	.	PUNCT
aji-28	195	1	the	the	DET
aji-28	195	2	overall	overall	ADJ
aji-28	195	3	sero	sero	ADJ
aji-28	195	4	-	-	PUNCT
aji-28	195	5	conversion	conversion	NOUN
aji-28	195	6	rate	rate	NOUN
aji-28	195	7	of	of	ADP
aji-28	195	8	hbsab	hbsab	NOUN
aji-28	195	9	51.7	51.7	NUM
aji-28	195	10	%	%	NOUN
aji-28	195	11	out	out	ADP
aji-28	195	12	of	of	ADP
aji-28	195	13	which	which	DET
aji-28	195	14	male	male	NOUN
aji-28	195	15	had	have	VERB
aji-28	195	16	18.9	18.9	NUM
aji-28	195	17	%	%	NOUN
aji-28	195	18	representing	represent	VERB
aji-28	195	19	34	34	NUM
aji-28	195	20	positive	positive	ADJ
aji-28	195	21	rate	rate	NOUN
aji-28	195	22	while	while	SCONJ
aji-28	195	23	female	female	ADJ
aji-28	195	24	with	with	ADP
aji-28	195	25	32.8	32.8	NUM
aji-28	195	26	%	%	NOUN
aji-28	195	27	had	have	VERB
aji-28	195	28	59	59	NUM
aji-28	195	29	tested	test	VERB
aji-28	195	30	positive	positive	ADJ
aji-28	195	31	.	.	PUNCT
aji-28	196	1	the	the	DET
aji-28	196	2	results	result	NOUN
aji-28	196	3	there	there	ADV
aji-28	196	4	showed	show	VERB
aji-28	196	5	no	no	DET
aji-28	196	6	statistically	statistically	ADV
aji-28	196	7	significant	significant	ADJ
aji-28	196	8	difference	difference	NOUN
aji-28	196	9	between	between	ADP
aji-28	196	10	male	male	NOUN
aji-28	196	11	and	and	CCONJ
aji-28	196	12	female	female	ADJ
aji-28	196	13	(	(	PUNCT
aji-28	196	14	χ	χ	NOUN
aji-28	196	15	2	2	NUM
aji-28	196	16	=	=	SYM
aji-28	196	17	3.612	3.612	NUM
aji-28	196	18	,	,	PUNCT
aji-28	196	19	p	p	NOUN
aji-28	196	20	=	=	NOUN
aji-28	196	21	.43	.43	NUM
aji-28	196	22	)	)	PUNCT
aji-28	196	23	see	see	VERB
aji-28	196	24	table	table	NOUN
aji-28	196	25	1	1	NUM
aji-28	196	26	.	.	PUNCT
aji-28	197	1	the	the	DET
aji-28	197	2	study	study	NOUN
aji-28	197	3	revealed	reveal	VERB
aji-28	197	4	the	the	DET
aji-28	197	5	highest	high	ADJ
aji-28	197	6	hbsab	hbsab	ADJ
aji-28	197	7	sero	sero	NOUN
aji-28	197	8	-	-	PUNCT
aji-28	197	9	conversion	conversion	NOUN
aji-28	197	10	rate	rate	NOUN
aji-28	197	11	of	of	ADP
aji-28	197	12	10.0	10.0	NUM
aji-28	197	13	%	%	NOUN
aji-28	197	14	among	among	ADP
aji-28	197	15	the	the	DET
aji-28	197	16	age	age	NOUN
aji-28	197	17	group	group	NOUN
aji-28	197	18	26	26	NUM
aji-28	197	19	–	–	PUNCT
aji-28	197	20	30	30	NUM
aji-28	197	21	years	year	NOUN
aji-28	197	22	with	with	ADP
aji-28	197	23	the	the	DET
aji-28	197	24	lowest	low	ADJ
aji-28	197	25	rate	rate	NOUN
aji-28	197	26	of	of	ADP
aji-28	197	27	3.3	3.3	NUM
aji-28	197	28	%	%	NOUN
aji-28	197	29	among	among	ADP
aji-28	197	30	16	16	NUM
aji-28	197	31	–	–	SYM
aji-28	197	32	20	20	NUM
aji-28	197	33	years	year	NOUN
aji-28	197	34	age	age	NOUN
aji-28	197	35	group	group	NOUN
aji-28	197	36	.	.	PUNCT
aji-28	198	1	this	this	PRON
aji-28	198	2	however	however	ADV
aji-28	198	3	,	,	PUNCT
aji-28	198	4	was	be	AUX
aji-28	198	5	not	not	PART
aji-28	198	6	statistically	statistically	ADV
aji-28	198	7	significant	significant	ADJ
aji-28	198	8	(	(	PUNCT
aji-28	198	9	table	table	NOUN
aji-28	198	10	2	2	NUM
aji-28	198	11	)	)	PUNCT
aji-28	198	12	(	(	PUNCT
aji-28	198	13	χ	χ	X
aji-28	198	14	2	2	NUM
aji-28	198	15	=	=	SYM
aji-28	198	16	5.604	5.604	NUM
aji-28	198	17	,	,	PUNCT
aji-28	198	18	p	p	X
aji-28	198	19	=	=	NOUN
aji-28	198	20	.70	.70	NUM
aji-28	198	21	)	)	PUNCT
aji-28	198	22	.	.	PUNCT
aji-28	199	1	for	for	SCONJ
aji-28	199	2	the	the	DET
aji-28	199	3	number	number	NOUN
aji-28	199	4	of	of	ADP
aji-28	199	5	vaccine	vaccine	NOUN
aji-28	199	6	shots	shot	VERB
aji-28	199	7	,	,	PUNCT
aji-28	199	8	40.6	40.6	NUM
aji-28	199	9	%	%	NOUN
aji-28	199	10	of	of	ADP
aji-28	199	11	those	those	PRON
aji-28	199	12	who	who	PRON
aji-28	199	13	completed	complete	VERB
aji-28	199	14	their	their	PRON
aji-28	199	15	vaccination	vaccination	NOUN
aji-28	199	16	were	be	AUX
aji-28	199	17	seroconverted	seroconverte	VERB
aji-28	199	18	followed	follow	VERB
aji-28	199	19	by	by	ADP
aji-28	199	20	those	those	PRON
aji-28	199	21	who	who	PRON
aji-28	199	22	took	take	VERB
aji-28	199	23	two	two	NUM
aji-28	199	24	shots	shot	NOUN
aji-28	199	25	with	with	ADP
aji-28	199	26	4.4	4.4	NUM
aji-28	199	27	%	%	NOUN
aji-28	199	28	while	while	SCONJ
aji-28	199	29	those	those	PRON
aji-28	199	30	who	who	PRON
aji-28	199	31	had	have	VERB
aji-28	199	32	one	one	NUM
aji-28	199	33	shot	shot	NOUN
aji-28	199	34	had	have	VERB
aji-28	199	35	6.7	6.7	NUM
aji-28	199	36	%	%	NOUN
aji-28	199	37	hbsab	hbsab	NOUN
aji-28	199	38	at	at	ADP
aji-28	199	39	χ	χ	NOUN
aji-28	199	40	2	2	NUM
aji-28	199	41	=	=	SYM
aji-28	199	42	30.665	30.665	NUM
aji-28	199	43	,	,	PUNCT
aji-28	199	44	p	p	X
aji-28	199	45	<	<	X
aji-28	199	46	.001	.001	NUM
aji-28	199	47	.	.	PUNCT
aji-28	200	1	this	this	PRON
aji-28	200	2	showed	show	VERB
aji-28	200	3	a	a	DET
aji-28	200	4	significant	significant	ADJ
aji-28	200	5	difference	difference	NOUN
aji-28	200	6	between	between	ADP
aji-28	200	7	the	the	DET
aji-28	200	8	vaccine	vaccine	NOUN
aji-28	200	9	shots	shot	VERB
aji-28	200	10	(	(	PUNCT
aji-28	200	11	table	table	NOUN
aji-28	200	12	3	3	NUM
aji-28	200	13	)	)	PUNCT
aji-28	200	14	.	.	PUNCT
aji-28	201	1	protective	protective	ADJ
aji-28	201	2	seroprotection	seroprotection	NOUN
aji-28	201	3	in	in	ADP
aji-28	201	4	relation	relation	NOUN
aji-28	201	5	to	to	ADP
aji-28	201	6	the	the	DET
aji-28	201	7	quantity	quantity	NOUN
aji-28	201	8	of	of	ADP
aji-28	201	9	hbv	hbv	NOUN
aji-28	201	10	vaccine	vaccine	NOUN
aji-28	201	11	with	with	ADP
aji-28	201	12	titre	titre	NOUN
aji-28	201	13	values	value	NOUN
aji-28	201	14	of	of	ADP
aji-28	201	15	≥100iu	≥100iu	NOUN
aji-28	201	16	/	/	SYM
aji-28	201	17	ml	ml	NOUN
aji-28	201	18	had	have	VERB
aji-28	201	19	34.6	34.6	NUM
aji-28	201	20	%	%	NOUN
aji-28	201	21	while	while	SCONJ
aji-28	201	22	≤	≤	ADJ
aji-28	201	23	100iu	100iu	NOUN
aji-28	201	24	/	/	SYM
aji-28	201	25	ml	ml	NOUN
aji-28	201	26	had	have	VERB
aji-28	201	27	16.1	16.1	NUM
aji-28	201	28	%	%	NOUN
aji-28	201	29	respectively	respectively	ADV
aji-28	201	30	.	.	PUNCT
aji-28	202	1	the	the	DET
aji-28	202	2	result	result	NOUN
aji-28	202	3	therefore	therefore	ADV
aji-28	202	4	showed	show	VERB
aji-28	202	5	statistically	statistically	ADV
aji-28	202	6	significant	significant	ADJ
aji-28	202	7	difference	difference	NOUN
aji-28	202	8	to	to	ADP
aji-28	202	9	the	the	DET
aji-28	202	10	quantity	quantity	NOUN
aji-28	202	11	of	of	ADP
aji-28	202	12	the	the	DET
aji-28	202	13	vaccine	vaccine	NOUN
aji-28	202	14	administered	administer	VERB
aji-28	202	15	at	at	ADP
aji-28	202	16	χ2	χ2	PROPN
aji-28	202	17	=	=	PUNCT
aji-28	202	18	6.98	6.98	NUM
aji-28	202	19	,	,	PUNCT
aji-28	202	20	p	p	X
aji-28	202	21	=	=	NOUN
aji-28	202	22	.08	.08	NUM
aji-28	202	23	.	.	PUNCT
aji-28	203	1	in	in	ADP
aji-28	203	2	table	table	NOUN
aji-28	203	3	4	4	NUM
aji-28	203	4	.	.	PUNCT
aji-28	204	1	this	this	DET
aji-28	204	2	study	study	NOUN
aji-28	204	3	did	do	AUX
aji-28	204	4	not	not	PART
aji-28	204	5	recruit	recruit	VERB
aji-28	204	6	equal	equal	ADJ
aji-28	204	7	number	number	NOUN
aji-28	204	8	of	of	ADP
aji-28	204	9	respondents	respondent	NOUN
aji-28	204	10	in	in	ADP
aji-28	204	11	the	the	DET
aji-28	204	12	one	one	NUM
aji-28	204	13	shot	shot	NOUN
aji-28	204	14	,	,	PUNCT
aji-28	204	15	two	two	NUM
aji-28	204	16	shots	shot	NOUN
aji-28	204	17	and	and	CCONJ
aji-28	204	18	three	three	NUM
aji-28	204	19	shots	shot	NOUN
aji-28	204	20	category	category	NOUN
aji-28	204	21	and	and	CCONJ
aji-28	204	22	did	do	AUX
aji-28	204	23	not	not	PART
aji-28	204	24	take	take	VERB
aji-28	204	25	into	into	ADP
aji-28	204	26	consideration	consideration	NOUN
aji-28	204	27	other	other	ADJ
aji-28	204	28	the	the	DET
aji-28	204	29	cellular	cellular	ADJ
aji-28	204	30	and	and	CCONJ
aji-28	204	31	genetic	genetic	ADJ
aji-28	204	32	factors	factor	NOUN
aji-28	204	33	that	that	PRON
aji-28	204	34	influence	influence	VERB
aji-28	204	35	sero	sero	NOUN
aji-28	204	36	-	-	PUNCT
aji-28	204	37	conversion	conversion	NOUN
aji-28	204	38	.	.	PUNCT
aji-28	205	1	table	table	NOUN
aji-28	205	2	1	1	NUM
aji-28	205	3	.	.	X
aji-28	205	4	sero	sero	NOUN
aji-28	205	5	-	-	PUNCT
aji-28	205	6	conversion	conversion	NOUN
aji-28	205	7	of	of	ADP
aji-28	205	8	adult	adult	NOUN
aji-28	205	9	subjects	subject	NOUN
aji-28	205	10	to	to	ADP
aji-28	205	11	hbv	hbv	NOUN
aji-28	205	12	vaccine	vaccine	NOUN
aji-28	205	13	in	in	ADP
aji-28	205	14	relation	relation	NOUN
aji-28	205	15	to	to	ADP
aji-28	205	16	gender	gender	NOUN
aji-28	205	17	gender	gender	NOUN
aji-28	205	18	no	no	INTJ
aji-28	205	19	.	.	PROPN
aji-28	205	20	tested	test	VERB
aji-28	205	21	for	for	ADP
aji-28	205	22	hbsab	hbsab	NOUN
aji-28	205	23	no	no	INTJ
aji-28	205	24	positive	positive	ADJ
aji-28	205	25	for	for	ADP
aji-28	205	26	hbsab	hbsab	ADJ
aji-28	205	27	%	%	INTJ
aji-28	205	28	positive	positive	ADJ
aji-28	205	29	male	male	NOUN
aji-28	205	30	61	61	NUM
aji-28	205	31	34	34	NUM
aji-28	205	32	18.9	18.9	NUM
aji-28	205	33	female	female	NOUN
aji-28	205	34	119	119	NUM
aji-28	205	35	59	59	NUM
aji-28	205	36	32.8	32.8	NUM
aji-28	205	37	total	total	NOUN
aji-28	205	38	180	180	NUM
aji-28	205	39	93	93	NUM
aji-28	205	40	51.7	51.7	NUM
aji-28	205	41	(	(	PUNCT
aji-28	205	42	χ	χ	NOUN
aji-28	205	43	2	2	NUM
aji-28	205	44	=	=	SYM
aji-28	205	45	3.612	3.612	NUM
aji-28	205	46	,	,	PUNCT
aji-28	205	47	p=	p=	ADJ
aji-28	205	48	.43	.43	NUM
aji-28	205	49	)	)	PUNCT
aji-28	205	50	table	table	NOUN
aji-28	205	51	2	2	NUM
aji-28	205	52	.	.	X
aji-28	205	53	sero	sero	NOUN
aji-28	205	54	-	-	PUNCT
aji-28	205	55	conversion	conversion	NOUN
aji-28	205	56	of	of	ADP
aji-28	205	57	adult	adult	NOUN
aji-28	205	58	subjects	subject	NOUN
aji-28	205	59	to	to	ADP
aji-28	205	60	hbv	hbv	NOUN
aji-28	205	61	vaccine	vaccine	NOUN
aji-28	205	62	in	in	ADP
aji-28	205	63	relation	relation	NOUN
aji-28	205	64	to	to	ADP
aji-28	205	65	age	age	NOUN
aji-28	205	66	age	age	NOUN
aji-28	205	67	group	group	NOUN
aji-28	205	68	no	no	PROPN
aji-28	205	69	.	.	PROPN
aji-28	205	70	tested	test	VERB
aji-28	205	71	for	for	ADP
aji-28	205	72	hbsab	hbsab	NOUN
aji-28	205	73	no	no	INTJ
aji-28	205	74	positive	positive	ADJ
aji-28	205	75	for	for	ADP
aji-28	205	76	hbsab	hbsab	ADJ
aji-28	205	77	%	%	NOUN
aji-28	205	78	positive	positive	ADJ
aji-28	205	79	16	16	NUM
aji-28	205	80	-	-	SYM
aji-28	205	81	20	20	NUM
aji-28	205	82	14	14	NUM
aji-28	205	83	6	6	NUM
aji-28	205	84	3.3	3.3	NUM
aji-28	205	85	21	21	NUM
aji-28	205	86	-	-	SYM
aji-28	205	87	25	25	NUM
aji-28	205	88	20	20	NUM
aji-28	205	89	11	11	NUM
aji-28	205	90	6.1	6.1	NUM
aji-28	205	91	26	26	NUM
aji-28	205	92	-	-	SYM
aji-28	205	93	30	30	NUM
aji-28	205	94	34	34	NUM
aji-28	205	95	18	18	NUM
aji-28	205	96	10	10	NUM
aji-28	205	97	31	31	NUM
aji-28	205	98	-	-	SYM
aji-28	205	99	35	35	NUM
aji-28	205	100	11	11	NUM
aji-28	205	101	8	8	NUM
aji-28	205	102	4.4	4.4	NUM
aji-28	205	103	36	36	NUM
aji-28	205	104	-	-	SYM
aji-28	205	105	40	40	NUM
aji-28	205	106	20	20	NUM
aji-28	205	107	12	12	NUM
aji-28	205	108	6.7	6.7	NUM
aji-28	205	109	41	41	NUM
aji-28	205	110	-	-	SYM
aji-28	205	111	45	45	NUM
aji-28	205	112	30	30	NUM
aji-28	205	113	16	16	NUM
aji-28	205	114	8.9	8.9	NUM
aji-28	205	115	46	46	NUM
aji-28	205	116	-	-	SYM
aji-28	205	117	50	50	NUM
aji-28	205	118	22	22	NUM
aji-28	205	119	8	8	NUM
aji-28	205	120	4.4	4.4	NUM
aji-28	205	121	50	50	NUM
aji-28	205	122	-	-	SYM
aji-28	205	123	55	55	NUM
aji-28	205	124	14	14	NUM
aji-28	205	125	6	6	NUM
aji-28	205	126	3.3	3.3	NUM
aji-28	205	127	≥55	≥55	NUM
aji-28	205	128	15	15	NUM
aji-28	205	129	8	8	NUM
aji-28	205	130	4.4	4.4	NUM
aji-28	205	131	total	total	NOUN
aji-28	205	132	180	180	NUM
aji-28	205	133	103	103	NUM
aji-28	205	134	57.2	57.2	NUM
aji-28	205	135	chi	chi	ADJ
aji-28	205	136	-	-	PUNCT
aji-28	205	137	square	square	NOUN
aji-28	205	138	(	(	PUNCT
aji-28	205	139	χ	χ	NOUN
aji-28	205	140	2	2	X
aji-28	205	141	)	)	PUNCT
aji-28	205	142	=	=	SYM
aji-28	205	143	5.604	5.604	NUM
aji-28	205	144	,	,	PUNCT
aji-28	205	145	p=.70	p=.70	ADJ
aji-28	205	146	table	table	NOUN
aji-28	205	147	3	3	NUM
aji-28	205	148	.	.	X
aji-28	205	149	sero	sero	NOUN
aji-28	205	150	-	-	PUNCT
aji-28	205	151	conversion	conversion	NOUN
aji-28	205	152	of	of	ADP
aji-28	205	153	adult	adult	NOUN
aji-28	205	154	subjects	subject	NOUN
aji-28	205	155	to	to	ADP
aji-28	205	156	hbv	hbv	NOUN
aji-28	205	157	vaccine	vaccine	NOUN
aji-28	205	158	in	in	ADP
aji-28	205	159	association	association	NOUN
aji-28	205	160	with	with	ADP
aji-28	205	161	the	the	DET
aji-28	205	162	number	number	NOUN
aji-28	205	163	vaccine	vaccine	NOUN
aji-28	205	164	shots	shot	NOUN
aji-28	205	165	received	receive	VERB
aji-28	205	166	no	no	PRON
aji-28	205	167	of	of	ADP
aji-28	205	168	shots	shot	NOUN
aji-28	205	169	received	receive	VERB
aji-28	205	170	no	no	NOUN
aji-28	205	171	.	.	PROPN
aji-28	205	172	tested	test	VERB
aji-28	205	173	for	for	ADP
aji-28	205	174	hbsab	hbsab	NOUN
aji-28	205	175	no	no	INTJ
aji-28	205	176	positive	positive	ADJ
aji-28	205	177	for	for	ADP
aji-28	205	178	hbsab	hbsab	ADJ
aji-28	205	179	%	%	NOUN
aji-28	205	180	positive	positive	ADJ
aji-28	205	181	one	one	NUM
aji-28	205	182	47	47	NUM
aji-28	205	183	12	12	NUM
aji-28	205	184	6.7	6.7	NUM
aji-28	205	185	two	two	NUM
aji-28	205	186	27	27	NUM
aji-28	205	187	8	8	NUM
aji-28	205	188	4.4	4.4	NUM
aji-28	205	189	three	three	NUM
aji-28	205	190	106	106	NUM
aji-28	205	191	73	73	NUM
aji-28	205	192	40.6	40.6	NUM
aji-28	205	193	total	total	NOUN
aji-28	205	194	180	180	NUM
aji-28	205	195	93	93	NUM
aji-28	205	196	51.7	51.7	NUM
aji-28	205	197	ibrahim	ibrahim	PROPN
aji-28	205	198	et	et	PROPN
aji-28	205	199	al	al	PROPN
aji-28	205	200	.	.	PROPN
aji-28	205	201	;	;	PUNCT
aji-28	206	1	aji	aji	PROPN
aji-28	206	2	,	,	PUNCT
aji-28	206	3	3(1	3(1	NUM
aji-28	206	4	):	):	PUNCT
aji-28	206	5	291	291	NUM
aji-28	206	6	-	-	SYM
aji-28	206	7	297	297	NUM
aji-28	206	8	,	,	PUNCT
aji-28	206	9	2020	2020	NUM
aji-28	206	10	;	;	PUNCT
aji-28	206	11	article	article	NOUN
aji-28	206	12	no.aji.60171	no.aji.60171	VERB
aji-28	206	13	295	295	NUM
aji-28	206	14	(	(	PUNCT
aji-28	206	15	χ	χ	NOUN
aji-28	206	16	2	2	NUM
aji-28	206	17	=	=	SYM
aji-28	206	18	30.665	30.665	NUM
aji-28	206	19	,	,	PUNCT
aji-28	206	20	df	df	PROPN
aji-28	206	21	=	=	SYM
aji-28	206	22	2	2	NUM
aji-28	206	23	,	,	PUNCT
aji-28	206	24	p	p	X
aji-28	206	25	<	<	X
aji-28	206	26	.001	.001	NUM
aji-28	206	27	)	)	PUNCT
aji-28	206	28	table	table	NOUN
aji-28	206	29	4	4	NUM
aji-28	206	30	.	.	PUNCT
aji-28	206	31	protective	protective	ADJ
aji-28	206	32	sero	sero	NOUN
aji-28	206	33	-	-	PUNCT
aji-28	206	34	conversion	conversion	NOUN
aji-28	206	35	in	in	ADP
aji-28	206	36	association	association	NOUN
aji-28	206	37	with	with	ADP
aji-28	206	38	quantity	quantity	NOUN
aji-28	206	39	of	of	ADP
aji-28	206	40	hbsab	hbsab	ADV
aji-28	206	41	produced	produce	VERB
aji-28	206	42	after	after	ADP
aji-28	206	43	vaccination	vaccination	NOUN
aji-28	206	44	quantity	quantity	NOUN
aji-28	206	45	of	of	ADP
aji-28	206	46	hbsab	hbsab	ADJ
aji-28	206	47	no	no	INTJ
aji-28	206	48	.	.	PROPN
aji-28	206	49	tested	test	VERB
aji-28	206	50	for	for	ADP
aji-28	206	51	hbsab	hbsab	NOUN
aji-28	206	52	no	no	INTJ
aji-28	206	53	positive	positive	ADJ
aji-28	206	54	for	for	ADP
aji-28	206	55	hbsab	hbsab	ADJ
aji-28	206	56	%	%	NOUN
aji-28	206	57	positive	positive	ADJ
aji-28	206	58	<	<	NOUN
aji-28	206	59	100	100	NUM
aji-28	206	60	94	94	NUM
aji-28	206	61	29	29	NUM
aji-28	206	62	16.1	16.1	NUM
aji-28	206	63	>	>	SYM
aji-28	206	64	100	100	NUM
aji-28	206	65	86	86	NUM
aji-28	206	66	64	64	NUM
aji-28	206	67	34.6	34.6	NUM
aji-28	206	68	total	total	NOUN
aji-28	206	69	180	180	NUM
aji-28	206	70	93	93	NUM
aji-28	206	71	51.7	51.7	NUM
aji-28	206	72	χ	χ	PRON
aji-28	206	73	2	2	NUM
aji-28	207	1	=	=	SYM
aji-28	207	2	13.98	13.98	NUM
aji-28	207	3	,	,	PUNCT
aji-28	207	4	p	p	NOUN
aji-28	207	5	=	=	SYM
aji-28	207	6	.08	.08	NUM
aji-28	207	7	4	4	NUM
aji-28	207	8	.	.	PUNCT
aji-28	208	1	discussion	discussion	VERB
aji-28	208	2	the	the	DET
aji-28	208	3	rate	rate	NOUN
aji-28	208	4	of	of	ADP
aji-28	208	5	sero	sero	NOUN
aji-28	208	6	-	-	PUNCT
aji-28	208	7	conversion	conversion	NOUN
aji-28	208	8	for	for	ADP
aji-28	208	9	all	all	DET
aji-28	208	10	subjects	subject	NOUN
aji-28	208	11	observed	observe	VERB
aji-28	208	12	by	by	ADP
aji-28	208	13	this	this	DET
aji-28	208	14	study	study	NOUN
aji-28	208	15	was	be	AUX
aji-28	208	16	51.7	51.7	NUM
aji-28	208	17	%	%	NOUN
aji-28	208	18	(	(	PUNCT
aji-28	208	19	93/180	93/180	NUM
aji-28	208	20	)	)	PUNCT
aji-28	208	21	regardless	regardless	ADV
aji-28	208	22	of	of	ADP
aji-28	208	23	the	the	DET
aji-28	208	24	number	number	NOUN
aji-28	208	25	of	of	ADP
aji-28	208	26	vaccine	vaccine	NOUN
aji-28	208	27	shots	shot	NOUN
aji-28	208	28	received	receive	VERB
aji-28	208	29	.	.	PUNCT
aji-28	209	1	none	none	NOUN
aji-28	209	2	of	of	ADP
aji-28	209	3	the	the	DET
aji-28	209	4	subjects	subject	NOUN
aji-28	209	5	tested	test	VERB
aji-28	209	6	was	be	AUX
aji-28	209	7	positive	positive	ADJ
aji-28	209	8	for	for	ADP
aji-28	209	9	hepatitis	hepatitis	PROPN
aji-28	209	10	b	b	PROPN
aji-28	209	11	envelope	envelope	NOUN
aji-28	209	12	antigen	antigen	NOUN
aji-28	209	13	(	(	PUNCT
aji-28	209	14	hbeag	hbeag	NOUN
aji-28	209	15	)	)	PUNCT
aji-28	209	16	or	or	CCONJ
aji-28	209	17	hepatitis	hepatitis	PROPN
aji-28	209	18	b	b	PROPN
aji-28	209	19	envelop	envelop	VERB
aji-28	209	20	antibody	antibody	NOUN
aji-28	209	21	.	.	PUNCT
aji-28	210	1	this	this	PRON
aji-28	210	2	showed	show	VERB
aji-28	210	3	that	that	SCONJ
aji-28	210	4	none	none	NOUN
aji-28	210	5	of	of	ADP
aji-28	210	6	the	the	DET
aji-28	210	7	subjects	subject	NOUN
aji-28	210	8	was	be	AUX
aji-28	210	9	at	at	ADP
aji-28	210	10	the	the	DET
aji-28	210	11	infectivity	infectivity	NOUN
aji-28	210	12	phase	phase	NOUN
aji-28	210	13	or	or	CCONJ
aji-28	210	14	has	have	AUX
aji-28	210	15	recovered	recover	VERB
aji-28	210	16	from	from	ADP
aji-28	210	17	the	the	DET
aji-28	210	18	phase	phase	NOUN
aji-28	210	19	.	.	PUNCT
aji-28	211	1	this	this	PRON
aji-28	211	2	could	could	AUX
aji-28	211	3	be	be	AUX
aji-28	211	4	as	as	ADP
aji-28	211	5	a	a	DET
aji-28	211	6	result	result	NOUN
aji-28	211	7	of	of	ADP
aji-28	211	8	prior	prior	ADJ
aji-28	211	9	resolved	resolve	VERB
aji-28	211	10	hbv	hbv	NOUN
aji-28	211	11	infection	infection	NOUN
aji-28	211	12	before	before	ADP
aji-28	211	13	the	the	DET
aji-28	211	14	onset	onset	NOUN
aji-28	211	15	of	of	ADP
aji-28	211	16	vaccination	vaccination	NOUN
aji-28	211	17	or	or	CCONJ
aji-28	211	18	a	a	DET
aji-28	211	19	resolved	resolve	VERB
aji-28	211	20	hbv	hbv	NOUN
aji-28	211	21	infection	infection	NOUN
aji-28	211	22	mid	mid	NOUN
aji-28	211	23	-	-	NOUN
aji-28	211	24	way	way	NOUN
aji-28	211	25	into	into	ADP
aji-28	211	26	the	the	DET
aji-28	211	27	vaccination	vaccination	NOUN
aji-28	211	28	process	process	NOUN
aji-28	211	29	.	.	PUNCT
aji-28	212	1	in	in	ADP
aji-28	212	2	this	this	DET
aji-28	212	3	study	study	NOUN
aji-28	212	4	,	,	PUNCT
aji-28	212	5	the	the	DET
aji-28	212	6	18.9	18.9	NUM
aji-28	212	7	%	%	NOUN
aji-28	212	8	rate	rate	NOUN
aji-28	212	9	of	of	ADP
aji-28	212	10	sero	sero	NOUN
aji-28	212	11	–	–	PUNCT
aji-28	212	12	conversion	conversion	NOUN
aji-28	212	13	among	among	ADP
aji-28	212	14	male	male	ADJ
aji-28	212	15	subjects	subject	NOUN
aji-28	212	16	lower	low	ADJ
aji-28	212	17	than	than	ADP
aji-28	212	18	32.8	32.8	NUM
aji-28	212	19	%	%	NOUN
aji-28	212	20	sero	sero	NOUN
aji-28	212	21	–	–	PUNCT
aji-28	212	22	conversion	conversion	NOUN
aji-28	212	23	rates	rate	NOUN
aji-28	212	24	recorded	record	VERB
aji-28	212	25	in	in	ADP
aji-28	212	26	female	female	ADJ
aji-28	212	27	subjects	subject	NOUN
aji-28	212	28	.	.	PUNCT
aji-28	213	1	this	this	PRON
aji-28	213	2	was	be	AUX
aji-28	213	3	in	in	ADP
aji-28	213	4	agreement	agreement	NOUN
aji-28	213	5	with	with	ADP
aji-28	213	6	findings	finding	NOUN
aji-28	213	7	of	of	ADP
aji-28	213	8	[	[	X
aji-28	213	9	16	16	NUM
aji-28	213	10	]	]	PUNCT
aji-28	213	11	who	who	PRON
aji-28	213	12	suggested	suggest	VERB
aji-28	213	13	that	that	SCONJ
aji-28	213	14	the	the	DET
aji-28	213	15	high	high	ADJ
aji-28	213	16	level	level	NOUN
aji-28	213	17	of	of	ADP
aji-28	213	18	testosterone	testosterone	NOUN
aji-28	213	19	in	in	ADP
aji-28	213	20	men	man	NOUN
aji-28	213	21	represses	repress	VERB
aji-28	213	22	transcription	transcription	NOUN
aji-28	213	23	factors	factor	NOUN
aji-28	213	24	implicated	implicate	VERB
aji-28	213	25	in	in	ADP
aji-28	213	26	immune	immune	ADJ
aji-28	213	27	activation	activation	NOUN
aji-28	213	28	and	and	CCONJ
aji-28	213	29	with	with	ADP
aji-28	213	30	findings	finding	NOUN
aji-28	213	31	by	by	ADP
aji-28	213	32	[	[	X
aji-28	213	33	17	17	NUM
aji-28	213	34	]	]	PUNCT
aji-28	213	35	that	that	PRON
aji-28	213	36	found	find	VERB
aji-28	213	37	higher	high	ADJ
aji-28	213	38	rates	rate	NOUN
aji-28	213	39	of	of	ADP
aji-28	213	40	seroconversion	seroconversion	NOUN
aji-28	213	41	in	in	ADP
aji-28	213	42	women	woman	NOUN
aji-28	213	43	than	than	ADP
aji-28	213	44	men	man	NOUN
aji-28	213	45	.	.	PUNCT
aji-28	214	1	however	however	ADV
aji-28	214	2	,	,	PUNCT
aji-28	214	3	this	this	DET
aji-28	214	4	study	study	NOUN
aji-28	214	5	agrees	agree	VERB
aji-28	214	6	with	with	ADP
aji-28	214	7	that	that	PRON
aji-28	214	8	by	by	ADP
aji-28	214	9	15	15	NUM
aji-28	214	10	who	who	PRON
aji-28	214	11	found	find	VERB
aji-28	214	12	that	that	SCONJ
aji-28	214	13	men	man	NOUN
aji-28	214	14	were	be	AUX
aji-28	214	15	more	more	ADV
aji-28	214	16	likely	likely	ADJ
aji-28	214	17	to	to	ADP
aji-28	214	18	sero	sero	NOUN
aji-28	214	19	-	-	PUNCT
aji-28	214	20	convert	convert	NOUN
aji-28	214	21	to	to	PART
aji-28	214	22	hbsab	hbsab	VERB
aji-28	214	23	than	than	ADP
aji-28	214	24	women	woman	NOUN
aji-28	214	25	.	.	PUNCT
aji-28	215	1	the	the	DET
aji-28	215	2	highest	high	ADJ
aji-28	215	3	rate	rate	NOUN
aji-28	215	4	of	of	ADP
aji-28	215	5	sero	sero	NOUN
aji-28	215	6	–	–	PUNCT
aji-28	215	7	conversion	conversion	NOUN
aji-28	215	8	of	of	ADP
aji-28	215	9	10.0	10.0	NUM
aji-28	215	10	%	%	NOUN
aji-28	215	11	in	in	ADP
aji-28	215	12	age	age	NOUN
aji-28	215	13	group	group	NOUN
aji-28	215	14	26	26	NUM
aji-28	215	15	–	–	SYM
aji-28	215	16	30	30	NUM
aji-28	215	17	years	year	NOUN
aji-28	215	18	had	have	VERB
aji-28	215	19	no	no	DET
aji-28	215	20	relationship	relationship	NOUN
aji-28	215	21	with	with	ADP
aji-28	215	22	sero	sero	NOUN
aji-28	215	23	–	–	PUNCT
aji-28	215	24	conversion	conversion	NOUN
aji-28	215	25	after	after	ADP
aji-28	215	26	hbv	hbv	NOUN
aji-28	215	27	vaccination	vaccination	NOUN
aji-28	215	28	as	as	SCONJ
aji-28	215	29	was	be	AUX
aji-28	215	30	found	find	VERB
aji-28	215	31	by	by	ADP
aji-28	215	32	[	[	X
aji-28	215	33	18,19	18,19	NUM
aji-28	215	34	]	]	PUNCT
aji-28	215	35	.	.	PUNCT
aji-28	216	1	this	this	DET
aji-28	216	2	finding	finding	NOUN
aji-28	216	3	may	may	AUX
aji-28	216	4	be	be	AUX
aji-28	216	5	as	as	ADP
aji-28	216	6	a	a	DET
aji-28	216	7	result	result	NOUN
aji-28	216	8	of	of	ADP
aji-28	216	9	active	active	ADJ
aji-28	216	10	immunity	immunity	NOUN
aji-28	216	11	as	as	ADP
aji-28	216	12	a	a	DET
aji-28	216	13	result	result	NOUN
aji-28	216	14	of	of	ADP
aji-28	216	15	physical	physical	ADJ
aji-28	216	16	exercise	exercise	NOUN
aji-28	216	17	possessed	possess	VERB
aji-28	216	18	by	by	ADP
aji-28	216	19	the	the	DET
aji-28	216	20	older	old	ADJ
aji-28	216	21	subjects	subject	NOUN
aji-28	216	22	in	in	ADP
aji-28	216	23	this	this	DET
aji-28	216	24	study	study	NOUN
aji-28	216	25	.	.	PUNCT
aji-28	217	1	the	the	DET
aji-28	217	2	number	number	NOUN
aji-28	217	3	of	of	ADP
aji-28	217	4	hbv	hbv	NOUN
aji-28	217	5	vaccine	vaccine	NOUN
aji-28	217	6	shots	shot	NOUN
aji-28	217	7	received	receive	VERB
aji-28	217	8	by	by	ADP
aji-28	217	9	subjects	subject	NOUN
aji-28	217	10	was	be	AUX
aji-28	217	11	analyzed	analyze	VERB
aji-28	217	12	in	in	ADP
aji-28	217	13	this	this	DET
aji-28	217	14	study	study	NOUN
aji-28	217	15	.	.	PUNCT
aji-28	218	1	result	result	NOUN
aji-28	218	2	of	of	ADP
aji-28	218	3	the	the	DET
aji-28	218	4	analysis	analysis	NOUN
aji-28	218	5	showed	show	VERB
aji-28	218	6	that	that	SCONJ
aji-28	218	7	there	there	PRON
aji-28	218	8	is	be	VERB
aji-28	218	9	a	a	DET
aji-28	218	10	relationship	relationship	NOUN
aji-28	218	11	between	between	ADP
aji-28	218	12	the	the	DET
aji-28	218	13	rate	rate	NOUN
aji-28	218	14	of	of	ADP
aji-28	218	15	sero	sero	ADJ
aji-28	218	16	conversion	conversion	NOUN
aji-28	218	17	and	and	CCONJ
aji-28	218	18	the	the	DET
aji-28	218	19	number	number	NOUN
aji-28	218	20	of	of	ADP
aji-28	218	21	vaccine	vaccine	NOUN
aji-28	218	22	shots	shot	NOUN
aji-28	218	23	received	receive	VERB
aji-28	218	24	[	[	X
aji-28	218	25	7	7	NUM
aji-28	218	26	]	]	PUNCT
aji-28	218	27	.	.	PUNCT
aji-28	219	1	this	this	PRON
aji-28	219	2	buttresses	buttress	VERB
aji-28	219	3	the	the	DET
aji-28	219	4	importance	importance	NOUN
aji-28	219	5	of	of	ADP
aji-28	219	6	completing	complete	VERB
aji-28	219	7	the	the	DET
aji-28	219	8	course	course	NOUN
aji-28	219	9	of	of	ADP
aji-28	219	10	vaccination	vaccination	NOUN
aji-28	219	11	as	as	SCONJ
aji-28	219	12	40.6%of	40.6%of	X
aji-28	219	13	the	the	DET
aji-28	219	14	subjects	subject	NOUN
aji-28	219	15	who	who	PRON
aji-28	219	16	completed	complete	VERB
aji-28	219	17	their	their	PRON
aji-28	219	18	vaccination	vaccination	NOUN
aji-28	219	19	sero	sero	NOUN
aji-28	219	20	-	-	PUNCT
aji-28	219	21	converted	convert	VERB
aji-28	219	22	and	and	CCONJ
aji-28	219	23	just	just	ADV
aji-28	219	24	6.5	6.5	NUM
aji-28	219	25	%	%	NOUN
aji-28	219	26	of	of	ADP
aji-28	219	27	those	those	PRON
aji-28	219	28	who	who	PRON
aji-28	219	29	received	receive	VERB
aji-28	219	30	just	just	ADV
aji-28	219	31	one	one	NUM
aji-28	219	32	shot	shot	NOUN
aji-28	219	33	of	of	ADP
aji-28	219	34	the	the	DET
aji-28	219	35	vaccine	vaccine	NOUN
aji-28	219	36	seroconverted	seroconverte	VERB
aji-28	219	37	.	.	PUNCT
aji-28	220	1	in	in	ADP
aji-28	220	2	this	this	DET
aji-28	220	3	study	study	NOUN
aji-28	220	4	,	,	PUNCT
aji-28	220	5	sero	sero	NOUN
aji-28	220	6	-	-	PUNCT
aji-28	220	7	conversion	conversion	NOUN
aji-28	220	8	of	of	ADP
aji-28	220	9	34.6	34.6	NUM
aji-28	220	10	%	%	NOUN
aji-28	220	11	(	(	PUNCT
aji-28	220	12	64/180	64/180	NUM
aji-28	220	13	)	)	PUNCT
aji-28	220	14	with	with	ADP
aji-28	220	15	titre	titre	NOUN
aji-28	220	16	values	value	NOUN
aji-28	220	17	of	of	ADP
aji-28	220	18	≥100iu	≥100iu	NOUN
aji-28	220	19	/	/	SYM
aji-28	220	20	ml	ml	NOUN
aji-28	220	21	of	of	ADP
aji-28	220	22	hbsab	hbsab	NOUN
aji-28	220	23	(	(	PUNCT
aji-28	220	24	level	level	NOUN
aji-28	220	25	deemed	deem	VERB
aji-28	220	26	protective	protective	ADJ
aji-28	220	27	by	by	ADP
aji-28	220	28	the	the	DET
aji-28	220	29	european	european	PROPN
aji-28	220	30	health	health	NOUN
aji-28	220	31	sector	sector	NOUN
aji-28	220	32	)	)	PUNCT
aji-28	220	33	was	be	AUX
aji-28	220	34	lower	low	ADJ
aji-28	220	35	than	than	ADP
aji-28	220	36	the	the	DET
aji-28	220	37	85	85	NUM
aji-28	220	38	-	-	SYM
aji-28	220	39	90	90	NUM
aji-28	220	40	%	%	NOUN
aji-28	220	41	of	of	ADP
aji-28	220	42	full	full	ADJ
aji-28	220	43	response	response	NOUN
aji-28	220	44	of	of	ADP
aji-28	220	45	vaccinated	vaccinated	ADJ
aji-28	220	46	individuals	individual	NOUN
aji-28	220	47	as	as	SCONJ
aji-28	220	48	reported	report	VERB
aji-28	220	49	[	[	X
aji-28	220	50	20	20	NUM
aji-28	220	51	]	]	PUNCT
aji-28	220	52	and	and	CCONJ
aji-28	220	53	the	the	DET
aji-28	220	54	82.9	82.9	NUM
aji-28	220	55	%	%	NOUN
aji-28	220	56	[	[	X
aji-28	220	57	21	21	NUM
aji-28	220	58	]	]	PUNCT
aji-28	220	59	.	.	PUNCT
aji-28	221	1	this	this	DET
aji-28	221	2	low	low	ADJ
aji-28	221	3	sero	sero	NOUN
aji-28	221	4	-	-	PUNCT
aji-28	221	5	conversion	conversion	NOUN
aji-28	221	6	rate	rate	NOUN
aji-28	221	7	reported	report	VERB
aji-28	221	8	by	by	ADP
aji-28	221	9	this	this	DET
aji-28	221	10	study	study	NOUN
aji-28	221	11	may	may	AUX
aji-28	221	12	be	be	AUX
aji-28	221	13	as	as	ADP
aji-28	221	14	a	a	DET
aji-28	221	15	result	result	NOUN
aji-28	221	16	of	of	ADP
aji-28	221	17	the	the	DET
aji-28	221	18	inclusion	inclusion	NOUN
aji-28	221	19	of	of	ADP
aji-28	221	20	subjects	subject	NOUN
aji-28	221	21	who	who	PRON
aji-28	221	22	received	receive	VERB
aji-28	221	23	one	one	NUM
aji-28	221	24	or	or	CCONJ
aji-28	221	25	two	two	NUM
aji-28	221	26	shots	shot	NOUN
aji-28	221	27	of	of	ADP
aji-28	221	28	the	the	DET
aji-28	221	29	vaccine	vaccine	NOUN
aji-28	221	30	.	.	PUNCT
aji-28	222	1	5	5	X
aji-28	222	2	.	.	X
aji-28	222	3	conclusion	conclusion	NOUN
aji-28	222	4	it	it	PRON
aji-28	222	5	was	be	AUX
aji-28	222	6	concluded	conclude	VERB
aji-28	222	7	based	base	VERB
aji-28	222	8	on	on	ADP
aji-28	222	9	the	the	DET
aji-28	222	10	findings	finding	NOUN
aji-28	222	11	that	that	SCONJ
aji-28	222	12	none	none	NOUN
aji-28	222	13	of	of	ADP
aji-28	222	14	the	the	DET
aji-28	222	15	subjects	subject	NOUN
aji-28	222	16	tested	test	VERB
aji-28	222	17	were	be	AUX
aji-28	222	18	positive	positive	ADJ
aji-28	222	19	for	for	ADP
aji-28	222	20	hepatitis	hepatitis	PROPN
aji-28	222	21	b	b	PROPN
aji-28	222	22	envelope	envelope	NOUN
aji-28	222	23	antigen	antigen	NOUN
aji-28	222	24	(	(	PUNCT
aji-28	222	25	hbeag	hbeag	NOUN
aji-28	222	26	)	)	PUNCT
aji-28	222	27	or	or	CCONJ
aji-28	222	28	hepatitis	hepatitis	PROPN
aji-28	222	29	b	b	PROPN
aji-28	222	30	envelop	envelop	VERB
aji-28	222	31	antibody	antibody	NOUN
aji-28	222	32	.	.	PUNCT
aji-28	223	1	this	this	PRON
aji-28	223	2	could	could	AUX
aji-28	223	3	be	be	AUX
aji-28	223	4	as	as	ADP
aji-28	223	5	a	a	DET
aji-28	223	6	result	result	NOUN
aji-28	223	7	of	of	ADP
aji-28	223	8	prior	prior	ADJ
aji-28	223	9	resolved	resolve	VERB
aji-28	223	10	hbv	hbv	NOUN
aji-28	223	11	infection	infection	NOUN
aji-28	223	12	before	before	ADP
aji-28	223	13	the	the	DET
aji-28	223	14	onset	onset	NOUN
aji-28	223	15	of	of	ADP
aji-28	223	16	vaccination	vaccination	NOUN
aji-28	223	17	or	or	CCONJ
aji-28	223	18	a	a	DET
aji-28	223	19	resolved	resolve	VERB
aji-28	223	20	hbv	hbv	NOUN
aji-28	223	21	infection	infection	NOUN
aji-28	223	22	mid	mid	NOUN
aji-28	223	23	-	-	NOUN
aji-28	223	24	way	way	NOUN
aji-28	223	25	into	into	ADP
aji-28	223	26	the	the	DET
aji-28	223	27	vaccination	vaccination	NOUN
aji-28	223	28	process	process	NOUN
aji-28	223	29	.	.	PUNCT
aji-28	224	1	low	low	ADJ
aji-28	224	2	sero	sero	NOUN
aji-28	224	3	-	-	PUNCT
aji-28	224	4	conversion	conversion	NOUN
aji-28	224	5	rate	rate	NOUN
aji-28	224	6	was	be	AUX
aji-28	224	7	observed	observe	VERB
aji-28	224	8	which	which	PRON
aji-28	224	9	could	could	AUX
aji-28	224	10	be	be	AUX
aji-28	224	11	as	as	ADP
aji-28	224	12	a	a	DET
aji-28	224	13	result	result	NOUN
aji-28	224	14	of	of	ADP
aji-28	224	15	the	the	DET
aji-28	224	16	inclusion	inclusion	NOUN
aji-28	224	17	of	of	ADP
aji-28	224	18	subjects	subject	NOUN
aji-28	224	19	who	who	PRON
aji-28	224	20	received	receive	VERB
aji-28	224	21	one	one	NUM
aji-28	224	22	or	or	CCONJ
aji-28	224	23	two	two	NUM
aji-28	224	24	shots	shot	NOUN
aji-28	224	25	of	of	ADP
aji-28	224	26	the	the	DET
aji-28	224	27	vaccine	vaccine	NOUN
aji-28	224	28	.	.	PUNCT
aji-28	225	1	consent	consent	VERB
aji-28	225	2	all	all	DET
aji-28	225	3	the	the	DET
aji-28	225	4	authors	author	NOUN
aji-28	225	5	reviewed	review	VERB
aji-28	225	6	and	and	CCONJ
aji-28	225	7	gave	give	VERB
aji-28	225	8	their	their	PRON
aji-28	225	9	consent	consent	NOUN
aji-28	225	10	for	for	SCONJ
aji-28	225	11	this	this	DET
aji-28	225	12	article	article	NOUN
aji-28	225	13	to	to	PART
aji-28	225	14	be	be	AUX
aji-28	225	15	submitted	submit	VERB
aji-28	225	16	for	for	ADP
aji-28	225	17	publication	publication	NOUN
aji-28	225	18	.	.	PUNCT
aji-28	226	1	ethical	ethical	ADJ
aji-28	226	2	approval	approval	NOUN
aji-28	226	3	before	before	ADP
aji-28	226	4	the	the	DET
aji-28	226	5	commencement	commencement	NOUN
aji-28	226	6	of	of	ADP
aji-28	226	7	the	the	DET
aji-28	226	8	project	project	NOUN
aji-28	226	9	,	,	PUNCT
aji-28	226	10	relevant	relevant	ADJ
aji-28	226	11	ethical	ethical	ADJ
aji-28	226	12	approval	approval	NOUN
aji-28	226	13	was	be	AUX
aji-28	226	14	sought	seek	VERB
aji-28	226	15	for	for	ADP
aji-28	226	16	and	and	CCONJ
aji-28	226	17	obtained	obtain	VERB
aji-28	226	18	from	from	ADP
aji-28	226	19	the	the	DET
aji-28	226	20	kaduna	kaduna	PROPN
aji-28	226	21	state	state	PROPN
aji-28	226	22	ministry	ministry	PROPN
aji-28	226	23	of	of	ADP
aji-28	226	24	health	health	PROPN
aji-28	226	25	.	.	PUNCT
aji-28	227	1	competing	compete	VERB
aji-28	227	2	interests	interest	NOUN
aji-28	227	3	authors	author	NOUN
aji-28	227	4	have	have	AUX
aji-28	227	5	declared	declare	VERB
aji-28	227	6	that	that	SCONJ
aji-28	227	7	no	no	DET
aji-28	227	8	competing	compete	VERB
aji-28	227	9	interests	interest	NOUN
aji-28	227	10	exist	exist	VERB
aji-28	227	11	.	.	PUNCT
aji-28	228	1	ibrahim	ibrahim	PROPN
aji-28	228	2	et	et	PROPN
aji-28	228	3	al	al	PROPN
aji-28	228	4	.	.	PROPN
aji-28	228	5	;	;	PUNCT
aji-28	228	6	aji	aji	PROPN
aji-28	228	7	,	,	PUNCT
aji-28	228	8	3(1	3(1	NUM
aji-28	228	9	):	):	PUNCT
aji-28	228	10	291	291	NUM
aji-28	228	11	-	-	SYM
aji-28	228	12	297	297	NUM
aji-28	228	13	,	,	PUNCT
aji-28	228	14	2020	2020	NUM
aji-28	228	15	;	;	PUNCT
aji-28	228	16	article	article	NOUN
aji-28	228	17	no.aji.60171	no.aji.60171	VERB
aji-28	228	18	296	296	NUM
aji-28	228	19	references	reference	NOUN
aji-28	228	20	1	1	NUM
aji-28	228	21	.	.	PUNCT
aji-28	228	22	centre	centre	NOUN
aji-28	228	23	for	for	ADP
aji-28	228	24	disease	disease	NOUN
aji-28	228	25	control	control	NOUN
aji-28	228	26	and	and	CCONJ
aji-28	228	27	prevention	prevention	NOUN
aji-28	228	28	,	,	PUNCT
aji-28	228	29	viral	viral	ADJ
aji-28	228	30	hepatitis	hepatitis	NOUN
aji-28	228	31	.	.	PUNCT
aji-28	229	1	hepatitis	hepatitis	PROPN
aji-28	229	2	b	b	PROPN
aji-28	229	3	information	information	NOUN
aji-28	229	4	;	;	PUNCT
aji-28	229	5	2015	2015	NUM
aji-28	229	6	.	.	PUNCT
aji-28	230	1	available	available	ADJ
aji-28	230	2	:	:	PUNCT
aji-28	230	3	www.cdc.gov	www.cdc.gov	ADJ
aji-28	230	4	/	/	SYM
aji-28	230	5	hepatitis	hepatitis	NOUN
aji-28	230	6	/	/	SYM
aji-28	230	7	hbv	hbv	NOUN
aji-28	230	8	/	/	SYM
aji-28	230	9	bfaq	bfaq	NOUN
aji-28	230	10	.	.	PUNCT
aji-28	231	1	htm	htm	PROPN
aji-28	231	2	retrieved	retrieve	VERB
aji-28	231	3	august	august	PROPN
aji-28	231	4	14	14	NUM
aji-28	231	5	,	,	PUNCT
aji-28	231	6	2016	2016	NUM
aji-28	231	7	.	.	PUNCT
aji-28	232	1	2	2	NUM
aji-28	232	2	.	.	X
aji-28	232	3	zuckerman	zuckerman	PROPN
aji-28	232	4	aj	aj	PROPN
aji-28	232	5	.	.	PUNCT
aji-28	233	1	hepatitis	hepatitis	NOUN
aji-28	233	2	viruses	virus	NOUN
aji-28	233	3	.	.	PUNCT
aji-28	234	1	in	in	ADP
aji-28	234	2	baron	baron	PROPN
aji-28	234	3	s	s	PROPN
aji-28	234	4	,	,	PUNCT
aji-28	234	5	et	et	PROPN
aji-28	234	6	al	al	PROPN
aji-28	234	7	.	.	PROPN
aji-28	234	8	baron	baron	PROPN
aji-28	234	9	's	's	PART
aji-28	234	10	medical	medical	ADJ
aji-28	234	11	microbiology	microbiology	NOUN
aji-28	234	12	(	(	PUNCT
aji-28	234	13	4th	4th	ADJ
aji-28	234	14	ed	ed	NOUN
aji-28	234	15	.	.	PUNCT
aji-28	234	16	)	)	PUNCT
aji-28	234	17	.	.	PUNCT
aji-28	235	1	university	university	PROPN
aji-28	235	2	of	of	ADP
aji-28	235	3	texas	texas	PROPN
aji-28	235	4	medical	medical	PROPN
aji-28	235	5	branch	branch	NOUN
aji-28	235	6	;	;	PUNCT
aji-28	235	7	1996	1996	NUM
aji-28	235	8	.	.	PUNCT
aji-28	236	1	3	3	X
aji-28	236	2	.	.	X
aji-28	236	3	world	world	PROPN
aji-28	236	4	health	health	PROPN
aji-28	236	5	organization	organization	NOUN
aji-28	236	6	.	.	PUNCT
aji-28	237	1	hepatitis	hepatitis	PROPN
aji-28	237	2	b.	b.	PROPN
aji-28	237	3	world	world	PROPN
aji-28	237	4	health	health	PROPN
aji-28	237	5	organization	organization	PROPN
aji-28	237	6	fact	fact	NOUN
aji-28	237	7	sheet	sheet	NOUN
aji-28	237	8	n	n	CCONJ
aji-28	237	9	°	°	ADP
aji-28	237	10	204	204	NUM
aji-28	237	11	who	who	PRON
aji-28	237	12	website	website	VERB
aji-28	237	13	;	;	PUNCT
aji-28	237	14	2000	2000	NUM
aji-28	237	15	.	.	PUNCT
aji-28	238	1	available	available	ADJ
aji-28	238	2	:	:	PUNCT
aji-28	238	3	http://who.int	http://who.int	NOUN
aji-28	238	4	/	/	SYM
aji-28	238	5	mediacentre	mediacentre	ADJ
aji-28	238	6	/	/	SYM
aji-28	238	7	factsh	factsh	NOUN
aji-28	238	8	eets	eet	NOUN
aji-28	238	9	/	/	SYM
aji-28	238	10	fs204	fs204	PROPN
aji-28	238	11	/	/	SYM
aji-28	238	12	en	en	X
aji-28	238	13	/	/	SYM
aji-28	238	14	index.html	index.html	NOUN
aji-28	238	15	(	(	PUNCT
aji-28	238	16	revised	revise	VERB
aji-28	238	17	august	august	PROPN
aji-28	238	18	2008	2008	NUM
aji-28	238	19	)	)	PUNCT
aji-28	238	20	.	.	PUNCT
aji-28	239	1	4	4	X
aji-28	239	2	.	.	X
aji-28	239	3	locarnini	locarnini	PROPN
aji-28	239	4	s.	s.	PROPN
aji-28	239	5	molecular	molecular	ADJ
aji-28	239	6	virology	virology	NOUN
aji-28	239	7	of	of	ADP
aji-28	239	8	hepatitis	hepatitis	PROPN
aji-28	239	9	b	b	PROPN
aji-28	239	10	virus	virus	NOUN
aji-28	239	11	.	.	PUNCT
aji-28	240	1	seminars	seminar	NOUN
aji-28	240	2	in	in	ADP
aji-28	240	3	liver	liver	NOUN
aji-28	240	4	disease	disease	NOUN
aji-28	240	5	.	.	PUNCT
aji-28	241	1	2004	2004	NUM
aji-28	241	2	;	;	PUNCT
aji-28	241	3	24	24	NUM
aji-28	241	4	3–10	3–10	NOUN
aji-28	241	5	.	.	PUNCT
aji-28	242	1	5	5	X
aji-28	242	2	.	.	X
aji-28	242	3	torbenson	torbenson	PROPN
aji-28	242	4	m	m	PROPN
aji-28	242	5	,	,	PUNCT
aji-28	242	6	thomas	thomas	PROPN
aji-28	242	7	dl	dl	PROPN
aji-28	242	8	.	.	PROPN
aji-28	242	9	occult	occult	PROPN
aji-28	242	10	hepatitis	hepatitis	PROPN
aji-28	242	11	b.	b.	PROPN
aji-28	242	12	lancet	lancet	PROPN
aji-28	242	13	.	.	PUNCT
aji-28	243	1	2002;2:479–486	2002;2:479–486	NUM
aji-28	243	2	.	.	NOUN
aji-28	244	1	6	6	NUM
aji-28	244	2	.	.	X
aji-28	244	3	dény	dény	PROPN
aji-28	244	4	p	p	X
aji-28	244	5	,	,	PUNCT
aji-28	244	6	zoulim	zoulim	PROPN
aji-28	244	7	f.	f.	PROPN
aji-28	244	8	hepatitis	hepatitis	PROPN
aji-28	244	9	virus	virus	PROPN
aji-28	244	10	:	:	PUNCT
aji-28	244	11	from	from	ADP
aji-28	244	12	diagnosis	diagnosis	NOUN
aji-28	244	13	to	to	ADP
aji-28	244	14	treatment	treatment	NOUN
aji-28	244	15	.	.	PUNCT
aji-28	245	1	elsevier	elsevier	NOUN
aji-28	245	2	.	.	PUNCT
aji-28	246	1	2010;58	2010;58	NUM
aji-28	246	2	:	:	PUNCT
aji-28	246	3	245	245	NUM
aji-28	246	4	-	-	SYM
aji-28	246	5	253	253	NUM
aji-28	246	6	.	.	PUNCT
aji-28	247	1	7	7	X
aji-28	247	2	.	.	PUNCT
aji-28	247	3	dorcas	dorcas	PROPN
aji-28	247	4	o	o	PROPN
aji-28	247	5	,	,	PUNCT
aji-28	247	6	yaw	yaw	PROPN
aji-28	247	7	aa	aa	NOUN
aji-28	247	8	,	,	PUNCT
aji-28	247	9	george	george	PROPN
aji-28	247	10	a	a	PROPN
aji-28	247	11	,	,	PUNCT
aji-28	247	12	anna	anna	PROPN
aji-28	247	13	hb	hb	PROPN
aji-28	247	14	,	,	PUNCT
aji-28	247	15	evans	evans	PROPN
aji-28	247	16	o	o	PROPN
aji-28	247	17	,	,	PUNCT
aji-28	247	18	daniel	daniel	PROPN
aji-28	247	19	a.	a.	PROPN
aji-28	247	20	post	post	PROPN
aji-28	247	21	hepatitis	hepatitis	PROPN
aji-28	247	22	b	b	PROPN
aji-28	247	23	vaccination	vaccination	NOUN
aji-28	247	24	sero	sero	NOUN
aji-28	247	25	conversion	conversion	NOUN
aji-28	247	26	among	among	ADP
aji-28	247	27	health	health	NOUN
aji-28	247	28	care	care	NOUN
aji-28	247	29	workers	worker	NOUN
aji-28	247	30	in	in	ADP
aji-28	247	31	the	the	DET
aji-28	247	32	cape	cape	NOUN
aji-28	247	33	coast	coast	PROPN
aji-28	247	34	metropolis	metropolis	PROPN
aji-28	247	35	of	of	ADP
aji-28	247	36	ghana	ghana	PROPN
aji-28	247	37	.	.	PUNCT
aji-28	248	1	available	available	ADJ
aji-28	248	2	:	:	PUNCT
aji-28	248	3	https://www.ncbi.nlm.nih.gov	https://www.ncbi.nlm.nih.gov	ADJ
aji-28	248	4	/	/	SYM
aji-28	248	5	pm	pm	NOUN
aji-28	248	6	c	c	NOUN
aji-28	248	7	/	/	SYM
aji-28	248	8	articles	article	NOUN
aji-28	248	9	/	/	SYM
aji-28	248	10	pmc6599216/	pmc6599216/	PROPN
aji-28	248	11	retrieved	retrieve	VERB
aji-28	248	12	8/8/2020	8/8/2020	NUM
aji-28	248	13	8	8	NUM
aji-28	248	14	.	.	PUNCT
aji-28	249	1	world	world	PROPN
aji-28	249	2	health	health	PROPN
aji-28	249	3	organization	organization	PROPN
aji-28	249	4	.	.	PUNCT
aji-28	250	1	global	global	ADJ
aji-28	250	2	health	health	NOUN
aji-28	250	3	observatory	observatory	NOUN
aji-28	250	4	(	(	PUNCT
aji-28	250	5	gho).hiv	gho).hiv	PROPN
aji-28	250	6	/	/	SYM
aji-28	250	7	aids	aid	NOUN
aji-28	250	8	;	;	PUNCT
aji-28	250	9	2013	2013	NUM
aji-28	250	10	.	.	PUNCT
aji-28	251	1	available	available	ADJ
aji-28	251	2	:	:	PUNCT
aji-28	251	3	http://www.who.int	http://www.who.int	NOUN
aji-28	251	4	/	/	SYM
aji-28	251	5	gho	gho	PROPN
aji-28	251	6	/	/	SYM
aji-28	251	7	hiv	hiv	PROPN
aji-28	251	8	/	/	SYM
aji-28	251	9	en/	en/	NOUN
aji-28	251	10	retrieved	retrieve	VERB
aji-28	251	11	august	august	PROPN
aji-28	251	12	19	19	NUM
aji-28	251	13	,	,	PUNCT
aji-28	251	14	2016	2016	NUM
aji-28	251	15	9	9	NUM
aji-28	251	16	.	.	PUNCT
aji-28	252	1	musa	musa	PROPN
aji-28	252	2	b	b	PROPN
aji-28	252	3	,	,	PUNCT
aji-28	252	4	bussell	bussell	PROPN
aji-28	252	5	s	s	NOUN
aji-28	252	6	,	,	PUNCT
aji-28	252	7	borodo	borodo	PROPN
aji-28	252	8	mm	mm	PROPN
aji-28	252	9	,	,	PUNCT
aji-28	252	10	samaila	samaila	PROPN
aji-28	252	11	aa	aa	PROPN
aji-28	252	12	,	,	PUNCT
aji-28	252	13	femi	femi	PROPN
aji-28	252	14	ol	ol	PROPN
aji-28	252	15	.	.	PUNCT
aji-28	253	1	(	(	PUNCT
aji-28	253	2	)	)	PUNCT
aji-28	253	3	.	.	PUNCT
aji-28	254	1	prevalence	prevalence	NOUN
aji-28	254	2	of	of	ADP
aji-28	254	3	hepatitis	hepatitis	PROPN
aji-28	254	4	b	b	PROPN
aji-28	254	5	virus	virus	NOUN
aji-28	254	6	infection	infection	NOUN
aji-28	254	7	in	in	ADP
aji-28	254	8	nigeria	nigeria	PROPN
aji-28	254	9	,	,	PUNCT
aji-28	254	10	2000	2000	NUM
aji-28	254	11	-	-	SYM
aji-28	254	12	2013	2013	NUM
aji-28	254	13	:	:	PUNCT
aji-28	254	14	a	a	DET
aji-28	254	15	systematic	systematic	ADJ
aji-28	254	16	review	review	NOUN
aji-28	254	17	and	and	CCONJ
aji-28	254	18	meta	meta	ADJ
aji-28	254	19	-	-	PUNCT
aji-28	254	20	analysis	analysis	NOUN
aji-28	254	21	.	.	PUNCT
aji-28	255	1	nigerian	nigerian	ADJ
aji-28	255	2	journal	journal	PROPN
aji-28	255	3	of	of	ADP
aji-28	255	4	clinical	clinical	ADJ
aji-28	255	5	practice	practice	NOUN
aji-28	255	6	.	.	PUNCT
aji-28	256	1	2015;18:163	2015;18:163	NUM
aji-28	256	2	-	-	SYM
aji-28	256	3	72	72	NUM
aji-28	256	4	.	.	PUNCT
aji-28	257	1	10	10	NUM
aji-28	257	2	.	.	PUNCT
aji-28	257	3	bonacini	bonacini	PROPN
aji-28	257	4	m	m	PROPN
aji-28	257	5	,	,	PUNCT
aji-28	257	6	louie	louie	PROPN
aji-28	257	7	s	s	PROPN
aji-28	257	8	,	,	PUNCT
aji-28	257	9	bzowej	bzowej	VERB
aji-28	257	10	n	n	CCONJ
aji-28	257	11	,	,	PUNCT
aji-28	257	12	wohl	wohl	PROPN
aji-28	257	13	ar	ar	PROPN
aji-28	257	14	.	.	PROPN
aji-28	257	15	survival	survival	PROPN
aji-28	257	16	in	in	ADP
aji-28	257	17	patients	patient	NOUN
aji-28	257	18	with	with	ADP
aji-28	257	19	hiv	hiv	PROPN
aji-28	257	20	infection	infection	NOUN
aji-28	257	21	and	and	CCONJ
aji-28	257	22	viral	viral	ADJ
aji-28	257	23	hepatitis	hepatitis	PROPN
aji-28	257	24	b	b	PROPN
aji-28	257	25	or	or	CCONJ
aji-28	257	26	c	c	NOUN
aji-28	257	27	:	:	PUNCT
aji-28	257	28	a	a	DET
aji-28	257	29	cohort	cohort	NOUN
aji-28	257	30	study	study	NOUN
aji-28	257	31	.	.	PUNCT
aji-28	258	1	aids	aids	PROPN
aji-28	258	2	.	.	PUNCT
aji-28	259	1	2004;18:2039	2004;18:2039	NUM
aji-28	259	2	2045	2045	NUM
aji-28	259	3	.	.	PUNCT
aji-28	260	1	11	11	NUM
aji-28	260	2	.	.	PUNCT
aji-28	261	1	joint	joint	ADJ
aji-28	261	2	committee	committee	NOUN
aji-28	261	3	on	on	ADP
aji-28	261	4	vaccination	vaccination	NOUN
aji-28	261	5	and	and	CCONJ
aji-28	261	6	immunizations	immunization	NOUN
aji-28	261	7	.	.	PUNCT
aji-28	262	1	hepatitis	hepatitis	PROPN
aji-28	262	2	b.	b.	PROPN
aji-28	262	3	immunisation	immunisation	NOUN
aji-28	262	4	against	against	ADP
aji-28	262	5	infectious	infectious	ADJ
aji-28	262	6	disease	disease	NOUN
aji-28	262	7	,	,	PUNCT
aji-28	262	8	(	(	PUNCT
aji-28	262	9	rev	rev	X
aji-28	262	10	,	,	PUNCT
aji-28	262	11	3	3	NUM
aji-28	262	12	rd	rd	NOUN
aji-28	262	13	ed	ed	NOUN
aji-28	262	14	.	.	PUNCT
aji-28	262	15	)	)	PUNCT
aji-28	263	1	(	(	PUNCT
aji-28	263	2	"	"	PUNCT
aji-28	263	3	the	the	DET
aji-28	263	4	green	green	PROPN
aji-28	263	5	book	book	NOUN
aji-28	263	6	"	"	PUNCT
aji-28	263	7	)	)	PUNCT
aji-28	263	8	.	.	PUNCT
aji-28	264	1	(	(	PUNCT
aji-28	264	2	3rd	3rd	ADJ
aji-28	264	3	edition	edition	NOUN
aji-28	264	4	)	)	PUNCT
aji-28	264	5	edinburgh	edinburgh	PROPN
aji-28	264	6	:	:	PUNCT
aji-28	264	7	stationery	stationery	NOUN
aji-28	264	8	office	office	NOUN
aji-28	264	9	;	;	PUNCT
aji-28	264	10	2007	2007	NUM
aji-28	264	11	.	.	PUNCT
aji-28	265	1	12	12	NUM
aji-28	265	2	.	.	PUNCT
aji-28	266	1	mikaeloff	mikaeloff	PROPN
aji-28	266	2	y	y	PROPN
aji-28	266	3	,	,	PUNCT
aji-28	266	4	caridade	caridade	VERB
aji-28	266	5	g	g	PROPN
aji-28	266	6	,	,	PUNCT
aji-28	266	7	rossier	rossier	PROPN
aji-28	266	8	m	m	PROPN
aji-28	266	9	,	,	PUNCT
aji-28	266	10	suissa	suissa	PROPN
aji-28	266	11	s	s	PROPN
aji-28	266	12	,	,	PUNCT
aji-28	266	13	tardieu	tardieu	ADJ
aji-28	266	14	m.	m.	NOUN
aji-28	266	15	hepatitis	hepatitis	PROPN
aji-28	266	16	b	b	PROPN
aji-28	266	17	vaccination	vaccination	NOUN
aji-28	266	18	and	and	CCONJ
aji-28	266	19	the	the	DET
aji-28	266	20	risk	risk	NOUN
aji-28	266	21	of	of	ADP
aji-28	266	22	childhood	childhood	NOUN
aji-28	266	23	-	-	PUNCT
aji-28	266	24	onset	onset	VERB
aji-28	266	25	multiple	multiple	ADJ
aji-28	266	26	sclerosis	sclerosis	NOUN
aji-28	266	27	.	.	PUNCT
aji-28	267	1	archives	archive	NOUN
aji-28	267	2	of	of	ADP
aji-28	267	3	pediatrics	pediatric	NOUN
aji-28	267	4	&	&	CCONJ
aji-28	267	5	adolescent	adolescent	ADJ
aji-28	267	6	medicine	medicine	NOUN
aji-28	267	7	.	.	PUNCT
aji-28	268	1	2007;161(12):1176	2007;161(12):1176	NUM
aji-28	268	2	–	–	PUNCT
aji-28	268	3	1182	1182	NUM
aji-28	268	4	.	.	PUNCT
aji-28	269	1	13	13	NUM
aji-28	269	2	.	.	X
aji-28	270	1	kazemi	kazemi	PROPN
aji-28	270	2	h	h	PROPN
aji-28	270	3	,	,	PUNCT
aji-28	270	4	yadegarinia	yadegarinia	PROPN
aji-28	270	5	d	d	PROPN
aji-28	270	6	,	,	PUNCT
aji-28	270	7	rasheki	rasheki	PROPN
aji-28	270	8	h	h	NOUN
aji-28	270	9	,	,	PUNCT
aji-28	270	10	evaluation	evaluation	NOUN
aji-28	270	11	of	of	ADP
aji-28	270	12	hepatitis	hepatitis	NOUN
aji-28	270	13	b	b	PROPN
aji-28	270	14	antibody	antibody	NOUN
aji-28	270	15	and	and	CCONJ
aji-28	270	16	factors	factor	NOUN
aji-28	270	17	related	relate	VERB
aji-28	270	18	to	to	ADP
aji-28	270	19	hepatitis	hepatitis	PROPN
aji-28	270	20	b	b	NOUN
aji-28	270	21	vaccination	vaccination	NOUN
aji-28	270	22	in	in	ADP
aji-28	270	23	tehran	tehran	PROPN
aji-28	270	24	hospital	hospital	NOUN
aji-28	270	25	staffs	staff	NOUN
aji-28	270	26	,	,	PUNCT
aji-28	270	27	journal	journal	NOUN
aji-28	270	28	of	of	ADP
aji-28	270	29	dental	dental	ADJ
aji-28	270	30	school	school	NOUN
aji-28	270	31	-	-	PUNCT
aji-28	270	32	shahid	shahid	PROPN
aji-28	270	33	beshiti	beshiti	PROPN
aji-28	270	34	university	university	PROPN
aji-28	270	35	of	of	ADP
aji-28	270	36	medical	medical	ADJ
aji-28	270	37	science	science	NOUN
aji-28	270	38	.	.	PUNCT
aji-28	271	1	2010;35:114–8	2010;35:114–8	NUM
aji-28	271	2	.	.	PUNCT
aji-28	272	1	14	14	NUM
aji-28	272	2	.	.	PUNCT
aji-28	272	3	roome	roome	PROPN
aji-28	272	4	aj	aj	PROPN
aji-28	272	5	,	,	PUNCT
aji-28	272	6	walsh	walsh	PROPN
aji-28	272	7	sj	sj	PROPN
aji-28	272	8	,	,	PUNCT
aji-28	272	9	carter	carter	PROPN
aji-28	272	10	ml	ml	PROPN
aji-28	272	11	,	,	PUNCT
aji-28	272	12	haddle	haddle	ADJ
aji-28	272	13	ml	ml	NOUN
aji-28	272	14	.	.	PUNCT
aji-28	273	1	hepatitis	hepatitis	PROPN
aji-28	273	2	b	b	PROPN
aji-28	273	3	vaccine	vaccine	NOUN
aji-28	273	4	responsiveness	responsiveness	NOUN
aji-28	273	5	in	in	ADP
aji-28	273	6	connecticut	connecticut	PROPN
aji-28	273	7	public	public	ADJ
aji-28	273	8	safety	safety	NOUN
aji-28	273	9	personnel	personnel	NOUN
aji-28	273	10	.	.	PUNCT
aji-28	274	1	journal	journal	PROPN
aji-28	274	2	of	of	ADP
aji-28	274	3	american	american	PROPN
aji-28	274	4	medical	medical	PROPN
aji-28	274	5	association	association	PROPN
aji-28	274	6	.	.	PUNCT
aji-28	275	1	1993;270	1993;270	NUM
aji-28	275	2	:	:	PUNCT
aji-28	276	1	2931–4	2931–4	NUM
aji-28	276	2	.	.	PUNCT
aji-28	276	3	15	15	NUM
aji-28	276	4	.	.	PUNCT
aji-28	277	1	rosman	rosman	NOUN
aji-28	277	2	as	as	ADP
aji-28	277	3	,	,	PUNCT
aji-28	277	4	basu	basu	PROPN
aji-28	277	5	p	p	PROPN
aji-28	277	6	,	,	PUNCT
aji-28	277	7	galvin	galvin	PROPN
aji-28	277	8	k	k	PROPN
aji-28	277	9	,	,	PUNCT
aji-28	277	10	lieber	lieber	PROPN
aji-28	277	11	cs	cs	PROPN
aji-28	277	12	.	.	PROPN
aji-28	277	13	efficacy	efficacy	NOUN
aji-28	277	14	of	of	ADP
aji-28	277	15	a	a	DET
aji-28	277	16	high	high	ADJ
aji-28	277	17	and	and	CCONJ
aji-28	277	18	accelerated	accelerate	VERB
aji-28	277	19	dose	dose	NOUN
aji-28	277	20	of	of	ADP
aji-28	277	21	hepatitis	hepatitis	PROPN
aji-28	277	22	b	b	PROPN
aji-28	277	23	vaccine	vaccine	NOUN
aji-28	277	24	in	in	ADP
aji-28	277	25	alcoholic	alcoholic	ADJ
aji-28	277	26	patients	patient	NOUN
aji-28	277	27	:	:	PUNCT
aji-28	277	28	a	a	DET
aji-28	277	29	randomized	randomized	ADJ
aji-28	277	30	clinical	clinical	ADJ
aji-28	277	31	trial	trial	NOUN
aji-28	277	32	.	.	PUNCT
aji-28	278	1	american	american	ADJ
aji-28	278	2	journal	journal	PROPN
aji-28	278	3	of	of	ADP
aji-28	278	4	medicine	medicine	NOUN
aji-28	278	5	.	.	PUNCT
aji-28	279	1	1997;103:217	1997;103:217	X
aji-28	279	2	.	.	PROPN
aji-28	279	3	16	16	NUM
aji-28	279	4	.	.	PUNCT
aji-28	279	5	adoga	adoga	PROPN
aji-28	279	6	mp	mp	PROPN
aji-28	279	7	,	,	PUNCT
aji-28	279	8	pennap	pennap	VERB
aji-28	279	9	g	g	NOUN
aji-28	279	10	,	,	PUNCT
aji-28	279	11	akande	akande	PROPN
aji-28	279	12	bo	bo	PROPN
aji-28	279	13	,	,	PUNCT
aji-28	279	14	mairiga	mairiga	ADJ
aji-28	279	15	jp	jp	NOUN
aji-28	279	16	,	,	PUNCT
aji-28	279	17	pechulano	pechulano	PROPN
aji-28	279	18	s	s	PROPN
aji-28	279	19	,	,	PUNCT
aji-28	279	20	agwale	agwale	PROPN
aji-28	279	21	sw	sw	PROPN
aji-28	279	22	.	.	PUNCT
aji-28	279	23	evaluation	evaluation	NOUN
aji-28	279	24	of	of	ADP
aji-28	279	25	a	a	DET
aji-28	279	26	recombinant	recombinant	ADJ
aji-28	279	27	dna	dna	NOUN
aji-28	279	28	hepatitis	hepatitis	PROPN
aji-28	279	29	b	b	PROPN
aji-28	279	30	vaccine	vaccine	NOUN
aji-28	279	31	in	in	ADP
aji-28	279	32	a	a	DET
aji-28	279	33	vaccinated	vaccinated	ADJ
aji-28	279	34	nigerian	nigerian	ADJ
aji-28	279	35	population	population	NOUN
aji-28	279	36	.	.	PUNCT
aji-28	280	1	journal	journal	PROPN
aji-28	280	2	of	of	ADP
aji-28	280	3	public	public	ADJ
aji-28	280	4	health	health	NOUN
aji-28	280	5	.	.	PUNCT
aji-28	281	1	2010	2010	NUM
aji-28	281	2	;	;	PUNCT
aji-28	282	1	14:212–190	14:212–190	NUM
aji-28	282	2	.	.	PUNCT
aji-28	283	1	17	17	NUM
aji-28	283	2	.	.	X
aji-28	284	1	klein	klein	PROPN
aji-28	284	2	sl	sl	PROPN
aji-28	284	3	,	,	PUNCT
aji-28	284	4	marriott	marriott	PROPN
aji-28	284	5	i	i	PROPN
aji-28	284	6	,	,	PUNCT
aji-28	284	7	fish	fish	NOUN
aji-28	284	8	en	en	NOUN
aji-28	284	9	.	.	PUNCT
aji-28	284	10	sex	sex	NOUN
aji-28	284	11	-	-	PUNCT
aji-28	284	12	based	base	VERB
aji-28	284	13	differences	difference	NOUN
aji-28	284	14	in	in	ADP
aji-28	284	15	immune	immune	ADJ
aji-28	284	16	function	function	NOUN
aji-28	284	17	and	and	CCONJ
aji-28	284	18	responses	response	NOUN
aji-28	284	19	to	to	ADP
aji-28	284	20	vaccination	vaccination	NOUN
aji-28	284	21	.	.	PUNCT
aji-28	285	1	transactions	transaction	NOUN
aji-28	285	2	of	of	ADP
aji-28	285	3	the	the	DET
aji-28	285	4	royal	royal	ADJ
aji-28	285	5	society	society	NOUN
aji-28	285	6	of	of	ADP
aji-28	285	7	tropical	tropical	ADJ
aji-28	285	8	medicine	medicine	NOUN
aji-28	285	9	and	and	CCONJ
aji-28	285	10	hygiene	hygiene	NOUN
aji-28	285	11	.	.	PUNCT
aji-28	286	1	2015;109:9–15	2015;109:9–15	X
aji-28	286	2	.	.	PROPN
aji-28	286	3	18	18	NUM
aji-28	286	4	.	.	PUNCT
aji-28	287	1	el	el	PROPN
aji-28	287	2	-	-	NOUN
aji-28	287	3	sawy	sawy	PROPN
aji-28	287	4	ih	ih	PROPN
aji-28	287	5	,	,	PUNCT
aji-28	287	6	mohamed	mohame	VERB
aji-28	287	7	on	on	ADP
aji-28	287	8	.	.	PUNCT
aji-28	288	1	long	long	ADJ
aji-28	288	2	term	term	NOUN
aji-28	288	3	immunogenicity	immunogenicity	NOUN
aji-28	288	4	and	and	CCONJ
aji-28	288	5	efficacy	efficacy	NOUN
aji-28	288	6	of	of	ADP
aji-28	288	7	recombinant	recombinant	ADJ
aji-28	288	8	hepatitis	hepatitis	PROPN
aji-28	288	9	b	b	PROPN
aji-28	288	10	vaccine	vaccine	NOUN
aji-28	288	11	in	in	ADP
aji-28	288	12	egyptian	egyptian	ADJ
aji-28	288	13	children	child	NOUN
aji-28	288	14	.	.	PUNCT
aji-28	289	1	east	east	PROPN
aji-28	289	2	mediterr	mediterr	PROPN
aji-28	289	3	health	health	NOUN
aji-28	289	4	.	.	PUNCT
aji-28	290	1	2000;5:922	2000;5:922	PROPN
aji-28	290	2	-	-	SYM
aji-28	290	3	932	932	NUM
aji-28	290	4	.	.	PUNCT
aji-28	290	5	19	19	NUM
aji-28	290	6	.	.	PUNCT
aji-28	290	7	kermode	kermode	PROPN
aji-28	290	8	m.	m.	PROPN
aji-28	290	9	unsafe	unsafe	ADJ
aji-28	290	10	injections	injection	NOUN
aji-28	290	11	in	in	ADP
aji-28	290	12	lowincome	lowincome	NOUN
aji-28	290	13	country	country	NOUN
aji-28	290	14	health	health	NOUN
aji-28	290	15	settings	setting	NOUN
aji-28	290	16	:	:	PUNCT
aji-28	290	17	need	need	VERB
aji-28	290	18	for	for	ADP
aji-28	290	19	injection	injection	NOUN
aji-28	290	20	safety	safety	NOUN
aji-28	290	21	promotion	promotion	NOUN
aji-28	290	22	to	to	PART
aji-28	290	23	prevent	prevent	VERB
aji-28	290	24	the	the	DET
aji-28	290	25	spread	spread	NOUN
aji-28	290	26	of	of	ADP
aji-28	290	27	blood	blood	NOUN
aji-28	290	28	-	-	PUNCT
aji-28	290	29	borne	bear	VERB
aji-28	290	30	viruses	virus	NOUN
aji-28	290	31	.	.	PUNCT
aji-28	291	1	health	health	NOUN
aji-28	291	2	promotion	promotion	PROPN
aji-28	291	3	international	international	PROPN
aji-28	291	4	.	.	PUNCT
aji-28	292	1	2004;19:95	2004;19:95	NUM
aji-28	292	2	-	-	SYM
aji-28	292	3	103	103	NUM
aji-28	292	4	.	.	PUNCT
aji-28	292	5	20	20	NUM
aji-28	292	6	.	.	PUNCT
aji-28	293	1	lozano	lozano	PROPN
aji-28	293	2	r	r	PROPN
aji-28	293	3	,	,	PUNCT
aji-28	293	4	naghavi	naghavi	ADJ
aji-28	293	5	m	m	PROPN
aji-28	293	6	,	,	PUNCT
aji-28	293	7	foreman	foreman	NOUN
aji-28	293	8	k	k	PROPN
aji-28	293	9	,	,	PUNCT
aji-28	293	10	lim	lim	PROPN
aji-28	293	11	s	s	PROPN
aji-28	293	12	,	,	PUNCT
aji-28	293	13	shibuya	shibuya	PROPN
aji-28	293	14	k	k	PROPN
aji-28	293	15	,	,	PUNCT
aji-28	293	16	aboyans	aboyan	VERB
aji-28	293	17	v	v	ADP
aji-28	293	18	,	,	PUNCT
aji-28	293	19	abraham	abraham	PROPN
aji-28	293	20	j	j	PROPN
aji-28	293	21	,	,	PUNCT
aji-28	293	22	aggarwal	aggarwal	PROPN
aji-28	293	23	r.	r.	PROPN
aji-28	293	24	global	global	PROPN
aji-28	293	25	and	and	CCONJ
aji-28	293	26	regional	regional	ADJ
aji-28	293	27	mortality	mortality	NOUN
aji-28	293	28	http://www.cdc.gov/hepatitis/hbv/bfaq.htm	http://www.cdc.gov/hepatitis/hbv/bfaq.htm	PUNCT
aji-28	294	1	http://www.cdc.gov/hepatitis/hbv/bfaq.htm	http://www.cdc.gov/hepatitis/hbv/bfaq.htm	X
aji-28	294	2	https://www.ncbi.nlm.nih.gov/pubmed/?term=obiri-yeboah%20d%5bauthor%5d&cauthor=true&cauthor_uid=31251790	https://www.ncbi.nlm.nih.gov/pubmed/?term=obiri-yeboah%20d%5bauthor%5d&cauthor=true&cauthor_uid=31251790	VERB
aji-28	294	3	https://www.ncbi.nlm.nih.gov/pubmed/?term=awuku%20ya%5bauthor%5d&cauthor=true&cauthor_uid=31251790	https://www.ncbi.nlm.nih.gov/pubmed/?term=awuku%20ya%5bauthor%5d&cauthor=true&cauthor_uid=31251790	ADP
aji-28	294	4	https://www.ncbi.nlm.nih.gov/pubmed/?term=adjei%20g%5bauthor%5d&cauthor=true&cauthor_uid=31251790	https://www.ncbi.nlm.nih.gov/pubmed/?term=adjei%20g%5bauthor%5d&cauthor=true&cauthor_uid=31251790	NOUN
aji-28	294	5	https://www.ncbi.nlm.nih.gov/pubmed/?term=benjamin%20ah%5bauthor%5d&cauthor=true&cauthor_uid=31251790	https://www.ncbi.nlm.nih.gov/pubmed/?term=benjamin%20ah%5bauthor%5d&cauthor=true&cauthor_uid=31251790	NOUN
aji-28	294	6	https://www.ncbi.nlm.nih.gov/pubmed/?term=benjamin%20ah%5bauthor%5d&cauthor=true&cauthor_uid=31251790	https://www.ncbi.nlm.nih.gov/pubmed/?term=benjamin%20ah%5bauthor%5d&cauthor=true&cauthor_uid=31251790	NOUN
aji-28	294	7	https://www.ncbi.nlm.nih.gov/pubmed/?term=obboh%20e%5bauthor%5d&cauthor=true&cauthor_uid=31251790	https://www.ncbi.nlm.nih.gov/pubmed/?term=obboh%20e%5bauthor%5d&cauthor=true&cauthor_uid=31251790	NUM
aji-28	294	8	https://www.ncbi.nlm.nih.gov/pubmed/?term=amoako-sakyi%20d%5bauthor%5d&cauthor=true&cauthor_uid=31251790	https://www.ncbi.nlm.nih.gov/pubmed/?term=amoako-sakyi%20d%5bauthor%5d&cauthor=true&cauthor_uid=31251790	NOUN
aji-28	294	9	http://www.dh.gov.uk/en/publichealth/healthprotection/immunisation/greenbook/dh_4097254?idcservice=get_file&did=152019&rendition=web	http://www.dh.gov.uk/en/publichealth/healthprotection/immunisation/greenbook/dh_4097254?idcservice=get_file&did=152019&rendition=web	NOUN
aji-28	294	10	ibrahim	ibrahim	PROPN
aji-28	294	11	et	et	PROPN
aji-28	294	12	al	al	PROPN
aji-28	294	13	.	.	PROPN
aji-28	294	14	;	;	PUNCT
aji-28	295	1	aji	aji	PROPN
aji-28	295	2	,	,	PUNCT
aji-28	295	3	3(1	3(1	NUM
aji-28	295	4	):	):	PUNCT
aji-28	295	5	291	291	NUM
aji-28	295	6	-	-	SYM
aji-28	295	7	297	297	NUM
aji-28	295	8	,	,	PUNCT
aji-28	295	9	2020	2020	NUM
aji-28	295	10	;	;	PUNCT
aji-28	295	11	article	article	NOUN
aji-28	295	12	no.aji.60171	no.aji.60171	AUX
aji-28	295	13	297	297	NUM
aji-28	295	14	from	from	ADP
aji-28	295	15	235	235	NUM
aji-28	295	16	causes	cause	NOUN
aji-28	295	17	of	of	ADP
aji-28	295	18	death	death	NOUN
aji-28	295	19	for	for	ADP
aji-28	295	20	20	20	NUM
aji-28	295	21	age	age	NOUN
aji-28	295	22	groups	group	NOUN
aji-28	295	23	in	in	ADP
aji-28	295	24	1990	1990	NUM
aji-28	295	25	and	and	CCONJ
aji-28	295	26	2010	2010	NUM
aji-28	295	27	:	:	PUNCT
aji-28	295	28	a	a	DET
aji-28	295	29	systematic	systematic	ADJ
aji-28	295	30	analysis	analysis	NOUN
aji-28	295	31	for	for	ADP
aji-28	295	32	the	the	DET
aji-28	295	33	global	global	ADJ
aji-28	295	34	burden	burden	NOUN
aji-28	295	35	of	of	ADP
aji-28	295	36	disease	disease	NOUN
aji-28	295	37	study	study	NOUN
aji-28	295	38	2010	2010	NUM
aji-28	295	39	.	.	PUNCT
aji-28	296	1	lancet	lancet	NOUN
aji-28	296	2	.	.	PUNCT
aji-28	297	1	2012;380:2095	2012;380:2095	NUM
aji-28	297	2	2128	2128	NUM
aji-28	297	3	.	.	PUNCT
aji-28	298	1	21	21	NUM
aji-28	298	2	.	.	X
aji-28	298	3	pasricha	pasricha	PROPN
aji-28	298	4	n	n	CCONJ
aji-28	298	5	,	,	PUNCT
aji-28	298	6	datta	datta	PROPN
aji-28	298	7	u	u	PROPN
aji-28	298	8	,	,	PUNCT
aji-28	298	9	chawla	chawla	PROPN
aji-28	298	10	y	y	PROPN
aji-28	298	11	,	,	PUNCT
aji-28	298	12	singh	singh	PROPN
aji-28	298	13	s	s	PROPN
aji-28	298	14	,	,	PUNCT
aji-28	298	15	arora	arora	PROPN
aji-28	298	16	s	s	PROPN
aji-28	298	17	,	,	PUNCT
aji-28	298	18	sud	sud	X
aji-28	298	19	a	a	X
aji-28	298	20	,	,	PUNCT
aji-28	298	21	minz	minz	ADJ
aji-28	298	22	r	r	NOUN
aji-28	298	23	,	,	PUNCT
aji-28	298	24	saikia	saikia	PROPN
aji-28	298	25	b	b	PROPN
aji-28	298	26	,	,	PUNCT
aji-28	298	27	singh	singh	PROPN
aji-28	298	28	h	h	NOUN
aji-28	298	29	,	,	PUNCT
aji-28	298	30	james	james	PROPN
aji-28	298	31	i	i	PROPN
aji-28	298	32	,	,	PUNCT
aji-28	298	33	sehgal	sehgal	PROPN
aji-28	298	34	s.	s.	PROPN
aji-28	298	35	immune	immune	PROPN
aji-28	298	36	responses	response	NOUN
aji-28	298	37	in	in	ADP
aji-28	298	38	patients	patient	NOUN
aji-28	298	39	with	with	ADP
aji-28	298	40	hiv	hiv	PROPN
aji-28	298	41	infection	infection	NOUN
aji-28	298	42	after	after	ADP
aji-28	298	43	vaccination	vaccination	NOUN
aji-28	298	44	with	with	ADP
aji-28	298	45	recombinant	recombinant	ADJ
aji-28	298	46	hepatitis	hepatitis	PROPN
aji-28	298	47	b	b	PROPN
aji-28	298	48	virus	virus	NOUN
aji-28	298	49	vaccine	vaccine	NOUN
aji-28	298	50	.	.	PUNCT
aji-28	299	1	bmc	bmc	VERB
aji-28	299	2	infectious	infectious	ADJ
aji-28	299	3	diseases	disease	NOUN
aji-28	299	4	.	.	PUNCT
aji-28	300	1	2006;6:65	2006;6:65	ADJ
aji-28	300	2	.	.	PUNCT
aji-28	301	1	_	_	PUNCT
aji-28	302	1	_	_	PUNCT
aji-28	303	1	_	_	PUNCT
aji-28	304	1	_	_	PUNCT
aji-28	305	1	_	_	PUNCT
aji-28	306	1	_	_	PUNCT
aji-28	307	1	_	_	PUNCT
aji-28	308	1	_	_	PUNCT
aji-28	309	1	_	_	PUNCT
aji-28	310	1	_	_	PUNCT
aji-28	311	1	_	_	PUNCT
aji-28	312	1	_	_	PUNCT
aji-28	313	1	_	_	PUNCT
aji-28	314	1	_	_	PUNCT
aji-28	315	1	_	_	PUNCT
aji-28	316	1	_	_	PUNCT
aji-28	317	1	_	_	PUNCT
aji-28	318	1	_	_	PUNCT
aji-28	319	1	_	_	PUNCT
aji-28	320	1	_	_	PUNCT
aji-28	321	1	_	_	PUNCT
aji-28	322	1	_	_	PUNCT
aji-28	323	1	_	_	PUNCT
aji-28	324	1	_	_	PUNCT
aji-28	325	1	_	_	PUNCT
aji-28	326	1	_	_	PUNCT
aji-28	327	1	_	_	PUNCT
aji-28	328	1	_	_	PUNCT
aji-28	329	1	_	_	PUNCT
aji-28	330	1	_	_	PUNCT
aji-28	331	1	_	_	PUNCT
aji-28	332	1	_	_	PUNCT
aji-28	333	1	_	_	PUNCT
aji-28	334	1	_	_	PUNCT
aji-28	335	1	_	_	PUNCT
aji-28	336	1	_	_	PUNCT
aji-28	337	1	_	_	PUNCT
aji-28	338	1	_	_	PUNCT
aji-28	339	1	_	_	PUNCT
aji-28	340	1	_	_	PUNCT
aji-28	341	1	_	_	PUNCT
aji-28	342	1	_	_	PUNCT
aji-28	343	1	_	_	PUNCT
aji-28	344	1	_	_	PUNCT
aji-28	345	1	_	_	PUNCT
aji-28	346	1	_	_	PUNCT
aji-28	347	1	_	_	PUNCT
aji-28	348	1	_	_	PUNCT
aji-28	349	1	_	_	PUNCT
aji-28	350	1	_	_	PUNCT
aji-28	351	1	_	_	PUNCT
aji-28	352	1	_	_	PUNCT
aji-28	353	1	_	_	PUNCT
aji-28	354	1	_	_	PUNCT
aji-28	355	1	_	_	PUNCT
aji-28	356	1	_	_	PUNCT
aji-28	357	1	_	_	PUNCT
aji-28	358	1	_	_	PUNCT
aji-28	359	1	_	_	PUNCT
aji-28	360	1	_	_	PUNCT
aji-28	361	1	_	_	PUNCT
aji-28	362	1	_	_	PUNCT
aji-28	363	1	_	_	PUNCT
aji-28	364	1	_	_	PUNCT
aji-28	365	1	_	_	PUNCT
aji-28	366	1	_	_	PUNCT
aji-28	367	1	_	_	PUNCT
aji-28	368	1	_	_	PUNCT
aji-28	369	1	_	_	PUNCT
aji-28	370	1	_	_	PUNCT
aji-28	371	1	_	_	PUNCT
aji-28	372	1	_	_	PUNCT
aji-28	373	1	_	_	PUNCT
aji-28	374	1	_	_	PUNCT
aji-28	375	1	_	_	PUNCT
aji-28	376	1	_	_	PUNCT
aji-28	377	1	_	_	PUNCT
aji-28	378	1	_	_	PUNCT
aji-28	379	1	_	_	PUNCT
aji-28	380	1	_	_	PUNCT
aji-28	381	1	_	_	PUNCT
aji-28	382	1	©	©	NOUN
aji-28	382	2	2020	2020	NUM
aji-28	382	3	ibrahim	ibrahim	PROPN
aji-28	382	4	et	et	PROPN
aji-28	382	5	al	al	PROPN
aji-28	382	6	.	.	PROPN
aji-28	382	7	;	;	PUNCT
aji-28	382	8	this	this	PRON
aji-28	382	9	is	be	AUX
aji-28	382	10	an	an	DET
aji-28	382	11	open	open	ADJ
aji-28	382	12	access	access	NOUN
aji-28	382	13	article	article	NOUN
aji-28	382	14	distributed	distribute	VERB
aji-28	382	15	under	under	ADP
aji-28	382	16	the	the	DET
aji-28	382	17	terms	term	NOUN
aji-28	382	18	of	of	ADP
aji-28	382	19	the	the	DET
aji-28	382	20	creative	creative	ADJ
aji-28	382	21	commons	common	NOUN
aji-28	382	22	attribution	attribution	NOUN
aji-28	382	23	license	license	NOUN
aji-28	382	24	(	(	PUNCT
aji-28	382	25	http://creativecommons.org/licenses/by/4.0	http://creativecommons.org/licenses/by/4.0	NOUN
aji-28	382	26	)	)	PUNCT
aji-28	382	27	,	,	PUNCT
aji-28	382	28	which	which	PRON
aji-28	382	29	permits	permit	VERB
aji-28	382	30	unrestricted	unrestricted	ADJ
aji-28	382	31	use	use	NOUN
aji-28	382	32	,	,	PUNCT
aji-28	382	33	distribution	distribution	NOUN
aji-28	382	34	,	,	PUNCT
aji-28	382	35	and	and	CCONJ
aji-28	382	36	reproduction	reproduction	NOUN
aji-28	382	37	in	in	ADP
aji-28	382	38	any	any	DET
aji-28	382	39	medium	medium	NOUN
aji-28	382	40	,	,	PUNCT
aji-28	382	41	provided	provide	VERB
aji-28	382	42	the	the	DET
aji-28	382	43	original	original	ADJ
aji-28	382	44	work	work	NOUN
aji-28	382	45	is	be	AUX
aji-28	382	46	properly	properly	ADV
aji-28	382	47	cited	cite	VERB
aji-28	382	48	.	.	PUNCT
aji-28	383	1	peer	peer	NOUN
aji-28	383	2	-	-	PUNCT
aji-28	383	3	review	review	NOUN
aji-28	383	4	history	history	NOUN
aji-28	383	5	:	:	PUNCT
aji-28	383	6	the	the	DET
aji-28	383	7	peer	peer	NOUN
aji-28	383	8	review	review	NOUN
aji-28	383	9	history	history	NOUN
aji-28	383	10	for	for	ADP
aji-28	383	11	this	this	DET
aji-28	383	12	paper	paper	NOUN
aji-28	383	13	can	can	AUX
aji-28	383	14	be	be	AUX
aji-28	383	15	accessed	access	VERB
aji-28	383	16	here	here	ADV
aji-28	383	17	:	:	PUNCT
aji-28	383	18	http://www.sdiarticle4.com/review-history/60171	http://www.sdiarticle4.com/review-history/60171	PROPN
aji-28	383	19	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc1525180	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc1525180	PROPN
aji-28	383	20	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc1525180	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc1525180	PROPN
aji-28	383	21	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc1525180	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc1525180	PROPN
aji-28	383	22	http://creativecommons.org/licenses/by/4.0	http://creativecommons.org/licenses/by/4.0	PROPN